














































now	 been	 attributed	 to	 cause	 BBS.	 However,	 ~32%	 of	 patients	 are	 affected	 by	 a	 recurrent	
missense	variant,	namely	BBS1	p.M390R,	which	contributes	greatly	to	the	overall	burden	of	BBS.	
Despite	 recent	 advances	 in	 understanding	 the	 syndrome’s	 genetic	 aetiology,	 much	 of	 the	
pathobiology	of	BBS1	p.M390R	remains	elusive.	This	thesis	aimed	to	use	an	innovative	multi-omic	





BBS1	 genotype,	 even	 if	 patients	 have	 the	 same	 underlying	 pathogenic	mutation.	 It	 has	 been	
suggested	that	differences	in	disease	expressivity	are	linked	to	secondary	mutations	that	modify	
the	 manifestation	 of	 the	 primary	 locus.	 Here,	 the	 objective	 was	 to	 identify	 putative	 genetic	
modifying	alleles	from	whole	genome	sequencing	data	generated	from	BBS1	p.M390R	patients	




variants	 contributed	 to	 the	 overall	 mutational	 burden	 of	 BBS.	 Mutational	 burden	 analysis	







resistance	 in	obesity	 (Log2FC:	2.56,	p	=	0.015).	 Similarly,	plasma	proteomic	analysis	 identified	
putative	 biomarkers	 that	 are	 linked	 to	 secondary	metabolic	 features	 of	 BBS,	 such	 as	 LEP	 and	





BBS	 patient-derived	 fibroblasts	 were	 profiled	 by	 transcriptomic	 and	 proteomic	 technologies,	
which	aimed	to	identify	dysregulated	pathways	at	a	cellular	level	compared	to	control	cultures.	
Pathway	 analysis	 uncovered	 discordant	 expression	 of	 centrosomal	 genes	 between	 BBS	 and	
control	cells,	as	well	as	a	significant	enrichment	of	genes	associated	with	adipogenesis,	which	
may	provide	 insight	 into	obesity	manifested	by	BBS	patients.	Analysis	of	protein	profiling	data	

















































































































































































































































































































































































































































































































































































































































































































































































































9	outer	microtubule	doublets.	Dynein	 arms	and	 radial	 spokes	protrude	 from	 regular	 intervals	
along	the	microtubule	doublets.	Hydrolysis	of	ATP	allows	the	dynein	arms	to	drive	a	sliding	motion	
between	the	microtubule	doublet	relative	to	the	central	pair,	causing	the	motile	cilia	to	beat	(King	







cilium	per	 cell,	 they	 use	 the	 retention	 between	 dynein	 arms	 and	microtubules	 to	 generate	 a	
rotatory	motion	(Szymanska	and	Johnson	2012).	This	mediates	a	leftward	flow	of	morphogens	





cellular	 signalling	 hub	 in	 postmitotic	 cells.	 They	 display	 a	 9	 +	 0	 arrangement,	 but	 lack	 dynein	
machinery	 rendering	 them	stationary.	 They	are	present	 in	 the	 single	 form	on	all	 non-dividing	
eukaryotic	cells,	with	the	exception	of	bone	marrow	derived	cells	(Praetorius	and	Spring	2005).	










The	 centrosome	 is	 an	 organelle	 comprised	 of	 barrel-shaped	mother	 and	 daughter	 centrioles,	
which	are	surrounded	by	an	unstructured	protein	mass,	called	pericentriolar	material	(PCM).	The	
centrioles	act	as	a	microtubule	organising	centre	(MTOC)	throughout	the	cell	cycle.	During	the	







that	 attach	 the	 axoneme	 to	 the	 ciliary	 membrane	 and	 act	 as	 a	 membrane	 diffusion	 barrier,	
referred	 to	 as	 the	 ciliary	 gate	 (Reiter	 et	 al.	 2012;	 Garcia-Gonzalo	 et	 al.	 2011).	 This	
compartmentalisation	allows	regulated	entry	and	exit	between	the	cytoplasm	and	the	cilium,	and	
instigates	 an	 exclusive	 signalling	 environment.	 The	 axoneme	extends	 from	 the	basal	 body	 via	








namely	kinesin	and	dynein,	 to	deliver	proteins	up	and	down	 the	organelle	 in	a	process	called	
intraflagellar	transport	(IFT).	 IFT	 is	a	highly	conserved	bi-directional	movement	of	cargo	within	
the	ciliary	membrane.	As	the	cilium	is	devoid	of	protein	synthesis	apparatus,	robust	anterograde	












Proteins	 KIF3A,	 KIF3B,	 and	 KAP3	 form	 the	 kinesin-2	motor	 complex,	which	 specifically	 travels	
towards	the	plus-ended	ciliary	tip.	The	kinesin	motor	associates	with	IFT	machinery,	made	up	of	
IFT-A	and	IFT-B	complexes	(table	1.1),	and	an	inactive	cytoplasmic	dynein	motor	(Pedersen	et	al.	
2008).	 Anterograde	 protein	 cargo	 is	 thought	 to	 specifically	 bind	 to	 a	 loading	 site	 on	 IFT-B	






















as	 RAB,	 ARF,	 and	 ARL	 families,	 the	 BBSome	 is	 recruited	 to	 the	 ciliary	 membrane.	 Here,	 the	




IFT-A	 IFT-B	 Kinesin-2	 Dynein-2	 BBSome	
IFT43	 IFT20	 KIF3A	 DYNC2H1	 BBS1	
IFT122A	 IFT27	 KIF3B	 DYNC2LI1	 BBS2	
IFT122B	 IFT46	 KAP3	 	 BBS4	
IFT139	 IFT52	 	 	 BBS5	
IFT140	 IFT57	 	 	 BBS7	
IFT144	 IFT72	 	 	 TTC8/BBS8	
	 IFT74	 	 	 BBS9	
	 IFT80	 	 	 BBIP10/BBS18	
	 IFT81	 	 	 	
	 IFT88	 	 	 	









signalling	antennae.	 Through	 IFT,	 as	many	as	1000	proteins	are	 trafficked	 to	 the	apical	 ciliary	
membrane	 (Liu	 et	 al.	 2007;	Gherman	 et	 al.	 2006)	 and	 translation	 of	 stimuli	 is	 facilitated	 into	






The	 cilium	 creates	 an	 efficient	 appendage	 for	 G-protein	 coupled	 receptor	 (GPCR)	 localisation	




GTP	 dissociates	 a	 subunit	 from	 the	 G-protein	 trimer,	 which	 prompts	 downstream	 signalling	
through	cAMP	transduction	(Schou	et	al.	2015).	
	
There	 are	 approximately	 800	 different	 GPCRs	 in	 humans,	 each	 activated	 by	 a	 vast	 range	 of	






et	al.	2014).	 It	 is	 thought	that	the	BBSome	directly	 interacts	with	components	of	some	GPCRs	
(Berbari	et	al.	2008;	Domire	et	al.	2011;	Jin	et	al.	2010).	Knockout	studies	in	mice	have	displayed	
aberrant	 localisation	 and	 signalling	 of	 the	 somatostatin	 receptor,	 Sstr3	 (Händel	 et	 al.	 1999),	
melanin-concentrating	 hormone	 receptor,	 Mchr1	 (Berbari	 et	 al.	 2008)	 and	 a	 neuropeptide	














connection	 between	 the	 primary	 cilium	 and	HH	 signalling	was	 acquired	 through	mutagenesis	
screens	in	mouse	embryos.	Disruption	of	two	components	of	the	IFT-B	complex,	Ift172	and	Ift88,	
resulted	in	a	marked	decrease	in	downstream	Shh	mediators,	as	well	as	aberrant	Shh-dependent	
development	 of	 the	 neural	 tube	 (Huangfu	 et	 al.	 2003).	 Further	 investigations	 disrupted	 both	
retrograde	and	anterograde	complexes	and	determined	 that	although	Shh	 ligand	binding	was	
unaffected,	downstream	mediators	were	aberrantly	expressed,	including	the	HH	receptor	Ptch1	





Despite	 their	 rigidity	 enforced	 by	 a	 strong	microtubule	 backbone,	 the	 primary	 cilium	 detects	
























Release	 of	 G	 proteins	 activates	 downstream	 pathways,	 for	 example,	 through	 the	 cAMP-dependent	
signalling.	
B)	 Hedgehog	 signalling:	 (1)	 Localisation	 of	 PTCH1	 at	 the	 plasma	 membrane	 sequestered	 SMO	 in	 the	
cytoplasm,	allowing	the	repressed	GLI	form	(GLI-R)	to	be	processed.	(2)	HH	binds	to	PTCH1,	quenching	its	









Similar	 to	 HH	 signalling,	 Wnt	 signalling	 is	 an	 evolutionarily	 conserved	 pathway	 and	 in	 some	
circumstances,	may	be	mediated	or	organised	by	the	primary	cilium.	Canonical	Wnt	signalling,	




the	 absence	 of	 β-catenin.	 Although	 the	 primary	 cilium	 is	 not	 essential	 for	 Wnt	 signalling	















Due	 to	 its	 pivotal	 role	 in	 development,	 cellular	 function	 and	 orchestration	 of	 key	 signalling	





syndrome	 (Coon	 et	 al.	 2012),	 3M	 syndrome,	 and	 Hermansky-Pudlak	 syndrome	 may	 be	 new	
ciliopathies	 (Boldt	 et	 al.	 2016).	 The	 well-defined	 ciliopathies	 are	 Alström	 syndrome	 (ALMS),	
Bardet-Biedl	 Syndrome	 (BBS),	 Ellis	 van	 Creveld	 syndrome	 (EVC),	 Jeune’s	 asphyxiating	 thoracic	
dystrophy	 (JATD),	 Joubert	 Syndrome	 (JBTS),	 Oro-Facial-Digital	 syndrome	 (OFD),	 McKusick-
Kaufman	Syndrome	(MKKS),	Meckel-Gruber	Syndrome	(MKS),	Nephronophthisis	(NPHP),	Leber	
Congenital	 Amaurosis	 (LCA),	 Senior-Løken	 Syndrome	 (SLS),	 and	 Usher	 syndrome	 (USH).	










Bardet-Biedl	 Syndrome	 (BBS)	 is	 an	 autosomal	 recessive	 disorder,	 characterised	 by	 retinal	
dystrophy,	obesity,	renal	dysfunction,	polydactyly,	genital	abnormalities,	and	learning	difficulties.	
Currently	21	genes	are	thought	to	cause	the	syndrome,	making	 it	one	of	 the	most	genetically	
heterogeneous	 ciliopathies.	As	 the	 subject	of	 this	 thesis,	BBS	 is	 comprehensively	described	 in	
section	1.8.	
	
McKusick-Kaufman	 Syndrome	 (MKKS)	 is	 an	 autosomal	 recessive	 disorder	 resulting	 in	 genital	
abnormalities,	 particularly	 hydrometrocolpos	 in	 females,	 polydactyly,	 and	 rarely,	 features	 of	
cardiac	defects.	As	with	ALMS,	there	can	often	be	diagnostic	overlap	with	BBS	in	early	childhood.	
The	key	distinguishing	feature	is	lack	of	retinal	dystrophy,	learning	problems,	renal	dysfunction,	













ALMS	 BBS	 MKKS	 MKS	 JBTS	 SLS	 USH	 EVC	 JATD	 OFD	 NPHP	 LCA	
Retinal	
dystrophy	
1	 1	 	 	 2	 1	 1	 	 2	 2	 	 1	
Renal	
dysfunction	
2	 1	 	 1	 2	 1	 	 	 2	 2	 1	 	
Polydactyly	 	 1	 1	 1	 2	 	 	 1	 1	 1	 	 	
Learning	
difficulties	
	 1	 	 	 1	 	 	 	 	 2	 	 	
Structural	CNS	
abnormalities	
	 	 	 1	 1	 	 	 	 2	 2	 	 	
Severe	skeletal	
abnormalities	
	 	 	 	 	 	 	 1	 1	 1	 	 	
Genital	
abnormalities	
2	 1	 1	 2	 	 	 	 	 	 	 	 	
Obesity	 1	 1	 	 	 	 	 	 	 	 	 	 	








malformations.	 Additional	 neurological	 symptoms	 include	 ataxia,	 hypoplasia	 of	 the	 cerebellar	
vermis,	 developmental	 delay,	 irregular	 breathing,	 and	 oculomotor	 apraxia	 (Tobin	 and	 Beales	
2009).	Secondary	features	have	some	overlap	with	other	ciliopathies,	such	as	retinal	dystrophy,	
renal	dysfunction	and	polydactyly	(table	1.2).	JBTS	is	highly	heterogeneous	with	at	least	17	genes	




Meckel-Gruber	 Syndrome	 (MKS)	 is	 a	 severe	 autosomal	 recessive	 disorder,	 which	 commonly	
results	in	embryonic	or	neonatal	lethality	due	to	cilia	dysfunction	during	development.	Cases	are	
characterised	 by	 severe	 renal	 failure,	 encephalocoele	 or	 other	 structural	 CNS	malformations,	




bowing	 of	 the	 limbs,	 and	 underdeveloped	 genitalia	 (Salonen	 1984).	 With	 both	 syndromes	
displaying	severe	CNS	defects,	there	is	clinical	and	genetic	overlap	between	MKS	and	JBTS;	8	out	







Usher	 syndrome	 (USH)	 is	 an	 autosomal	 recessive	 condition	 resulting	 in	 early	 onset	 retinal	
dystrophy	and	congenital	 sensorineural	hearing	defects.	 In	Usher	 syndrome	 type	 I,	 caused	by	
mutations	 in	MYO7A,	USH1C,	CDH23,	PCDH15,	 or	USH1G,	 unintelligible	 speech	 and	 constant	
vestibular	 dysfunction	 are	 also	 observed.	 It	 is	 a	 relatively	 recent	 addition	 to	 the	 ciliopathy	





Jeune’s	 asphyxiating	 thoracic	 dystrophy	 (JATD)	 is	 a	 severe	 autosomal	 recessive	 ciliopathy,	
characterised	 by	 short	 ribs,	 narrowed	 thoracic	 cage,	 and	 shortening	 of	 bones.	 Polydactyly	 is	
commonly	an	additional	feature,	as	well	as	secondary	phenotypes	including	renal,	liver,	or	retinal	
dysfunction.	Mortality	commonly	occurs	within	the	first	 few	years	of	 life,	owing	to	respiratory	





Ellis	 van	 Creveld	 syndrome	 (EVC)	 is	 an	 autosomal	 recessive	 skeletal	 dysplasia,	 displaying	
phenotypic	 overlap	 with	 JATD.	 Features	 include	 short	 limbs,	 polydactyly,	 short	 ribs,	 and	
developmental	delay,	while	ectodermal	and	cardiac	defects	distinguish	the	syndrome	from	JATD	








Oro-Facial-Digital	 syndrome	 (OFD)	 is	 an	 X-linked	 dominant	 disorder,	 characterised	 by	
developmental	malformations	of	the	oral	cavity,	face,	and	digits.	Commonly	these	features	are	
accompanied	 by	 polycystic	 kidneys,	 structural	 CNS	 abnormalities,	 and	 learning	 difficulties	





retinal	 degeneration,	 pigmentation	 (retinitis	 pigmentosa	 (RP)),	 and	 nystagmus.	 Degeneration	
usually	presents	within	the	first	year	of	life,	but	patients	have	been	reported	to	have	profound	

















exhibits	 a	 range	 of	 severities	 and	 phenotypes.	 Ciliopathies	 span	 from	 severe	 multisystem	








retinal	 defects,	 digit	 malformations,	 and	 renal	 or	 hepatic	 dysfunction	 can	 present	 in	 all	
ciliopathies	(Gerdes	et	al.	2009).	
Genes	 BBS	 JATD	 JBTS	 MKKS	 MKS	 NPHP	 LCA	 SLS	 OFD	 Location	
BBS1	 	 	 	 	 	 	 	 	 	
BB	
BBS2	 	 	 	 	 	 	 	 	 	
ARL6	(BBS3)	 	 	 	 	 	 	 	 	 	
BBS4	 	 	 	 	 	 	 	 	 	
BBS5	 	 	 	 	 	 	 	 	 	
MKKS	(BBS6)	 	 	 	 	 	 	 	 	 	
BBS7	 	 	 	 	 	 	 	 	 	
TTC8	(BBS8)	 	 	 	 	 	 	 	 	 	
BBS9	 	 	 	 	 	 	 	 	 	
BBS10	 	 	 	 	 	 	 	 	 	
BBS12	 	 	 	 	 	 	 	 	 	
MKS1	(BBS13)	 	 	 	 	 	 	 	 	 	
LZTFL1	(BBS17)	 	 	 	 	 	 	 	 	 	
BBIP10	(BBS18)	 	 	 	 	 	 	 	 	 	
C8ORF37	(BBS21)	 	 	 	 	 	 	 	 	 	
LCA5	 	 	 	 	 	 	 	 	 	
RP2	 	 	 	 	 	 	 	 	 	
OFD1	 	 	 	 	 	 	 	 	 	
TMEM216	 	 	 	 	 	 	 	 	 	
ARL13B	 	 	 	 	 	 	 	 	 	
AHI1	 	 	 	 	 	 	 	 	 	
TRIM32	(BBS11)	 	 	 	 	 	 	 	 	 	 IF	
CEP290	(BBS14)	 	 	 	 	 	 	 	 	 	
TZ	
WDPCP	(BBS15)	 	 	 	 	 	 	 	 	 	
SDCCAG8	(BBS16)	 	 	 	 	 	 	 	 	 	
IQCB1	 	 	 	 	 	 	 	 	 	
RPGRIP1L	 	 	 	 	 	 	 	 	 	
RPGR	 	 	 	 	 	 	 	 	 	
RP1	 	 	 	 	 	 	 	 	 	
RPGRIP1	 	 	 	 	 	 	 	 	 	
NPHP4	 	 	 	 	 	 	 	 	 	
NEK8	 	 	 	 	 	 	 	 	 	
NPHP3	 	 	 	 	 	 	 	 	 	
B9D2	 	 	 	 	 	 	 	 	 	
NPHP1	 	 	 	 	 	 	 	 	 	
CC2D2A	 	 	 	 	 	 	 	 	 	
B9D1	 	 	 	 	 	 	 	 	 	
TCTN2	 	 	 	 	 	 	 	 	 	
TCTN3	 	 	 	 	 	 	 	 	 	




TMEM67	 	 	 	 	 	 	 	 	 	
Ax	INPP5E	 	 	 	 	 	 	 	 	 	
INVS	 	 	 	 	 	 	 	 	 	
IFT27	(BBS19)	 	 	 	 	 	 	 	 	 	
IFT	
IFT172	(BBS20)	 	 	 	 	 	 	 	 	 	
TTC21B	 	  	 	 	  	 	 	
WDR19	 	 	 	 	 	 	 	 	 	
WDR35	 	  	 	 	 	 	 	 	
DYNC2H1	 	  	 	 	 	 	 	 	
IFT80	 	 	 	 	 	 	 	 	 	
KIF7	 	 	 	 	 	 	 	 	 	
CT	







The	 spectrum	 also	 exists	 at	 a	 molecular	 level.	 ALMS	 and	 MKKS	 are	 molecularly	 defined	 by	
mutations	 in	 a	 single	 gene,	ALMS1	 and	MKKS	 (BBS6),	 respectively.	On	 the	other	hand,	BBS	 is	
caused	by	pathogenic	variants	across	at	least	21	genes	(table	1.3).	A	single	gene	is	also	capable	





results	 from	 a	 deep	 intronic	 variant	 in	CEP290,	 which	 produces	 a	 cryptic	 exon	 as	 a	 result	 of	
aberrant	 splicing.	 This	 variant	 is	 thought	 to	 specifically	 affect	 the	 retina	 due	 to	 a	 residual	
unaffected	CEP290	transcript	rescuing	other	cell	types	(Drivas	et	al.	2015;	Parfitt	et	al.	2016).	
	
Although	 primary	 cilia	 are	 ubiquitously	 expressed,	 each	 ciliopathy	 affects	 a	 combination	 of	























novel	 ciliary	 genes,	 complexes,	 functions	 and	 interactions	 (J.	 Kim	 et	 al.	 2010;	 Lai	 et	 al.	 2011;	
Wheway	et	 al.	 2015).	A	 study	by	Kim	and	 colleagues	 (2010)	 validated	49	putative	 genes	 that	










Large-scale	 studies	 have	 implemented	whole	 genome	 screens	 or	 systems	biology	 approaches	
using	proteomics	techniques.	Wheway	et	al.	(2015)	instigated	a	whole	genome	screen	using	small	




















create	 a	 gold	 standard	 set	 of	 cilia	 interacting	 genes.	 The	 SYSCILIA	 gold	 standard	 v1	 (SCGSv1)	









The	 studies	 described	 above	have	 augmented	our	 knowledge	of	 how	 the	 components	 of	 the	








table	 1.3)	 (Coppieters	 et	 al.	 2010).	 A	 theory	 for	 its	 multifaceted	 involvement	 is	 that	 CEP290	












Solid	 lines	 refer	 to	 direct	 interactions	 between	 CEP290	 and	 associating	 proteins.	 Dotted	 lines	 refer	 to	
interactions	not	directly	involving	CEP290.	Proteins	are	also	grouped	by	disorders	they	are	implicated	in,	
where	BBS	=	Bardet-Biedl	 Syndrome,	 LCA	=	 Leber	 congenital	 amaurosis,	 SLS	=	Senior-Løken	Syndrome,	




Bardet-Biedl	 Syndrome	 (BBS)	 is	 a	 pleiotropic	 genetic	 disorder	 that	 exhibits	 both	 genetic	 and	



















‘incomplete’	 (4/5	 cardinal	 features,	 exclusive	 of	 renal	 dysfunction),	 ‘abortive’	 (2/5	 cardinal	
features)	or	undetermined	condition.	Therefore,	a	set	of	diagnostic	criteria	was	set	out	where	
4/5	traits	were	required	for	a	BBS	diagnosis	(Schachat	and	Maumenee	1982).	Moreover,	there	
were	often	difficulties	 in	diagnosing	patients	at	a	young	age	due	 to	 the	progressive	nature	of	
some	 symptoms.	 The	 age	 of	 onset	 for	 retinal	 dysfunction	 and	 renal	 abnormalities	 can	 vary	
considerably.	 Polydactyly	 is	 the	 only	 dysmorphic	 cardinal	 feature	 seen	 at	 birth,	 which	 is	 not	
uncommon	 or	 distinct	 to	 BBS.	 To	 facilitate	 an	 earlier	 diagnosis	 age,	 a	 number	 of	 secondary	
features	 have	 been	 incorporated	 into	 the	 diagnostic	 criteria.	 These	 features	 include	
developmental	 delay,	 speech	 disorders,	 behavioural	 traits,	 diabetes	 mellitus,	 strabismus/	
cataracts,	 orodental	 abnormalities,	 cardiovascular	 anomalies,	 syndactyly/brachydactyly,	 and	
fibrocystic	 liver	 disease	 (Waters	 and	Beales	 2011;	 Beales	 et	 al.	 1999).	 Therefore,	 Beales	 et	 al	














































Loci	 Frequency	 Known	Function	 Localisation	 References	
BBS1	 		 11q13.2	 23%	 Part	of	the	BBSome	complex	 BB	 (Leppert	et	al.	1994;	Mykytyn	et	al.	2002;	Jin	et	al.	2010)	
BBS2	 		 16q21	 8%	 Part	of	the	BBSome	complex	 BB	 (Kwitek-Black	et	al.	1993;	Jin	et	al.	2010)	




BBS4	 		 15q24.1	 2%	 Part	of	the	BBSome	complex	 BB	 (Carmi	et	al.	1995;	Jin	et	al.	2010)	
BBS5	 		 2q31.1	 <1%	 Part	of	the	BBSome	complex	 BB	 (Young,	Penney,	et	al.	1999;	Jin	et	al.	2010)	
BBS6	 MKKS	 20p12.2	 6%	 Forms	chaperonin	complex	for	BBSome	assembly	 BB	 (Katsanis	et	al.	2000;	Seo	et	al.	2010)	
BBS7	 		 4q27	 2%	 Part	of	the	BBSome	complex	 BB	 (Badano	et	al.	2003;	Jin	et	al.	2010)	
BBS8	 TTC8	 14q31.3	 1%	 Part	of	the	BBSome	complex	 BB	 (Ansley	et	al.	2003;	Jin	et	al.	2010)	
BBS9	 		 7p14.3	 6%	 Part	of	the	BBSome	complex	 BB	 (Nishimura	et	al.	2005;	Jin	et	al.	2010)	
BBS10	 		 12q21.2	 20%	 Forms	chaperonin	complex	for	BBSome	assembly	 BB	 (Stoetzel	et	al.	2006;	Seo	et	al.	2010)	
BBS11	 TRIM32	 9q33.1	 <1%	 E3	ubiquitin	ligase	 IF	 (Chiang	et	al.	2006)	
BBS12	 		 4q27	 5%	 Forms	chaperonin	complex	for	BBSome	assembly	 BB	 (Stoetzel	et	al.	2007;	Seo	et	al.	2010)	
BBS13	 MKS1	 17q22	 5%	 Regulates	ciliogenesis	and	centriole	migration	 BB	 (Tammachote	et	al.	2009;	Leitch	et	al.	2008)	





BBS15	 WDPCP	 2p15	 <1%	 Necessary	for	ciliogenesis	 Axoneme	 (S.	K.	Kim	et	al.	2010)	
BBS16	 SDCCAG8	 1q43	 <1%	 Unknown	
BB,	
centriole,	TZ	 (Metzler	2011;	Insolera	et	al.	2014)	
BBS17	 LZTFL1		 3p21.31	 <1%	 Regulates	BBSome	trafficking	and	HH	signalling	 BB,	cytosol	 (Marion,	Stutzmann,	et	al.	2012;	Seo	et	al.	2011)	
BBS18	 BBIP10	 10q25.2	 <1%	 Part	of	the	BBSome	complex.	Necessary	for	
microtubule	maintenance	
BB	 (Scheidecker	et	al.	2014;	Jin	et	al.	2010)	
BBS19	 IFT27	 22q12.3	 <1%	 Anterograde	IFT	 IFT-B	 (Aldahmesh	et	al.	2014;	Lucker	et	al.	2005)	
BBS20	 IFT172	 2p23.3	 <1%	 Anterograde	IFT	 IFT-B	 (Schaefer	et	al.	2016;	Lucker	et	al.	2005)	






Despite	 successful	 cloning	 of	BBS1-BBS5	 at	 the	 turn	 of	 the	 century,	 the	 aetiology	 of	 BBS	 still	




repeats	 (TPRs).	 TPRs	 are	 structural	motifs	 that	 are	 common	 in	 complexing	 proteins,	 and	 are	
















BBS1,	 BBS2,	 BBS5,	 BBS7,	 BBS8	 and	 BBS9	 (Nachury	 et	 al.	 2007).	 Subsequently,	 an	 additional	
protein,	BBIP10	(BBS18)	was	found	to	associate,	forming	the	fully	assembled	BBSome	complex	
(Loktev	et	al.	2008).	It	has	been	established	that	this	core	complex	is	required	for	recruitment	of	
cargo	 to	 the	 ciliary	membrane,	 through	 interaction	 with	 RABIN8	 and	 RAB8,	 and	may	 have	 a	









interaction	with	 phototransduction	 protein,	 Arrestin1	 (Smith,	 2013).	 External	 to	 the	 BBSome,	














with	 homology	 to	 the	 TCP-1	 Ring	 Complex	 (TRiC)	 chaperonin	 family	 (also	 called	 chaperone	









By	 contrast,	 the	 ciliary	 function	 of	 the	 outstanding	 BBS	 proteins	 remains	 elusive.	BBS11	 was	
identified	as	the	RING	finger	E3	ubiquitin	 ligase,	TRIM32	 (Chiang	et	al.	2006).	BBS11	has	been	
shown	 to	 be	 associated	 with	 SHH	 repressor,	 GLIS2,	 (Ramachandran	 et	 al.	 2014)	 and	 other	
ubiquitin	 ligases	 were	 shown	 to	 localise	 to	 primary	 cilia,	 indicating	 a	 potential	 role	 in	 ciliary	
function	(Boldt	et	al.	2016).	However,	little	else	is	known	about	its	BBS-specific	role.	Mutation	of	




























Retinal	dystrophy	 is	 the	most	prevalent	BBS	 feature,	predicted	 to	be	present	 in	93%	of	 cases	
(Forsythe	 and	 Beales	 2013).	 Patients	 are	 thought	 to	 have	 functional	 eyesight	 at	 birth,	 but	
progressive	visual	decline	begins	early,	typically	leading	to	registered	blindness	before	adulthood	
(Beales	 et	 al.	 1999).	 Retinal	 dystrophy	 in	 BBS	 is	 usually	 diagnosed	 as	 rod-cone	 dystrophy,	
describing	 the	 deterioration	 of	 rod	 photoreceptor	 first,	 followed	 by	 decline	 of	 cone	










Obesity	 is	 a	 result	 of	 energy	 imbalance	 caused	 by	 a	 greater	 calorific	 intake	 than	 metabolic	
expenditure.	 Childhood	 truncal	 obesity	 has	 been	 reported	 to	 affect	 72-92%	 of	 BBS	 patients	
(Forsythe	and	Beales	2013),	though	other	surveys	suggest	72%	are	overweight	and	52%	are	obese	
(Beales	 et	 al.	 1999).	 Obesity	 is	 diagnosed	 by	 the	World	 Health	 Organisation	 (WHO)	 through	
assessment	 of	 body	mass	 index	 (BMI),	 calculated	 by	 dividing	 body	weight	 by	 height	 squared	
(kg/m2).	The	BMI	healthy	weight	range	is	18.5-24.9	kg/m2,	whereas	25-29.9	kg/m2	is	classed	as	
overweight	and	>30	kg/m2	is	obese.	Although	there	is	a	high	prevalence	of	obesity	in	BBS	patients,	














in	 hypothalamic	 neurons.	BBS4	 null	mice	 exhibited	 hyperphagia,	 consuming	 between	 20-30%	




greater	 intraabdominal	 fat	mass,	 insulin	 resistance	and	blood	pressure	compared	to	100	BMI,	
age,	and	sex	matched	controls	(Feuillan	et	al.	2011).	This	finding	contributed	to	the	hypothesis	












et	 al.	 2009;	 Marion,	 Mockel,	 et	 al.	 2012).	 Marion	 and	 colleagues	 (2009)	 determined	 that	
preadipocytes	 were	 transiently	 ciliated	 during	 adipogenesis,	 and	 ablation	 of	BBS10	 or	BBS12	












may	 manifest	 as	 fully	 developed	 digits	 or	 subtly	 as	 a	 nubbin.	 Polydactyly	 is	 not	 distinct	 to	
ciliopathies	 and	 can	 present	 in	 1	 in	 1400	 live	 Caucasian	 births,	 with	 up	 to	 10	 times	 greater	
prevalence	 in	 African	 populations	 (Aucourt	 et	 al.	 2012).	 As	 a	 result,	 extra	 digits	 are	 routinely	
surgically	removed	after	birth,	which	highlights	the	importance	of	maintaining	a	detailed	clinical	
















et	 al.	 2011).	 Reports	 of	 delayed	 puberty	 and	 irregular	menstruation	 cycles	 are	 also	 common	
(Beales	et	al.	1999).	
	
The	 mechanism	 causing	 genital	 abnormalities	 in	 BBS	 remains	 uncertain.	 The	 developmental	
defects	may	be	a	product	of	aberrant	SHH	signalling,	as	 Shh	 is	 required	 for	development	of	a	
genital	tubercle	and	androgen-independent	morphogenesis	in	mice	(Lin	et	al.	2009).	Anomalies	
may	 be	 attributed	 to	 improper	 hormone	 signalling.	 The	 GCPR	 KISSR1	 is	 known	 to	 localise	 to	
primary	 cilia	 of	 gonadotropin-releasing	 hormone	 (GnRH)	 neurons	 in	 the	 hypothalamus	
(Hilgendorf	et	al.	2016).	Signalling	by	Kisspeptin,	the	ligand	for	KISSR1,	is	involved	in	puberty	onset	








Renal	 anomalies	 are	 estimated	 to	 affect	 53%	 of	 patients	 (Forsythe	 and	 Beales	 2013).	 Renal	





and	 morbidity,	 but	 transplantation	 for	 treatment	 of	 chronic	 kidney	 failure	 can	 successfully	
prolong	life	(Sharifian	et	al.	2007).	
	
The	 renal	 malformations	 observed	 in	 ciliopathies	 are	 thought	 to	 result	 from	 dysfunctional	
mechanosensation	in	the	renal	tubule,	caused	by	aberrant	trafficking	of	PC1	and	PC2.	As	seen	in	

























and	 cognitive	 dysfunction	 and	 the	 receptor	 SSTR3	 is	 known	 to	 localise	 to	 primary	 cilia	 of	





As	 over	 20	 genes	 have	 been	 described	 to	 manifest	 BBS,	 it	 is	 perhaps	 not	 surprising	 that	
phenotypic	heterogeneity	is	a	common	hallmark	described	across	cohorts	(Deveault	et	al.	2011).	










mutations	 affecting	 the	 chaperone-like	 BBS	 genes,	 BBS6,	 BBS10,	 and	 BBS12	 had	 renal	
abnormalities,	compared	to	15%	of	patients	with	variants	affecting	BBSome	genes	(Imhoff	et	al.	






with	a	genetic	diagnosis	 in	 the	same	gene,	or	with	the	same	disease-causing	variant	 (Estrada-
Cuzcano	et	al.	2012;	Beales	et	al.	2003).	This	phenomenon	extends	to	BBS	cases	within	the	same	
family,	 where	 there	 have	 been	 reports	 of	 siblings	 with	 clinical	 features	 of	 other	 ciliopathies	
alongside	 patients	 with	 BBS	 (Zaki	 et	 al.	 2011).	 It	 is	 widely	 considered	 that	 this	 phenotypic	
expressivity	is	accounted	for	by	secondary	genetic	modifiers.	These	may	present	at	a	second	site	













patients	 with	 mutations	 in	 BBS10	 (Feuillan	 et	 al.	 2011;	 Forsythe	 et	 al.	 2015).	 This	 may	 be	
attributed	 to	 the	 characteristics	of	 the	 variant	more	 than	 the	 loci.	 The	most	 common	variant	
found	in	BBS10	 is	a	frameshift	mutation	resulting	in	a	truncated	protein	(p.C91Lfs*5),	whereas	
p.M390R	 is	 a	 single	 base	 change	 that	 retains	 the	 full-length	 protein.	 Evaluations	 of	 retinal	
dystrophy	have	also	highlighted	the	vast	spectrum	of	severity	that	is	typical	in	patients	with	BBS1	







Genetic	 variants	 that	 drastically	 alter	 protein	 structure,	 such	 as	 nonsense,	 frameshift	 or	
mutations	affecting	the	splice	junctions,	induce	a	loss	of	function	response,	as	resulting	proteins	
will	 either	 be	 dysfunctional	 or	 degraded	 by	 NMD.	 In	 the	 case	 of	 missense	 variants,	 such	 as	
p.M390R,	the	full-length	protein	is	translated	and	the	aetiology	is	not	so	clear.	BBS1	p.M390R	is	
known	 to	 be	 a	 hypomorphic	 variant	 (Zaghloul	 et	 al.	 2010),	 where	 protein	 exhibits	 reduced	
performance	as	function	is	partially	lost.	The	disease	mechanism	of	the	variant	has	seldom	been	
studied.	 Mourão	 and	 colleagues	 (2010)	 published	 the	 first	 study	 investigating	 the	 protein	
structure	of	BBS1	and	its	interaction	with	ARL6,	essential	for	recruitment	of	the	BBSome	to	the	


















(UCL	GOS	 ICH)	 launched	an	 innovative	project;	High	definition,	 In-depth	phenotyping	at	Great	
Ormond	Street	Hospital,	coined	the	HIGH-5	project.	Funded	by	the	National	Institute	of	Health	
Research	(NIHR)	Great	Ormond	Street	Hospital	 (GOSH)	Biomedical	Research	Centre	(BRC),	 the	
project	 aimed	 to	 use	 next	 generation	 sequencing	 (NGS)	 technologies	 to	 elucidate	 the	
pathobiology	of	rare	diseases,	identify	genetic	modifiers	or	clinical	biomarkers,	and	personalise	
patient	 care.	 Patients	 were	 recruited	 into	 cohorts	 from	 7	 different	 genetic	 or	 multifactorial	
diseases.	15	patients	with	the	common	BBS1	c.1169T>G/	p.M390R	mutation	were	enrolled	into	











of	 a	 population.	 The	 definition	 of	 a	 rare	 disease	 is	 not	 universal.	 According	 to	 Rare	 Diseases	
Europe	 (EURORDIS),	 a	 disease	 is	 classified	 as	 rare	 if	 it	 affects	 less	 than	 1	 in	 2000	 individuals,	
whereas	 in	the	United	States	a	rare	disease	affects	 fewer	than	200,000	Americans	at	any	one	
time	(Azie	and	Vincent	2012).	It	is	predicted	that	in	Europe,	at	least	30	million	individuals	may	be	








(Boycott	 et	 al.	 2017).	 This	 is	 partly	 due	 to	 overlapping	 features	 of	 rare	 diseases	 in	 common	
disorders,	where	mechanistic	insight	into	disrupted	pathways	may	reveal	therapeutic	targets	for	
more	 common	diseases.	 Ciliopathies	 are	 a	prime	example,	where	 collectively	 phenotypes	 are	
rare.	However,	 features	 such	as	obesity,	 retinal	dystrophy,	hearing	 loss,	 and	 renal	 failure,	 are	
individually	more	common	in	the	general	population.	In	addition,	rare	disease	research	augments	







Next	generation	 sequencing	 (NGS)	 refers	 to	high	 throughput	nucleic	acid	 sequencing,	 such	as	
whole	exome	sequencing	(WES),	whole	genome	sequencing	(WGS),	and	RNA	sequencing	(RNA-
seq).	In	the	time	since	the	Human	Genome	Project	(HGP),	there	has	been	an	exponential	increase	














of	 research	 have	 been	 coined	 omics,	 encompassing	 genomics,	 transcriptomics,	 proteomics,	








As	 sequencing	 has	 become	more	 affordable,	 large-scale	 population	 sequencing	 projects	 have	




















different	 loss	 of	 function	 outcomes.	 For	 example,	 a	 deletion	 of	 p.F508	 results	 in	 protein	
misfolding	and	subsequent	proteasomal	degradation,	whereas	a	missense	mutation	at	p.G551D	
leads	to	defective	channel	opening	at	the	epithelial	membrane	(Ashley	2016;	Brodlie	et	al.	2015).	
The	 small	 molecule	 Ivacaftor	 was	 developed	 as	 a	 CF	 treatment,	 which	 targets	 CFTR	 at	 the	
membrane,	keeping	the	channel	in	an	active,	open	state.	This	treatment	would	only	be	beneficial	
in	patients	with	CFTR	at	the	cell	surface,	and	thus	would	not	be	useful	in	patients	with	p.508del	
variants	 (Ramsey	et	al.	2011;	Brodlie	et	al.	2015).	This	demonstrates	 that	 individuals	with	 the	









omics	 profile	 (iPOP)	 study	 followed	 Synder	 over	 a	 period	 of	 2	 years,	 serially	 sampling	 blood	
components	 at	 20	 different	 time	 points	 for	 a	 combination	 of	WGS,	 RNA-seq,	 proteomic	 and	




associated	 with	 increased	 risk	 of	 basal	 cell	 carcinoma,	 coronary	 artery	 disease,	
hypertriglyceridemia,	 and	 type	 II	 diabetes	 (Chen	 et	 al.	 2012).	 They	 subsequently	 utilised	 this	





bring	 his	 glucose	 levels	 back	 to	 normal	 (Chen	et	 al.	 2012).	 Further	 to	 the	 iPOP	 study,	 Synder	
shared	his	knowledge	with	family	members	who	were	similarly	at	risk,	encouraging	them	to	also	
change	their	lifestyle	choices	(Topol	2014).	The	study	also	demonstrated	the	benefits	of	a	multi-


























































causing	 mutations,	 correct	 classification	 of	 variants	 is	 critical	 to	 prevent	 publication	 of	 false	
positive	findings.	Databases	of	population	frequency	data	can	aid	classification	of	rare,	private	or	
common	 variants.	 Rare	 or	 private	 variants	 are	 more	 likely	 to	 be	 disease	 causing,	 as	 natural	
selection	 is	expected	 to	eradicate	deleterious	disease	variants	before	 they	 reach	a	high	allele	
frequency	 (Lupski	 et	 al.	 2011).	 Rare	 variants	 are	 typically	 defined	 as	 having	 a	 minor	 allele	
frequency	(MAF)	<1%,	whereas	private	mutations	are	novel,	in	the	sense	that	they	have	never	
been	 detected	 in	 prior	 sequencing	 experiments	 from	 the	 same	 population	 (Gao	 and	 Keinan	
2014).	Within	this	project,	ExAC	and	GnomAD	databases	have	been	utilised	(Lek	et	al.	2016).	ExAC	







to	 help	 establish	 the	pathogenicity	 of	 a	 variant	 based	on	 amino	 acid	 conservation,	molecular	
interactions	of	the	tertiary	structure.	Within	this	thesis,	Sorting	Intolerant	From	Tolerant	(SIFT)	
(Ng	 and	 Henikoff	 2003),	 PolyPhen-2	 (Adzhubei	 et	 al.	 2010),	 Protein	 Variation	 Effect	 Analyser	




















SIFT	 utilises	 protein	 sequence	homology	 to	 ascertain	whether	 an	 amino	 acid	 substitution	will	
result	in	a	phenotypic	change.	This	method	assumes	that	the	change	of	a	conserved	amino	acid	






elucidation	 of	whether	 the	 amino	 acid	 change	may	 affect	 intermolecular	 interactions,	 or	 the	
interface	with	complexing	ligands	or	proteins.	However,	the	structural	features	of	PolyPhen-2	can	
only	 be	 utilised	 if	 there	 is	 a	 known	 or	 homologous	 3D	 structure	 for	 the	 protein	 of	 interest	
(Adzhubei	et	al.	2010).	
	










including	 conservation	 scores,	 consideration	 of	 functional	 motifs	 and	 gene	 expression	






Of	 note,	 functional	 prediction	 algorithms	 should	 be	 interpreted	with	 caution	 as	 false	 positive	








Whereas	 an	 organism’s	 DNA	 sequence	 is	 highly	 stable	 and	 relatively	 static,	 tangible	 cellular	
processes	are	far	from	it.	RNA	takes	the	form	of	DNA’s	messenger,	where	the	transcription	of	
DNA	 into	messenger	 RNA	 (mRNA)	 defines	 the	 cell	 identity.	 In	 contrast	 to	DNA,	 RNA	 is	 highly	
dynamic	and	reflects	a	snapshot	of	a	cellular	physiological	state.	The	whole	transcriptome	refers	
to	the	total	RNA	of	a	given	tissue	or	cell	type.	Although	there	are	different	types	of	RNA	molecule,	
mRNA	 transcripts	 were	 utilised	 within	 this	 thesis.	 Before	 the	 advent	 of	 NGS	 technologies,	



































recent	 years,	NGS	 technologies	have	 favoured	nucleic	 acids,	which	 takes	 advantage	of	 innate	
chemical	properties,	such	as	hybridisation.	However,	although	the	central	dogma	dictates	that	
DNA	makes	 RNA	makes	 protein,	 in	 reality	 this	 is	 not	 an	 equivalent	 process,	 as	 correlation	 of	
abundances	between	RNA	and	protein	have	been	reported	as	only	~40%	similar	(de	Sousa	Abreu	
et	 al.	 2009).	 As	 the	 functional	 product	 of	 a	 cell,	 reliable	 protein	 sequencing	 techniques	 are	
required	that	can	sensitively	detect	and	quantify	an	organism’s	proteome.	Protein	composition	
is	a	direct	indication	of	a	time-specific	snap	shot	of	a	cell.	By	investigation	of	the	proteome,	there	
is	an	opportunity	to	gain	 information	that	 is	 immediately	 instructive	of	a	tissue’s	pathobiology	
that	the	genome	and	transcriptome	cannot	offer.	
	












their	 proteomes	 identified	 (Nagaraj	 et	 al.	 2011;	 de	 Godoy	 et	 al.	 2008;	Wilhelm	 et	 al.	 2014).	
Concurrently,	 the	 study	 of	 proteins	 by	 mass	 spectrometry	 can	 produce	 variable	 results,	









Muddiman	 2009).	 At	 present,	 most	 mass	 spectrometers	 do	 not	 have	 the	 resolution	 to	













spectrometry	 can	 fall	 short.	 Antibody	 based	 approaches	 are	 currently	 the	 gold	 standard	 for	
individual	 protein	 detection,	 as	 a	well-derived	 antibody	 has	 high	 affinity	 and	 specificity	 to	 its	
target	(Lollo	et	al.	2014).	Western	blotting	is	a	simple	and	widely	used	method	for	identification	




(Elshal	 and	 McCoy	 2006).	 However,	 the	 prosperity	 of	 this	 technique	 depends	 on	 antibody	
availability	for	each	analyte,	and	critically	developing	antibodies	that	do	not	cross-react.	
	
Within	 this	 thesis	 a	 novel	 targeted	 proteomics	 technology	 was	 trialled,	 called	 SOMAscan	
(SOMAlogic	 Inc,	 Boulder,	 CO,	USA).	 This	was	 inspired	by	 the	 specificity	of	 the	ELISA,	with	 the	
added	advantage	that	it	can	be	multiplexed	to	analyse	over	1000	proteins	(Gold	et	al.	2010).	This	
utilises	aptamers,	compounds	derived	from	nucleic	acid	structures	that	can	specifically	recognise	













or	 proteins	 can	 reduce	 this	 data	 into	 statistically	 significant	 changes,	 the	 resulting	 list	 of	
genes/protein	 provides	 limited	 biological	 insight.	 It	 is	 well	 known	 that	 gene	 products	 do	 not	
function	as	discrete	components,	but	in	large,	often	overlapping,	biological	processes.	Pathway	
analysis	 provides	 a	 method	 of	 classifying	 findings	 from	 RNA-seq	 or	 proteomic	 profiling	
experiments	 into	 statistically	 driven,	 informative	 groups.	 Not	 only	 does	 this	 reduce	 data	
complexity,	but	it	also	allows	identification	of	pathways	that	are	different	between	patient	and	
control	groups,	which	may	link	to	disease	pathology.	Multiple	knowledge	based	tools	are	available	
for	pathway	analysis.	Within	 this	 thesis,	gene	set	enrichment	analysis	 (GSEA),	Protein	Analysis	





















was	 developed	 by	MSigDB	 to	 reduce	 redundancy	 and	 heterogeneity	 between	 the	 exhaustive	
gene	sets	already	present	in	MSigDB	(Liberzon	et	al.	2015).	The	resulting	database	features	50	
reviewed	and	manually	annotated	gene	sets,	containing	7343	genes	in	total.	These	extensively	



















compared	 to	what	 is	 expected	 for	 a	 random	sample	of	 genes	of	 the	 same	 size	 (Goeman	and	
Bühlmann	 2007).	 The	 output	 is	 the	 fold	 enrichment	 between	 the	 observed	 number	 of	 genes	
within	a	pathway	and	the	expected	number	from	the	2x2	test.	This	method	is	fairly	crude	as	it	
does	not	take	independent	changes	into	account,	and	thus	each	gene	has	equal	weighting	in	the	















statistically	 positively	 or	 negatively	 enriched	 (figure	1.6).	 The	benefit	 of	 statistical	 enrichment	
over	 the	 overrepresentation	 test	 is	 that	 all	 genes	 are	 considered	 and	 up	 and	 downregulated	






in	 fact	 are	 highly	 dynamic	 and	 cross-talking.	 Furthermore,	 the	 same	 protein	may	 function	 in	
different	pathways.	Classification	of	protein-protein	interactions	within	a	biological	pathway	or	




exist	 from	 5	 sources.	 They	 may	 be	 known	 from	 experimental	 interactions,	 found	 in	 primary	
manually	 curated	 bases,	 determined	 through	 text	 mining,	 known	 interactions	 through	 co-







of	 the	 three	 germ	 layers.	 Human	 embryonic	 stem	 cells	 (ESCs)	 have	 been	 used	 to	 model	
development	 and	 disease	 since	 they	 were	 first	 isolated	 by	 Thomson	 and	 colleagues	 in	 1998	
(Thomson	 et	 al.	 1998).	 However,	 due	 to	 the	 ethical	 impediments	 associated	 with	 ESCs,	
researchers	attempted	to	reverse	differentiated	cells	 through	addition	of	 transcription	 factors	






affectionately	 termed	 the	 Yamanaka	 cocktail,	 and	was	 subsequently	 used	 to	 reprogram	adult	
fibroblasts	 (Takahashi	 et	 al.	 2007).	 These	 iPSCs	 were	 established	 to	 be	 analogous	 to	 ESCs	 in	
morphology,	 gene	 expression,	 and	 their	 ability	 to	 differentiate	 into	 the	 three	 germ	 layers	
(Takahashi	 et	 al.	 2007;	 Yoshida	 and	 Yamanaka	 2010).	 iPSCs	 have	 been	 presented	 as	 an	
indispensable	 tool	 to	 help	 uncover	 disease	 mechanisms	 from	 patient	 cells,	 bypassing	 the	
dependency	on	animal	models.	iPSCs	can	be	derived	from	patients	and	differentiated	into	cells	






pluripotent	stem	cell	 initiative	 (HipSci)	as	 the	Wellcome	Trust	Sanger	 Institute,	Cambridge,	UK	
(Kilpinen	et	al.	2017).	This	initiative	has	reprogrammed	nearly	500	cell	lines	from	healthy	donors	
and	86	lines	from	patients	with	rare	genetic	diseases,	of	which	BBS	constitutes	50	lines	(Streeter	
et	 al.	 2017).	 Each	 line	 has	 been	 comprehensively	 assayed,	 creating	 phenomic,	 genomic,	
transcriptomic,	proteomic,	and	epigenomic	information,	the	majority	of	which	is	open	access	and	
available	 via	 their	 data	 portal	 (www.hipsci.org).	 iPSCs	 reprogrammed	 by	 HipSci	 from	 3	 BBS	




This	 project	 functioned	 alongside	 the	 pilot	 initiative	 for	 the	 NIHR	 GOSH	 BRC	 funded	 HIGH-5	
project,	which	had	three	general	aims	with	the	goal	of	personalising	patient	care.	These	were	to	
elucidate	 the	 pathobiology	 of	 rare	 diseases	 through	 NGS	 technologies,	 determine	 genetic	 or	
regulatory	 factors	 that	 may	 attribute	 to	 heterogeneity	 of	 rare	 diseases,	 and	 identify	 novel	
biomarkers	that	may	help	to	predict	or	pre-empt	disease	onset.	Experiments	within	this	thesis	
















sequencing	 and	 proteomic	 profiling,	 respectively.	 Protein	 was	 also	 isolated	 from	 urine	 for	
proteomic	label-free	mass	spectrometry.	Patient-derived	dermal	fibroblast	cells	were	obtained	
from	skin	biopsies,	which	were	used	for	transcriptomic	and	proteomic	profiling.	These	cells	are	
responsible	 for	 extracellular	 matrix	 organisation	 in	 the	 dermis,	 as	 well	 as	 regulation	 of	 skin	
physiology	 (Sorrell	 and	Caplan	2004).	 Furthermore,	 they	 can	be	 readily	 cultured	 from	a	 small	
biopsy	obtained	by	a	minimally	invasive	procedure,	making	them	a	suitable	cell	type	for	a	pilot	



















• Implement	 a	 multi-omic	 strategy	 via	 integration	 of	 transcriptomic	 and	 proteomic	



































biopsy	 was	 couriered	 to	 the	 Wellcome	 Trust	 Sanger	 Institute,	 Cambridge,	 UK	 to	 be	

















Each	 piece	 was	 compressed,	 skin	 side	 down,	 onto	 a	 T25	 tissue	 culture	 flask.	 To	 facilitate	
adherence,	the	tissue	was	left	at	room	temperature	for	10	minutes	before	2ml	of	DMEM,	10%	
FBS,	1%	Pen-Strep	was	added.	The	biopsies	were	incubated	for	4	hours	at	37°C,	5%	CO2,	after	








cells	 had	 detached,	 3ml	 of	 DMEM,	 10%	 FBS,	 1%	 Pen-Strep	 was	 added	 to	
inhibit	the	proteolytic	activity	of	trypsin.	The	trypsin-DMEM	mix	was	transferred	to	a	15ml	falcon	

















T25	 25	 0.7	x	106	 2.5	x	106	 5	 2.5	 1	
T75	 75	 2.1	x	106	 7.5	x	106	 15	 5	 3	
T175	 175	 4.6	x	106	 1.75	x	107	 35	 10	 7	







After	 trypsinisation	 and	 centrifugation	 (as	 above),	 the	 cell	 pellet	 from	 a	 T25	 flask	 was	
resuspended	in	1ml	freezing	media,	consisting	of	90%	supplemented	DMEM	and	10%	dimethyl	
sulfoxide	(DMSO)	(Sigma-Aldrich).	Cells	were	transferred	to	a	cryovial	and	initially	stored	in	a	Mr.	
Frosty	 freezing	 container	 (ThermoFisher)	 filled	with	 isopropanol	 at	 -80°C.	 This	 allowed	 gentle	
cryopreservation	 before	 long-term	 storage	 in	 liquid	 nitrogen	 (LN2).	 Each	 cryovial	 of	 cells	 was	
thawed	in	a	water	bath	at	37°C	and	resuspended	with	4ml	of	DMEM,	10%	FBS,	1%	Pen-Strep.	























DPBS	 three	 times.	 After	 the	 final	wash,	 5ml	 of	 DPBS	was	 added	 to	 each	 flask	 and	 cells	were	
collected	using	a	cell	scraper	and	transferred	to	a	15ml	falcon.	This	step	was	repeated	with	an	






















1	minute.	 The	 flow-through	was	 discarded	 and	 the	 column	 placed	 in	 a	 fresh	 collection	 tube,	
where	500µl	of	buffer	AW1	was	added	and	centrifuged	at	6000	g	for	1	minute.	The	column	was	
passed	 in	 another	 fresh	 collection	 tube,	 500µl	 of	 buffer	 AW2	was	 added	 and	 centrifuged	 at	
maximum	speed	 for	3	minutes.	 The	 flow-through	was	discarded	and	 column	 transferred	 to	 a	






mini	 kit	 (QIAGEN)	 according	 to	 manufacturer’s	 instructions.	 Surfaces	 and	 equipment	 were	











for	 15	 seconds.	 RNase-free	 DNase	 I	 (QIAGEN)	mix	 was	 added	 to	 the	 column	 to	 remove	 any	
contaminating	DNA	and	incubated	for	15	minutes	at	room	temperature.	The	column	was	washed	
again	with	350µl	RW1	buffer	by	centrifugation	at	10,000g	 for	15	seconds.	Next,	x2	500µl	RPE	





















A	 1%	 gel	 was	 made	 by	 dissolving	 0.5g	 of	 UltraPure	 Agarose	 (Invitrogen)	 in	 50ml	 1x	


















filtered	 by	 ultracentrifugation	 at	 4,000	 rpm	 for	 50	 minutes.	 The	 protein	 concentrate	 was	












plasma	was	applied	 to	20µl	of	primed	beads	on	 the	ProteoMiner	column	and	 incubated	on	a	
rotational	shaker	for	2	hours	at	room	temperature.	The	column	was	centrifuged	at	1,000g	for	60	
seconds	and	flow-through	was	discarded	(one	sample	flow-through	was	retained	to	run	on	SDS	
PAGE).	200µl	wash	buffer	was	added	and	 incubated	 for	5	minutes	at	 room	temperature	on	a	













were	 thawed	 on	 ice,	 resuspended	 in	 500µl	 50	 mM	 Ammonium	 bicarbonate	 pH	 7.8,	 2%	
Amidosulfobetaine	 (ASB)-14	 and	 added	 to	 0.5ml	 homogenisation	 tubes	 with	 1.4mm	 ceramic	






Protein	 was	 quantified	 using	 the	 Pierce	 BCA	 assay	 kit	 (ThermoFisher),	 which	 was	 completed	
according	to	manufacturer’s	instructions	in	a	96-well	microplate	suitable	for	absorbance	assays.	
Bovine	serum	albumin	 (BSA)	 standards	were	generated	by	serial	dilution	 to	create	a	standard	
curve	at	concentrations	of	2000,	1500,	1000,	750,	500,	250,	125	ng/µl.	Working	solution	was	
created	 by	 dilution	 of	 BCA	 reagent	 B	 (containing	 4%	 cupric	 sulphate)	 with	 BCA	 reagent	 A	
(containing	 sodium	 carbonate,	 sodium	 bicarbonate,	 bicinchonicic	 acid	 and	 sodium	 tartrate	 in	













Protein	 extracted	 from	 plasma	 and	 urine	 for	 in-house	 mass	 spectrometry	 were	 acetone	
precipitated	to	desalt	and	help	purify	the	samples.	The	correct	quantity	of	protein	calculated	from	
the	BCA	assay	standard	curve	was	aliquoted	to	new	microcentrifuge	tubes.	Ice	cold	acetone	was	











2%	 ASB-14	 and	 incubated	 on	 a	 shaker	 at	 900	 rpm	 for	 1	 hour	 at	 room	 temperature.	 1.5µl	
dithioerythritol	(DTE)	(Sigma-Aldrich)	(3mg	DTE	in	100µl	50mM	Ammonium	bicarbonate,	pH	7.8)	
was	added	and	incubated	on	a	shaker	for	1	hour	at	900	rpm.	3µl	of	Iodoacetamide	(IAA)	(Sigma-








0.2%	 TFA,	 added	 to	 a	 primed	 column	 and	 allowed	 to	 slowly	 drip	 through.	 The	 sample	 was	
collected	and	reapplied	to	the	column.	Residual	salts	were	washed	away	by	addition	of	2x	1ml	of	



















minutes.	 The	 protein	 electrophoresis	 gel	 tank	 (Bio-Rad)	 was	 prepared	 and	 filled	 with	 1x	
Tris/Glycine/SDS	running	buffer	(ThermoFisher).	A	precast	4-15%	Mini-PROTEAN	TGX	stain-free	









































42	samples	consisting	of	300	µg	of	protein	each	was	sent	 to	Beijing	Genomics	 Institute	 (BGI),	
Hong	Kong,	China	for	iTRAQ	mass	spectrometry.	Protein	was	extracted	by	homogenisation	from	
21	 starved	 (treated)	 and	21	 fed	 (untreated)	 fibroblasts	 of	 15	patients	 and	6	 controls.	 Protein	
processing	was	completed	by	BGI.	Before	processing,	samples	were	pooled	into	14	groups	of	3	
(5x	3	treated	patients,	2x	3	treated	controls,	5x	3	untreated	patients,	2x	3	untreated	controls).	





























BGI,	 Hong	 Kong.	 BGI	 quantified	 and	 checked	 DNA	 integrity	 before	 commencing	 library	






16	 patient	 and	 25	 control	 DNA	 samples	 were	 sent	 to	 PerkinElmer	 Inc,	 Connecticut,	 USA	 for	
sequencing.	The	samples	were	prepared	using	Agilent	SureSelect	exome	version	3	50Mb	library	















(Waters)	 for	profiling.	 Protein	extracted	 from	urine	was	profiled	using	 the	Synapt	G2	Si	QToF	
tandem	 mass	 spectrometer	 (Waters),	 whereas	 the	 plasma	 fractions	 were	 profiled	 on	 the	
























2.5µg	of	 plasma	peptides	 for	 each	 fraction	was	 injected	onto	 the	 20mm	NanoACQUITY	UPLC	
Symmetry	 C18	 Trap	 column	 with	 5µm	 beads.	 Fractions	 were	 loaded	 and	 eluted	 under	 the	
conditions	in	table	2.2ii	from	the	column	into	the	QToF	Premier	tandem	mass	spectrometer	fitted	
with	a	MALDI	source.	Data	was	acquired	at	a	MALDI	laser	firing	rate	of	200,	resolution	of	8,500	


















Stage	 Time	(min)	 Flow	rate	(µl/min)	 %	buffer	A	 %	buffer	B	
Trapping	 1	 15	 99	 1	
Elution	
Initial	 0.3	 97	 3	
40	 0.3	 60	 40	
42	 0.3	 15	 85	
45	 0.3	 97	 3	
	 	 	 	 	
ii)	Premier	MALDI	QToF	(Waters)	conditions	[1]	
Stage	 Time	(min)	 Flow	rate	(µl/min)	 %	buffer	A	 %	buffer	B	
Trapping	 1	 10	 97	 3	
Elution	
Initial	 0.3	 97	 3	
35	 0.3	 45	 55	
36	 0.3	 1	 99	
41	 0.3	 97	 3	
	 	 	 	 	
iii)	TripleTOF	5600	(AB	SCIEX)	conditions	[2]	
Stage	 Time	(min)	 Flow	rate	(µl/min)	 %	buffer	A	 %	buffer	B	
Trapping	 4	 8	 95	 5	
Elution	
Initial	 0.3	 95	 5	
41	 0.3	 65	 35	
46	 0.3	 20	 80	






























that	 had	more	 than	 10	 reads	 in	 4	 or	more	 samples	were	 retained	 for	 further	 analysis.	 From	






(Waters).	 Peptide	 spectra	 from	 samples	 within	 the	 same	 run	 were	 uploaded	 into	 a	 single	




(from	 January	 2015,	 containing	 20,198	 sequences).	 Proteins	 with	 no	 unique	 peptide	
identifications	or	a	peptide	length	<5	were	omitted.	Proteins	were	quantified	by	ion	abundance	
quantification	 in	 Progenesis	QIP.	 Samples	were	 separated	 into	biological	 groups	 to	 compared	
between	patients	and	controls.	Plasma	fractions	were	processed	per	fraction	creating	8	individual	
experiments,	which	were	 combined	after	quantitation.	 Statistical	 significance	was	ascertained	








sapiens	 was	 used	 as	 the	 input	 database,	 containing	 134,169	 sequences.	 At	 least	 one	 unique	
peptide	 was	 required	 for	 a	 successful	 identification.	 Proteins	 were	 quantified	 using	 IQuant	












comparison	of	 gene	expression	 for	 starved	 vs.	 fed	BBS	 fibroblasts	 and	 starved	 vs.	 fed	 control	
fibroblasts.	 A	 covariate	 ‘sex’	 adjustment	 was	 used	 to	 correct	 for	 gene/protein	 expression	







were	 further	 analysed	 using	 Protein	 Analysis	 Through	 Evolutionary	 Relationships	 (PANTHER)	
















analysis	 is	 also	 encompassed	within	 the	GSEA	 framework,	where	 false	discovery	 rate	 (FDR)	 is	






(right)	enriched	gene	sets.	The	top	of	 the	plot	shows	the	running	enrichment	score	 (ES)	as	 the	analysis	
progresses	down	the	ranked	dataset.	The	peak	of	the	graph	is	the	ES	for	the	dataset,	where	peaks	at	the	
front	of	the	plot	are	positively	enriched	(positive	ES)	and	peaks	at	the	end	of	the	plot	are	negative	enriched	




















A	4-tier	 categorisation	 strategy	was	developed	 to	 keep	 genetic	 variants	 that	may	modify	 BBS	
disease	expressivity.	Variants	from	15	BBS	patients	were	filtered	from	WGS	vcfs	uploaded	into	






primary	ciliopathies	was	added.	These	qualifying	variants	were	separated	 into	4	 tiers,	 starting	
with	 the	most	 stringent	 criteria,	which	gradually	 relaxed.	At	each	 stage	of	analysis,	either	 the	
population	 frequency	based	on	ExAC	European	 frequency	data	 (Tier	1&2,	MAF<1%;	Tier	3&4,	
MAF<5%)	or	the	prediction	of	deleterious	calls	by	PROVEAN	or	PolyPhen-2	was	manipulated.	To	
help	assign	functionality	when	PolyPhen-2	and	PROVEAN	were	discordantly	called,	a	CADD	score	




















(ACMG)	guidelines	 (Richards	et	 al.	 2015)	or	disease-associated	according	 to	 the	Human	Gene	
Mutation	Database	(HGMD)	(Stenson	et	al.	2017)	or	a	CADD	score	>20.	Variants	that	exhibited	a	
frameshift,	 in-frame	indel,	start/stop	codon	loss,	splice	site	loss,	or	missense	change	predicted	
deleterious	 by	 SIFT	 or	 PolyPhen-2	 functional	 prediction	 software,	 were	 also	 retained.	 Finally,	























induced	 pluripotent	 stem	 cells	 (iPSCs)	 by	 the	 Human	 induced	 pluripotent	 stem	 cell	 initiative	
(HipSci)	project.	 Fibroblasts	were	 cultured	 from	 the	biopsy	by	 the	 same	method	as	described	
previously.	 Fibroblasts	 were	 transduced	 using	 Cytotune	 2.0	 Sendai	 virus	 (ThermoFisher)	
























a	 concentration	 of	 1:1000	 was	 used.	 A	 cryovial	 of	 iPSC	 colonies	 was	 thawed	 at	 37°C	 and	
immediately	added	dropwise	to	the	E8/Y-27632	mix,	careful	to	not	disrupt	the	colonies.	The	cells	






iPSC	 colonies	 were	 dissociated	 using	 0.5mM	 EDTA	 by	 diluting	 UltraPure	 0.5M	 EDTA	 (Life	
Technologies)	 with	 DPBS	 at	 a	 1:1000	 dilution.	 Spent	 medium	 was	 aspirated	 and	 cells	 gently	
washed	with	2ml	DPBS.	1ml	of	0.5mM	EDTA	was	added	to	the	colonies	and	incubated	at	room	
temperature	for	4	minutes.	EDTA	was	aspirated	and	colonies	were	gently	collected	in	a	falcon	



















The	 experimental	 design	 for	 differentiation	 was	 developed	 to	 maximise	 the	 number	 of	
differentiations	 for	 each	 line.	 This	was	because	differentiation	of	 separate	 cell	 lines,	 and	 also	
within	differentiation	attempts	for	the	same	line,	were	sometimes	 inconsistent.	To	counteract	




























Embryoid	 body	 media	 (EBM)	 was	 prepared	 by	 filter	 sterilising	 the	 components	 in	 table	 2.3.	
Colonies	were	dissociated	with	EDTA	as	described	previously.	After	centrifugation	at	200g	for	1	









On	day	6	of	differentiation,	EBs	were	 transferred	 to	 laminin	coated	6-well	plates.	These	were	

















































Plates	 were	 regularly	 examined	 over	 the	 differentiation	 period,	 where	 cultures	 with	 poor	
morphology	were	removed.	It	was	observed	that	over	time	a	 layer	of	cells	would	grow	on	the	


























































































































A	 2%	 gel	 was	 made	 by	 dissolving	 4g	 of	 UltraPure	 Agarose	 (Invitrogen)	 with	 200ml	 1x	
















and	 3’	 MGB-NFQ	 quencher	 (table	 2.8).	 TaqMan	 master	 mix	 contained	 AmpliTaq	 Gold	 DNA	












threshold	 for	 amplification	 curves	 were	 calculated	 automatically	 by	 the	 sequence	 detection	
system	 in	 the	 StepOne	 software	 and	 checked	 manually.	 Samples	 were	 quantified	 using	 the	
comparative	 ∆∆Ct	 quantitation	 method,	 which	 was	 implemented	 using	 Microsoft	 Excel.	
Quantitations	 were	 first	 normalised	 to	 an	 endogenous	 control,	 namely	 SNRPD3	 or	 ACTB,	 to	
generate	the	∆Ct.	The	∆∆Ct	of	each	sample	was	calculated	by	normalisation	to	a	calibrator	sample,	
usually	the	sample	from	the	earliest	day	of	differentiation	in	the	experiment.	Relative	fold	change	











SNRPD3	 FAM/MGB-NFQ	 Reference	gene	 68	 Hs00188207_m1	
LDHA	 FAM/MGB-NFQ	 Reference	gene	 66	 Hs01378790_g1	
TBP	 FAM/MGB-NFQ	 Reference	gene	 91	 Hs00427620_m1	
PGK1	 FAM/MGB-NFQ	 Reference	gene	 73	 Hs00943178_g1	
GAPDH	 FAM/MGB-NFQ	 Reference	gene	 93	 Hs02758991_g1	
ACTB	 FAM/MGB-NFQ	 Reference	gene	 63	 Hs01060665_g1	
HPRT1	 FAM/MGB-NFQ	 Reference	gene	 82	 Hs02800695_m1	
NANOG	 FAM/MGB-NFQ	 Pluripotency	marker	 101	 Hs04399610_g1	
PAX6	 FAM/MGB-NFQ	 Eye	field	marker	 76	 Hs00240871_m1	
RAX	 FAM/MGB-NFQ	 Eye	field	marker	 106	 Hs00429459_m1	
MITF	 FAM/MGB-NFQ	 RPE	marker	 81	 Hs01117294_m1	
VSX2	 FAM/MGB-NFQ	 Neural	retina	marker	 125	 Hs01584047_m1	
CRX	 FAM/MGB-NFQ	 Photoreceptor	specific	 73	 Hs00230899_m1	







product	 on	 a	 2%	 agarose	 gel	 (described	 previously).	 Excess	 primers	 and	 nucleotides	 were	
removed	by	addition	of	2µl	ExoSap-IT	PCR	product	cleanup	reagent	 (Affymatrix)	 to	5µl	of	PCR	
product.	 Samples	 were	 incubated	 at	 37°C	 for	 15	 minutes	 followed	 by	 80°C	 for	 15	 minutes.	
Samples	prepared	to	a	concentration	of	3ng/µl	were	sent	with	BBS1	primers	at	3.2pmol/µl	 to	







room	 temperature.	 After	 3x	 10	 minute	 PBS	 washes,	 the	 optic	 cups	 were	 cryoprotected	 by	
incubation	 in	 30%	 sucrose	 solution	 at	 room	 temperature	 for	 1	 hour.	 The	 cups	 were	 then	
embedded	 in	 optimal	 cutting	 temperature	 (OCT)	 compound	 (VWR)	 and	 fast	 frozen	 in	 a	




















Primary	 antibodies	 were	 diluted	 as	 indicated	 and	 samples	 were	 incubated	 with	 primary	
antibodies	overnight	at	4°C.	Samples	were	washed	in	3	times	in	PBS	for	5	minutes	each	prior	to	
application	 of	 species-specific	 secondary	 antibodies.	 Either	 anti-IgG	 Alexa	 Fluor	 594	 or	 488	
(ThermoFisher)	were	used	as	appropriate,	which	were	diluted	1:1000	in	PBST	and	incubated	for	




The	 following	 antibodies	 were	 used	 to	 stain	 the	 primary	 cilium,	 basal	 body	 and	 anterograde	
intraflagellar	transport	machinery:	anti-mouse	acetylated	tubulin	at	1:500	(Sigma-Aldrich),	anti-











Institute	 of	Ophthalmology,	 London,	UK).	 Donkey	 anti-mouse,	 donkey	 anti-rabbit	 and	 donkey	




All	 fluorescence	 images	 were	 obtained	 using	 the	 Carl	 Zeiss	 Z1	 imager	 at	 20x,	 40x	 or	 63x	
magnification	and	captured	with	 the	AxioCam	MRm	camera.	For	 images	at	63x	magnification,	
immersion	oil	 (Sigma-Aldrich)	was	used.	 Images	were	taken	using	AxioVision	4.8	software	and	





acetylated	 tubulin	 to	 identify	 primary	 cilia.	 6	 images	 representative	 of	 each	 line	were	 taken,	
resulting	in	30	images	for	each	condition.	Nuclei	were	identifiable	by	DAPI	counterstain,	which	







and	 0.08	 M	 sodium	 cacodylate-HCl	 buffered	 to	 pH	 7.4.	 Following	 this,	 the	 optic	 cups	 were	





















The	 raw	data	 for	 transcriptomic	and	proteomic	experiments,	as	well	as	outputs	 for	GSEA	and	
















Corporation	 v.2.0	 http://www.nonlinear.com/progenesis/qi-for-proteomics/	 Chapter	4	 -	
Exome	aggregate	
consortium	(ExAC)	
Broad	Institute	 v.0.3.1	 http://exac.broadinstitute.org	 Chapter	3	 (Lek	et	al.	2016)	
Genome	aggregation	
database	(GnomAD)	
Broad	Institute	 v.2	 http://gnomad.broadinstitute.org	 Chapter	3	 (Lek	et	al.	2016)	
Sorting	Intolerant	From	
Tolerant	(SIFT)	 J.	Craig	Venter	Institute	 v.1.03	 http://sift.jcvi.org	 Chapter	3	 (Ng	and	Henikoff	2003)	
PolyPhen-2	 Harvard	University	 v.2.2.2	 http://genetics.bwh.harvard.edu/pph2/	 Chapter	3	 (Adzhubei	et	al.	2013)	
Protein	Variation	Effect	





























Broad	Institute	 v.6.0	 http://software.broadinstitute.org/gsea/index.jsp	 Chapter	5	 (Liberzon	et	al.	2015)	








Patients	were	 recruited	 to	 the	 study	 from	April	 to	December	2014.	All	 clinical	data	described	
below	was	relevant	at	the	time	of	recruitment.	The	conditions	for	recruitment	were	as	follows:	













Gender:	Female		 Genotype:	BBS1	p.M390R/	p.M390R	 	 Age:	30-39	
Retinal	pigmentation	was	observed	at	the	age	of	7	and	rod-cone	dystrophy	diagnosed	at	13	years.	
The	patient	had	a	clinically	obese	BMI	of	35.6	when	samples	for	this	study	were	taken	and	has	
moderate	 learning	 difficulties.	 She	 suffered	 from	 recurrent	 renal	 and	 urinary	 tract	 infections	
(UTIs),	 including	vesicoureteral	reflux	and	pyelonephritis	with	renal	abscess	formation.	Despite	













Gender:	Female		 Genotype:	BBS1	p.M390R/	p.M390R	 	 Age:	40-49	
Patient	BBS003	suffers	from	severe	rod-cone	dystrophy	and	was	born	with	polydactyly	of	the	left	
hand.	She	presented	with	persistent	fetal	lobulation,	a	structural	defect	of	the	kidney.	At	the	time	





Gender:	Male	 	 Genotype:	BBS1	p.M390R/	c.723+1G>A	 	 Age:	20-29	
Patient	BBS004	has	severe	rod-cone	dystrophy	and	moderate	learning	difficulties	but	displays	no	
other	symptoms	indicative	of	BBS.	He	was	identified	as	a	patient	due	to	a	sibling	who	presents	a	












Gender:	Male	 	 Genotype:	BBS1	p.M390R/	p.G73*	 	 Age:	40-49	
BBS-related	symptoms	were	first	diagnosed	in	this	patient	at	the	age	of	11	and	he	was	registered	










Gender:	Female		 Genotype:	BBS1	p.M390R/	p.M390R	 	 Age:	40-49	
Patient	BBS007	was	diagnosed	with	BBS	in	her	40s	due	to	a	 late	onset	of	rod-cone	dystrophy.	
Despite	this,	her	vision	has	diminished	quickly.	This	patient	had	a	severely	obese	BMI	of	51.3	at	
recruitment	 and	 presents	 stage	 III	 chronic	 kidney	 disease.	 Developmental	 features	 include	




Gender:	Male	 	 Genotype:	BBS1	p.M390R/	p.M390R	 	 Age:	40-49	
Patient	BBS008	has	profound	rod-cone	dystrophy	and	was	registered	blind	in	his	20s.	At	the	time	
of	recruitment,	he	was	clinically	obese	with	a	BMI	of	35.1.	He	was	born	with	polydactyly	of	the	




Gender:	Male	 	 Genotype:	BBS1	p.M390R/	p.M390R	 	 Age:	30-39	





















Gender:	Female		 Genotype:	BBS1	p.M390R/	p.Y284Sfs*5	 	 Age:	50-59	
Patient	BBS012	is	the	affected	sibling	of	BBS010	and	BBS011.	In	comparison	to	her	siblings,	she	
had	later	onset	of	rod-cone	dystrophy	and	milder	learning	difficulties.	She	was	clinically	obese	at	


















Gender:	Male	 	 Genotype:	BBS1	p.M390R/	p.M390R	 	 Age:	40-49	
Night	 blindness	was	 first	 reported	 in	 BBS015	 at	 the	 age	of	 9	 years,	 developing	 into	 rod-cone	
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Sample	ID	 Gender	 Age	 Ethnicity	 Material/cells	obtained	
CTRL019	 Female	 40-49	 European	 Urine/	plasma/	fibroblasts	
CTRL020	 Female	 30-39	 European	 Fibroblasts	
CTRL021	 Female	 20-29	 European	 Urine/	plasma	
CTRL022	 Male	 30-39	 European	 Urine/	plasma	
CTRL023	 Female	 30-39	 European	 Urine/	plasma	
CTRL024	 Male	 20-29	 European	 Urine/	plasma	
CTRL025	 Male	 30-39	 European	 Urine/	plasma	
CTRL026	 Male	 50-59	 European	 Urine/	plasma	
CTRL030	 Female	 20-29	 European	 Fibroblasts	
CTRL031	 Female	 30-39	 European	 Fibroblasts	
CTRL032	 Female	 20-29	 European	 Fibroblasts	
CTRL033	 Male	 30-39	 European	 Fibroblasts	
CTRL037	 Male	 65-69	 European	 iPSCs	































from	 isolated	 neuropathy	 towards	 a	 JBTS-like	 syndrome	 (Tory	 et	 al.	 2007).	 In	 addition,	 BBS	












sign	 indicative	 of	 JBTS,	 without	 obesity	 or	 nephropathy	 (Zaki	 et	 al.	 2011).	 These	 findings	
demonstrate	the	close	interconnectivity	of	the	ciliary	proteome	and	highlight	the	delicate	nature	










Although	 it	 has	 been	 shown	 that	 CCDC28B	 directly	 interacts	 with	 the	 BBSome,	 TTC21B	 and	
RPGRIP1L	 have	 yet	 to	 demonstrate	 an	 experimentally	 determined	 interaction	 with	 BBSome	




Although	modifiers	 are	 predicted	 to	 explain	 the	 substantial	 variability	 observed	 in	Mendelian	
disorders,	relatively	few	numbers	of	potential	modifiers	have	been	identified	so	far	(Génin	et	al.	
2008).	The	reason	for	this	can	be	attributed	to	the	techniques	for	modifier	identification,	which	
can	 be	 difficult	 to	 replicate	 and	 validate.	 Detection	 of	 cis-modifiers	 can	 be	 relatively	 straight	
forward	compared	to	trans-modifiers,	as	they	can	be	detected	through	linkage	analysis	(Wright	
et	 al.	 2011).	 Cis-modifiers	 act	 within	 close	 range	 of	 the	 primary	 driving	 mutation,	 and	 thus	
segregate	with	the	disease	variant.	The	presence	or	absence	of	a	cis-modifier	can	occasionally	
explain	variability	 in	disease	penetrance	 (Azaiez	et	al.	2004;	Shawky	2014).	By	contrast,	trans-
modifiers	 exhibit	 their	 effects	 in	 other	 regions	 of	 the	 genome	 and	 can	 often	 appear	 as	









variants,	 and	 thus	 cannot	 be	 determined	 through	 genetic	 segregation.	 Sibling	 or	 twin	
investigations	can	provide	additional	insight	into	the	function	of	a	potential	modifier,	if	discordant	
phenotypes	 are	 observed	 with	 the	 presence	 or	 absence	 of	 a	 third	 allele.	 Additionally,	 these	
studies	 can	 further	 assist	 in	 discriminating	 between	 variability	 caused	 by	 genetic	 or	
environmental	contributing	factors	(Czyz	et	al.	2012).		
	
Secondly,	 quantifying	 the	 severity	 of	 a	 modifier	 can	 prove	 challenging	 (Khanna	 et	 al.	 2009),	
especially	when	it	is	hypothesised	that	they	implement	temporal	changes,	such	as	age	of	onset	
or	developmental	defects.	These	changes	are	particularly	difficult	to	validate	through	functional	
assays,	as	some	developmental	 features	may	express	differently	 in	model	organisms,	as	 is	the	
case	 with	 the	 lack	 of	 polydactyly	 phenotype	 in	 BBS	 mouse	 models	 (Davis	 et	 al.	 2007).	
Furthermore,	 prediction	 of	 phenotype	 is	 made	 harder	 by	 variable	 transcript	 expressivity,	 as	
discrepancies	may	exist	for	the	same	mutant	transcript	in	different	tissue	types	(Shaheen	et	al.	
2016).	 This	 phenomenon	 is	 thought	 to	 account	 for	 some	 of	 the	 disparity	 observed	 for	 splice	




2007),	an	 issue	that	 is	exacerbated	 in	a	rare	disease	cohort.	Furthermore,	potential	modifying	
variants	should	not	be	excluded	if	common	in	the	general	population,	as	these	alleles	can	still	
augment	 an	 aberrant	 pathway	 when	 expressed	 in	 trans	 with	 a	 disease	 locus	 (Zaghloul	 and	





Current	 published	 BBS	 modifiers	 were	 identified	 in	 large	 patient	 cohorts	 of	 heterogeneous	
ciliopathy	patients	(Badano	et	al.	2006).	Typically,	patient	DNA	was	screened	for	an	enrichment	
of	predicted	loss	of	function	variants	in	known	ciliopathy	genes	(Khanna	et	al.	2009;	Davis	et	al.	
2011).	 After	 identification,	 potential	 modifiers	 were	 tested	 to	 establish	 functionality	 through	
large	scale	functional	assays	using	either	a	secondary	cell	 line	known	to	ciliate,	such	as	kidney	
derived	IMCD3	cells,	or	zebrafish	morphants	(Davis	et	al.	2011;	Wheway	et	al.	2015).	Zebrafish	













just	 the	 gene,	 is	 critical	 to	 expected	 phenotypic	 outcome.	 Davis	 et	 al.	 tested	 48	 previously	
unreported	polymorphisms	in	TTC21B,	a	member	of	the	IFT-B	complex	that	can	cause	NPHP	and	
JS.	The	effect	of	mutant	alleles	on	ciliogenesis	was	assayed	in	IMCD3	cells	and	varied	from	benign,	




presentation,	an	 intriguing	study	deemed	to	 increase	the	complexity	of	ciliopathies	 further	by	
revealing	 a	 protective	 effect	 of	 a	 triple	 allelic	 mouse.	 Separately,	 mice	 exhibiting	 BBS6-/-	 or	











defined	 by	 the	 accumulation	 of	 deleterious	mutations	 in	 the	 general	 population.	 A	 landmark	
study	 determined	 that	 mutational	 load	 would	 tend	 to	 be	 attributed	 to	 more	 common,	 less	
damaging	variants,	as	very	harmful	mutations	would	quickly	be	eliminated	from	the	population	
(Kimura	et	al.	1963).	Recently,	 rare	mutations	have	been	recognised	to	accumulate	 in	disease	




(Gonzaga-Jauregui	 et	 al.	 2015),	 schizophrenia	 (Girard	 et	 al.	 2015)	 and	 atrioventricular	 septal	
defect	(AVSD)	(Alessandro	et	al.	2016).	It	is	hypothesised	that	this	increased	mutational	burden	
cumulatively	acts	to	further	destabilise	the	network	of	affected	biological	pathways	and	influence	
disease	penetrance	or	 expressivity	 (Gonzaga-Jauregui	 et	 al.	 2015).	Due	 to	 the	 interconnected	
relationship	of	proteins	within	the	primary	cilium,	it	is	possible	that	ciliopathies,	such	as	BBS,	will	







locus.	Despite	all	presenting	with	pathogenic	variants	 in	 the	same	gene,	 there	 is	 considerable	





























patient	 group	 compared	 to	 the	 control	 subjects	 was	 investigated.	 Qualifying	 variants	 were	
defined	as	 rare	 (MAF<1%)	 and	predicted	pathogenic	by	 SIFT,	 PolyPhen-2,	 or	CADD>20.	 Three	
















Prior	 to	whole	 genome	 sequencing,	DNA	was	 assessed	 for	 quality	 and	 concentration,	 using	 a	









































analysis	 and	 sequencing	 was	 completed	 by	 PerkinElmer	 Inc	 (Connecticut,	 USA).	 Batch	 and	
sequencing	information	for	all	samples	are	presented	in	the	appendix	(table	A.4).	
	



































aimed	 to	 encompass	 potential	 modifiers	 of	 varying	 characteristics	 without	 producing	 an	





data	 (Tier	 1	 and	2,	MAF<1%;	 Tier	 3	 and	4,	MAF<5%)	or	 the	prediction	of	 deleterious	 calls	 by	





















Next,	 Tier	 2	 analysis	 generated	 rare	 nonsynonymous	 variants	 that	 were	 predicted	 to	 be	
innocuous	by	at	least	2	out	of	PROVEAN,	PolyPhen-2	or	CADD	(score<20)	(table	3.3ii).	These	were	

























NPHP4	 p.R735W	 BBS005	 Missense	 Possibly	
Damaging	
Deleterious	 32	 0.026	 0.026	 NPHP	(OMIM:	606966),		
SLS	(OMIM:	606996)	
SDCCAG8	 p.R82C	 BBS013	 Missense	
Possibly	
Damaging	 Deleterious	 23.8	 0.008	 0.011	
BBS	(OMIM:	615993);		
SLS	(OMIM:	613615)	
C2ORF71	 p.S1085L	 BBS007	 Missense	
Possibly	
Damaging	 Deleterious	 17.67	 0.004	 0.006	 RP	(OMIM:	613428)	
TTC21B	 p.L1002V[1]	 BBS006;	BBS008	 Missense	
Possibly	
Damaging	 Deleterious	 25.2	 0.800	 0.874	 NPHP	(OMIM:	613820);		
JATD	(OMIM:	613819)	
TTC21B	 p.R616C	 BBS006	 Missense	 Benign	 Deleterious	 20.7	 0.304	 0.289	
ARL6	 p.T32M	 BBS005	 Missense	
Probably	
Damaging	 Deleterious	 33	 0.000	 0.000	 BBS	(OMIM:	600161)	






	 	 27	 0.000	 0.000	
BBS1†	 p.Y284fs*5	 BBS010;	BBS011;	
BBS012	






Missense	 Benign	 Deleterious	 28.2	 0.227	 0.274	
CEP164	 p.Q1410*	 BBS014	 Stop	Gain	 	 	 40	 0.109	 0.135	 NPHP	(OMIM:	614845)	






















USH2A	 p.S5188G	 BBS014	 Missense	 Benign	 Neutral	 22.7	 0.314	 0.367	
RP	(OMIM:	613809);	
USH	(OMIM:	276901)	
USH2A	 p.K5026E	 BBS014	 Missense	 Benign	 Neutral	 <10	 0.315	 0.367	
USH2A	 p.R4848Q	 BBS014	 Missense	 Benign	 Neutral	 10.5	 0.320	 0.368	
USH2A	 p.G4838E	 BBS014	 Missense	 Benign	 Neutral	 <10	 0.330	 0.378	
USH2A	 p.Q4541P	 BBS002	 Missense	 Benign	 Neutral	 16.94	 0.001	 0.001	
WDR35	 p.I285F	 BBS002	 Missense	 Benign	 Deleterious	 <10	 0.055	 0.074	 JATD	(OMIM:	614091)	
WDPCP	 p.R290H	 BBS010;	BBS011;	BBS012	 Missense	 Benign	 Neutral	 <10	 0.000	 0.001	 BBS	(OMIM:	615992)	
BBS12	 p.S429T[2]	 BBS009	 Missense	 Benign	 Neutral	 <10	 0.094	 0.062	 BBS	(OMIM:	615989)	
PKHD1	 p.G698D	 BBS010;	BBS011	 Missense	 Benign	 Neutral	 <10	 0.015	 0.015	 Polycystic	kidney	and	hepatic	disease	(OMIM:	263200)	
CEP164	 p.P127L	 BBS013	 Missense	 Benign	 Neutral	 19.55	 0.223	 0.168	 NPHP	(OMIM:	614845)	
PKHD1	 p.I3309V	 BBS010;	BBS011	 Missense	 Possibly	
Damaging	
Neutral	 15.02	 0.016	 0.039	 Polycystic	kidney	and	hepatic	
disease	(OMIM:	263200)	
PKHD1	 p.V3263A	 BBS014	 Missense	 Benign	 Neutral	 23.5	 0.267	 0.315	
CDH23	 p.D1806E	 BBS009	 Missense	 Probably	
Damaging	
Neutral	 18.96	 0.585	 0.646	 USH	(OMIM:	601067)	



















NPHP4	 p.E618K	 BBS013	 Missense	
Probably	
Damaging	 Neutral	 23.3	 1.507	 1.440	
NPHP	(OMIM:	606966),		
SLS	(OMIM:	606996)	
CC2D2A	 p.K507E	 BBS009	 Missense	 Probably	
Damaging	
Neutral	 27.1	 1.080	 1.038	 JBTS	(OMIM:	612285);		
MKS	(OMIM:	612284)	
PCDH15	 p.N637S	 BBS014	 Missense	
Possibly	





Neutral	 28.3	 1.291	 1.245	 BBS	(OMIM:	615987)	



























NPHP4	 p.R740H	 BBS003	 Missense	 Benign	 Neutral	 <10	 4.079	 3.304	 NPHP	(OMIM:	606966),		SLS	(OMIM:	606996)	








PCDH15	 p.P1718S	 BBS005	 Missense	 Benign	 Neutral	 <10	 2.752	 1.603	 USH	(OMIM:	601067/602083)	
TCTN1	 p.I412V	 BBS002	(Hom)	 Missense	 Benign	 Neutral	 <10	 1.005	 0.926	 JBTS	(OMIM:	614173)	
TCTN2	 p.R200Q	
BBS003;	
BBS008	 Missense	 Benign	 Neutral	 <10	 1.242	 1.240	 JBTS	(OMIM:	616654)	




(Hom)	 Start	Loss	 	 Neutral	 <10	 2.201	 0.996	 JBTS	(OMIM:	614173)	
RPGRIP1L	 p.A1183G	 BBS013	 Missense	 Possibly	
Damaging	




























0	 0	 0	 0	 0	 0	 		
BBS002	 BBS1	p.M390R	
BBS1	























BBS1	p.G73*	 2	 0	 0	 0	 2	 1	 TTC21B	
BBS007	 BBS1	p.M390R	
BBS1	
































































(50%	 =	 heterozygous;	 100%	 =	 homozygous).	 Tiered	 strategy	 is	 as	 previously	 described,	where	 tier	 1	 =	















database	 (Szklarczyk	 et	 al.	 2015)	 was	 utilised	 to	 predict	 direct	 and	 indirect	 protein-protein	
interactions	with	BBS1,	which	were	assembled	into	a	network	(figure	3.4).	This	interaction	map	
demonstrates	 the	 close-knit	 relationship	 between	 these	 genes.	 BBS1	 is	 known	 through	
experimental	means	or	curated	databases	to	 interact	directly	with	BBS10,	ARL6,	BBS4,	BBS12,	
and	CEP290.	A	further	7	interactions	are	predicted	to	interact	by	knowledge	obtained	from	text	
mining	 (namely,	WDPCP,	 TTC21B,	 NPHP4,	 RPGRIP1L,	 CC2D2A,	 AHI1,	 and	 TMEM67).	 Through	
investigation	 of	 indirect	 interactions,	 BBS1	 is	 predicted	 to	 network	 with	 all	 remaining	 gene	





categorisation.	 Interactions	 are	 experimentally	 determined	 (pink	 connectors),	 from	 literature	 mining	

















disease	 (Parisi	 et	 al.	 2006).	 	 However,	 lack	 of	 segregation	 does	 not	 exclude	 this	 variant	 from	
having	 a	 role	 as	 a	 modifier.	 Similarly,	 the	 heterozygous	 variant	 in	NPHP4	 p.R735W	 found	 in	










database	 reports	 a	 frequency	of	 2/245868	 in	 the	 total	 population,	MAF=8.1x10-6,	 due	 to	 two	
heterozygous	 variants	 identified	 in	 the	 South	 Asian	 population.	 Furthermore,	 this	 variant	 is	
adjacent	 to	 an	 amino	 acid	 change	 known	 to	 cause	 BBS	 (p.T31M).	 Indeed,	 ARL6	 p.T31	 was	











is	conserved	through	vertebrates	and	adjacent	 to	 the	 functional	






likely	 candidate	 mutations	 has	 been	 compiled	 (table	 3.5).	 These	 have	 been	 chosen	 after	
assessment	of	the	commonality,	functional	prediction,	the	 location	of	affected	proteins	within	
the	 primary	 cilium,	 and	 the	 network	 of	 interactions	 in	 close	 proximity	 with	 BBS1.	 Where	
applicable,	known	modifiers	have	also	been	included.	A	confidence	grading	of	low	or	high	was	
assigned	 to	each	 candidate	depending	on	 the	 strength	of	 evidence	as	 a	modifier	 of	BBS.	 The	
justification	 for	 each	 confidence	 rating	 is	 further	 examined	 in	 the	 discussion	 section	 of	 this	
chapter.	
	
Patient	ID	 Gene	 Variant	 Tier	 Confidence	 Confidence	justification	
BBS002	 TCTN1	 p.M1I	 4	 Low	 Uncertain	significance	
BBS003	 RPGRIP1L	 p.A229T	 4	 High	 Known	modifier	
BBS005	 ARL6	 p.T32M	 1	 High	
Highly	conserved/next	to	known	BBS	
variant/direct	interaction	with	BBS1	
BBS006	 TTC21B	 p.L1002V	 1	 High	 Known	modifier	
BBS007	 C2ORF71	 p.S1085L	 1	 Low	 Uncertain	significance	
BBS008	 TTC21B	 p.L1002V	 1	 High	 Known	modifier	
BBS009	 BBS12	 p.S429T	 2	 High	 Known	modifier	
BBS010/011†	 PKHD1	
p.I3309V	 2	 Low	 Uncertain	significance	
p.G698D	 2	 Low	 Uncertain	significance	
BBS010/011/012†	 WDPCP	 p.R290H	 2	 Low	 Uncertain	significance	
BBS012†	 XPNPEP3	 p.P493A	 1	 Low	 Uncertain	significance	
BBS013	 BBS4	 p.V266G	 2	 High	 Direct	interaction	with	BBS1	
BBS014	 CEP164	 p.Q1410*	 1	 High	 Deleterious	nonsense	variant	













rare	 variants	 (MAF<1%)	 predicted	 pathogenic	 by	 SIFT	 or	 PolyPhen-2	 or	 CADD	 score>20	were	
considered.	First,	variant	counting	was	restricted	to	a	panel	of	genes	known	to	cause	ciliopathies	







to	 identify	 the	 disease-causing	 alleles	 (appendix,	 table	 A.4).	Mutational	 analysis	 for	 a	 genetic	








WES_508	 BBS12	 p.G540V	 p.V409M	
WES_511	 BBS12	 p.L530P	 p.L530P	
WES_512	 MKKS	 p.T259fs*21	 p.T259fs*21	
WES_513	 MKKS	 p.T259fs*21	 p.T259fs*21	
WES_514	 BBS12	 p.L530P	 p.L530P	
WES_519	 BBS12	 p.C426Y	 p.E365fs*18	
WES_521	 BBS1	 p.R570*	 p.I200_T201del	
WES_522	 MKKS	 p.I339fs*3	 p.I339fs*3	
WES_524	 TTC8	 c.116+2T>C	 c.116+2T>C	
























variants	 reduced	 to	 a	 level	 that	 was	 similar	 to	 controls	 (table	 3.7ii).	 This	 suggested	 that	 the	







removed	 the	 mean	 variant	 count	 diminished	 to	 a	 comparable	 count	 as	 the	 6	 undiagnosed	
















i)	 +PDM	 16	BBS	vs.	25	controls	 4.8	 3.1	 0.006*	
ii)	 -PDM	 16	BBS	vs.	25	controls	 3.6	 3.1	 0.419	
	 		 	 	 	 	
iii)	
+PDM	 10	diagnosed	vs.	25	controls	 5.5	 3.1	 0.001*	
-PDM	 10	diagnosed	vs.	25	controls	 3.5	 3.1	 0.524	



































i)	 +PDM	 14	patients	vs.	30	controls	 3.7	 3.6	 0.863	

























i)	 +PDM	 WES	+	WGS	combined	 4.3	 3.4	 0.035*	
















PDMs	 were	 included	 in	 the	 calculations,	 there	 were	 significantly	 more	 variants	 in	 the	 WES	
patients	compared	to	controls	(mean	of	12.8	vs.	10.6	variants,	respectively;	p=0.006)	(table	3.10i).	


























-PDM	 11.6	 10.6	 0.350	





-PDM	 7.2	 9.9	 0.006*	























The	 average	 number	 of	 variants	were	 concordant	 between	 patient	 and	 controls	 (table	 3.11),	
though	some	variability	was	observed	between	WES	and	WGS	sets	(combined	mean	of	1.9	and	
2.5,	 respectively).	 This	 inconsistency	 could	 be	 due	 to	 sequencing	 artefacts	 distinct	 to	 one	















WGS	only	 1.8	 2.0	 0.723	
WES	only	 2.6	 2.4	 0.678	























cohort	 (figure	 3.6A).	 However,	 at	 α=0.05	 there	was	 not	 sufficient	 evidence	 to	 reject	 the	 null	
hypothesis	 that	 the	 group	means	 differ	 significantly	 (p=0.078;	 supplemental	 data	 table	 S.40).	
Further	 testing	 was	 completed	 throughout	 the	 filtering	 process,	 where	 the	 conclusion	 that	















All	 samples	 were	 whole	 genome	 sequenced	 to	 an	 average	 coverage	 of	 30X.	 Although	 the	
sequencing	is	expected	to	be	robust	across	different	batches,	there	can	be	some	variability	due	
to	 sequencing	errors	caused	by	GC	 rich	or	 repetitive	 regions	of	 the	genome.	 It	was	 therefore	
inspected	whether	there	were	any	irregularities	in	sequence	coverage	over	71	genes	from	the	
ciliopathy	 panel	 for	 patients	 and	 controls	 (OFD1	 and	 RPGR	 found	 on	 chromosome	 X	 were	
removed	from	this	analysis,	as	they	would	add	sex	bias)	(Figure	3.7).	
	






bases	 covered	 with	 coverage	 greater	 than	 20X.	 Taken	 together,	 these	 data	 show	 no	 clear	
technical	sequencing	abnormalities	in	both	datasets,	and	they	were	sequenced	to	a	high	quality.	



















could	 explain	 the	 phenotypic	 heterogeneity	 commonly	 observed	 in	 BBS	 patients.	 A	 4-tier	




defined	 as	 rare	 (MAF<1%).	 Furthermore,	 the	 tiered	 system	 identified	 previously	 established	
hypomorphic	modifying	mutations	 in	BBS12,	TTC21B	and	RPGRIP1L	 in	4	patients.	From	the	41	
candidate	modifiers,	 each	affected	gene	was	 considered	 for	 their	distribution	 throughout	 the	
primary	cilium	and	assessed	for	their	direct	interaction	with	BBS1.	As	a	result	of	this,	as	well	as	




For	 comprehensive	 characterisation	of	 these	 candidate	modifying	 variants,	 functional	 analysis	
should	be	undertaken,	as	well	as	further	assessment	of	these	candidates	in	a	larger	population	of	
BBS	patients.	However,	as	this	is	beyond	the	scope	of	this	project,	I	have	selected	a	number	of	





RP	and	 renal	defects.	RPGRIP1L	 is	mutated	 in	MKS	and	 JBST,	but	has	been	 shown	 to	act	as	a	




p.A229T	was	 validated	 to	 act	 as	 a	 hypomorph.	 In	 particular,	 this	 variant	was	 only	 present	 in	
ciliopathy	cases	where	RP	is	a	diagnostic	feature,	such	as	BBS	or	SLS.	The	manuscript	continued	





BBS	 patients	 in	 this	 study	 who	 also	 suffer	 from	 RP.	 The	 proposed	 mechanism	 involved	 the	
collaborative	relationship	between	RPGRIP1L	and	RPGR,	which	was	abrogated	by	substitution	to	
p.T229.	 The	 study	 by	 Khanna	 et	 al.	 suggested	 that	 this	 interaction	may	 play	 a	 larger	 role	 in	
photoreceptors,	 due	 to	 the	 significant	 role	 of	 RPGR	 in	 RP	 (Ayyagari	 et	 al.	 2002).	 It	 may	 be	
postulated	 that	 this	 phenomenon	 also	 affect	 kidney	 cells,	 as	 both	 RPGRIP1L	 and	 RPGR	 are	
expressed	in	renal	tissue	and	aberrations	can	lead	to	ciliopathies	featuring	nephropathy	(Wolf	et	
























as	a	 second	site	hit	 in	5	ciliopathy	patients.	An	mRNA	construct	of	p.L1002	was	 subsequently	
























interaction	 with	 centriolar	 satellite	 proteins.	 One	 such	 interactor	 is	 pericentriolar	 material	 1	
(PCM1),	which	is	required	for	correct	localisation	of	proteins	to	the	centrosome	for	cilia	assembly	
(Kim	 et	 al.	 2004;	 Chamling	 et	 al.	 2014).	 The	 BBS4	 protein	 has	 a	 well	 conserved	 structure,	
consisting	of	13	tandem	tetratricopeptide	repeat	(TPR)	motifs	(Kim	et	al.	2004).	These	motifs	are	
found	in	many	proteins	involved	in	complex	formation,	and	critically,	are	highly	enriched	in	ciliary	





Except	 for	 two	 variants,	 the	 majority	 of	 candidate	 modifying	 variants	 discovered	 were	
heterozygous	 missense	 mutations.	 One	 exception	 is	 a	 heterozygous	 nonsense	 mutation	 in	







damage	 response	 pathway	 and	 cell	 cycle	 progression	 (Graser	 et	 al.	 2007;	 Slaats	 et	 al.	 2014).	
Furthermore,	CEP164	interacts	with	SDCCAG8	(Chaki	et	al.	2012),	a	centrosomal	protein	that	has	





Patient	 BBS015	 has	 a	 fairly	 mild	 presentation	 of	 BBS	 but	 suffered	 from	 early	 onset	 retinal	











modifiers.	 This	 may	 be	 due	 to	 tissue	 specific	 gene	 expression	 that	 contradicts	 the	 patient	




In	 patient	 BBS002,	 a	 homozygous	 start	 loss	 variant	 was	 discovered	 in	 a	 transcript	 of	 TCTN1	
(p.M1I).	TCTN1	is	a	regulator	of	the	Hedgehog	pathway	(Reiter	and	Skarnes	2006).	In	addition	to	
this	 role,	 TCTN1	 regulates	 ciliogenesis	 in	 certain	 tissues	 and	 controls	 the	 localisation	of	 some	
transition	zone	proteins,	such	as	MKS1	and	TMEM67	(Garcia-Gonzalo	et	al.	2011).	Mutations	in	
TCTN1	can	cause	the	developmental	ciliopathy,	JBTS	(Huppke	et	al.	2015).	There	are	at	least	5	
















Protein	 Atlas	 (Uhlén	 et	 al.	 2015)	 shows	 some	 expression	 in	 other	 tissue	 types,	 including	 the	




The	 discovery	 of	 genetic	modifiers	 can	 be	 facilitated	 by	 examining	 discordant	 siblings,	where	
segregation	analysis	can	be	utilised	for	discovery	of	unique	variants	that	may	explain	a	phenotype	
in	one	sibling	and	not	the	other	(Génin	et	al.	2008).	In	this	study,	patients	BBS010	and	BBS011	
are	 monozygotic	 (MZ)	 twins	 and	 BBS012	 is	 an	 older	 sibling.	 Interestingly,	 despite	 the	 same	























In	 contrast	 to	 the	MZ	 twins,	 BBS012	 has	 a	 variant	 in	XPNPEP3	 (p.P493A),	which	 interestingly	
localises	 to	 the	mitochondria	 of	 renal	 cells	 and	 causes	 a	NPHP-like	 ciliopathy.	 Suppression	 of	
XPNPEP3	exhibits	a	deleterious	effect	on	the	cilium	and	thus	is	predicted	to	have	a	dual	role	at	
the	 basal	 body	 (O’Toole	 et	 al.	 2010).	 BBS012	 does	 not	 present	 renal	 defects	 except	 for	
nephrolithiasis,	which	is	not	considered	a	symptom	of	BBS.	Due	to	the	presence	of	this	mutation	
in	 the	 less	 severe	 sibling,	 it	 could	be	possible	 that	 the	variant	acts	protectively	and	 slows	 the	
progression	of	symptoms	like	retinal	degeneration.	XPNPEP3	is	undoubtedly	an	interesting	gene	





heterogeneity	 observed	 throughout	 the	 cohort.	However,	 there	were	 2	 patients	who	did	 not	
present	any	modifiers,	and	others	exhibited	less	suitable	candidates	that	could	not	explain	the	
differences	in	expressivity.	For	example,	I	could	not	find	a	genetic	explanation	for	why	the	MZ	
twins	were	discordant	 for	polydactyly.	This	may	be	an	obvious	statement,	 since	MZ	 twins	are	
supposedly	genetically	identical.	However,	this	assumption	needs	to	be	re-evaluated,	as	somatic	






























by	genetic	 factors.	However,	expressivity	could	also	be	 impacted	by	 lifestyle	or	environmental	
influences,	such	as	gender,	diet,	physical	activity	etc.	(Hunter	2005).	Undoubtedly,	environment	
can	affect	the	degree	of	obesity	and	metabolic	syndrome.	On	the	other	hand,	there	are	other	





















this	 technique	was	 displayed	when	 15	 out	 of	 117	 JBTS	 patients	were	 discovered	 to	manifest	
retinal	dystrophy	and	renal	dysfunction	as	a	result	of	modifying	mutations	in	AHI1	(Parisi	et	al.	







et	 al.	 2014;	 Leitch	 et	 al.	 2008;	 Cardenas-Rodriguez	 et	 al.	 2013).	 Practicality	 comes	 from	 their	
number,	 short	 gastrulation,	 and	 transparent	 embryos	 that	makes	 it	 possible	 to	monitor	 their	


























Modifier	validation	 in	 in	 vitro	models	would	also	be	highly	useful.	The	benefit	of	 in	 vitro	over	
zebrafish	 experiments	 is	 that	 it	 is	 possible	 to	 directly	 visualise	 cilia	 via	 immunohistochemical	
staining.	 This	 can	 provide	 greater	 understanding	 of	 the	 functional	 role	 of	 the	 modifier,	 for	
example,	 whether	 it	 induces	 mislocalisation	 of	 proteins	 or	 impaired	 ciliogenesis.	 Here	 knock	
down	 is	 achieved	 through	 addition	 of	 specific	 short-hairpin	 RNAs	 and	 rescued	 by	 transiently	




cell	 (iPSC)	 models	 could	 be	 used.	 The	 benefit	 of	 patient-derived	 cells	 is	 that	 the	 genetic	








true,	 there	 should	be	an	enrichment	of	 functional	 variants	 in	 the	disease	group	 compared	 to	





Two	 sets	 of	 ciliopathy	 patient	 cohorts	were	 assessed	 for	mutational	 burden	 against	 controls,	
featuring	 patients	 sequenced	 by	 either	 whole	 exome	 (16	 patients	 vs.	 25	 controls)	 or	 whole	
genome	sequencing	(14	patients	vs.	30	controls).	The	experimental	justification	of	using	two	data	
sets	was	that	these	could	be	combined	for	a	greater	statistical	power	(30	patients	vs.	55	controls).	














genes	 were	 associated	 with	 the	 neuropathy	 CMT,	 and	 have	 previously	 been	 affiliated	 with	
increased	 mutational	 burden	 in	 a	 cohort	 of	 40	 CMT	 patients	 vs.	 5748	 control	 individuals	
(Gonzaga-Jauregui	 et	 al.	 2015).	 For	my	 analysis,	 the	mean	 number	 of	 qualifying	 variants	was	
consistent	 between	 control	 and	 patient	 groups	 (p=0.678),	 which	 suggests	 that	 the	 statistical	
enrichment	of	variants	was	specific	to	primary	cilia	genes.	
	






























Further	 investigation	 into	 technical	 error	 was	 carried	 out	 by	 counting	 the	 mean	 number	 of	
variants	at	each	stage	of	the	filtering	analysis.	This	showed	that	there	were	overall	more	variants	
in	the	control	data	than	the	patients.	However,	the	large	statistical	variance	illustrated	by	95%	




One	of	 the	advantages	of	WGS	 technology	 is	 that	 reads	are	 contiguous,	which	allows	greater	
accuracy	for	mapping	and	uniformity	of	sequence	coverage.	Therefore,	it	is	more	likely	that	WGS	
would	outperform	WES	 for	 reliability	 across	batches,	 as	WES	 reads	 can	differ	 in	hybridisation	





The	 datasets	 from	 WES	 and	 WGS	 were	 integrated	 to	 increase	 the	 sample	 size	 for	 a	 better	
representation	of	the	BBS	population.	Where	previously	there	were	a	similar	number	of	variants	
in	WGS	patients	(with	PDMs)	and	controls,	the	combined	set	increased	the	number	of	variants	in	
favour	 of	 the	 patients	 (ciliopathy	 panel,	 p=0.035).	 Although	 it	 could	 be	 considered	 that	 the	
integration	enhanced	the	experimental	power	to	statistically	distinguish	between	the	patient	and	
control	 sets,	 this	 data	 should	 be	 interpreted	with	 caution.	 The	 significance	 observed	may	 be	
























The	 results	 indicate	 that	PDMs	are	 the	driving	 factors	 that	 lead	 to	a	significant	enrichment	of	
pathogenic	 variants	 in	 WES	 patients	 vs.	 controls.	 When	 the	 PDMs	 were	 removed	 from	 the	
analysis,	the	mean	number	of	variants	resembled	the	mean	of	the	controls.	This	suggests	that	the	
PDM	alone	is	driving	disease	expressivity.	On	the	other	hand,	it	has	been	shown	that	a	single	locus	
mutation	 does	 not	 sufficiently	 explain	 the	 clinical	 heterogeneity	 observed	 in	 BBS.	 Studies	
including	this	one,	have	provided	evidence	of	modifying	mutations	that,	to	a	degree,	determine	















































Perhaps	 it	 could	 act	 as	 a	 beneficial	 allele	 in	 times	 of	 famine,	 as	 it	 has	 been	 suggested	 that	
heterozygous	carriers	are	prone	to	obesity	(Croft	et	al.	1995).	Furthermore,	patients	with	BBS1	
p.M390R	 mutations	 exhibit	 a	 spectrum	 of	 severity,	 where	 with	 modern	 treatments	 some	
individuals	are	able	to	raise	families.	Therefore,	there	is	limited	opportunity	for	the	allele	to	be	










an	 underpowered	 study	 design.	 Therefore,	 further	 investigations	must	 be	 undertaken	with	 a	





Another	 line	 of	 investigation	 would	 be	 to	 determine	 whether	 asymptomatic	 patients	 exhibit	
protective	 variants.	 For	 example,	 asymptomatic	 carriers	may	 have	 an	 enrichment	 of	 variants	
compared	to	syndromic	patients,	which	safeguard	against	 the	onset	of	BBS.	This	 investigation	








can	 help	 identify	 causative	 variants	 in	 undiagnosed	 patients	 or	 discover	 potential	 modifying	





For	 this	 analysis,	 a	 relatively	 simplistic	 testing	 method	 was	 utilised.	 Two	 gene	 lists	 were	







multiple	predicted	deleterious	mutations	but	not	exhibit	 an	effect	 (Petrovski	 et	 al.	 2013).	 For	
genes	in	a	mutational	burden	panel,	the	challenge	is	to	decide	between	the	biological	importance	
of	a	gene	and	its	genic	tolerance.	Furthermore,	the	true	deleterious	nature	of	a	variant	cannot	
be	 ascertained	 through	 computational	 means.	 In	 this	 study,	 the	 variants	 were	 filtered	 by	
functional	 prediction	 software,	 retaining	 calls	 predicted	 deleterious	 by	 SIFT	 or	 PolyPhen-2	 or	
CADD>20.	However,	the	use	of	these	algorithms	would	have	overestimated	the	deleterious	calls,	





variants	 is	 not	 sufficient	 to	determine	differences	 in	disease	expressivity.	Within	 the	modifier	












































For	 BBS	 patients,	 DNA	 sequencing	 allows	 identification	 of	 the	 genetic	 marker	 of	 disease.	
















obese,	 patients	 BBS003	 and	 BBS007	 were	 morbidly	 obese,	 and	 BBS004	 and	 BBS015	 were	





al.	 (2010).	Of	 these,	17.6%	were	overweight	 (25-29.9	kg/m2),	64.9%	were	obese	 (BMI	30-39.9	
kg/m2)	and	17.6%	morbidly	obese	(BMI	<40	kg/m2).	As	a	consequence	of	high	adiposity,	patients	
exhibited	detrimental	secondary	features,	such	as	elevated	triglyceride	levels,	high	cholesterol,	
hypertension,	 cardiovascular	 abnormalities,	 diabetes	 mellitus,	 and	 non-alcoholic	 fatty	 liver	
disease	(phenotype	frequency:	50%,	72.6%,	32.4%,	19.1%,	17.1%	and	18%	of	cases,	respectively)	
(Deveault	 et	 al.	 2011).	 These	 features	 overlap	 closely	 with	 metabolic	 syndrome,	 which	 is	
predicted	to	affect	30-40%	of	people	in	the	UK	by	age	65	(Han	and	Lean	2016).	However,	BBS	
subjects	are	thought	to	be	molecularly	distinct	from	obese	subjects;	BBS	patients	are	known	to	








The	 goal	 of	 biomarker	 discovery	 is	 to	 uncover	 an	 easily	 measureable	 molecule	 related	 to	 a	
pathophysiological	 pathway	 that	 presents	 prognostic	 or	 diagnostic	 value.	 Regardless	 of	many	
publications	describing	new	biomarkers,	only	a	handful	are	considered	reliable	enough	for	use	in	
clinic	 (Poste	 2011).	 The	path	 from	discovery	 to	 validation	 is	 a	multi-step	 process	 (figure	 4.1),	
where	 success	 lies	 in	 correct	 stratification	 of	 patients,	 independent	 preclinical	 validation,	
verification	 in	 large	 cohorts,	 and	 appropriate	 control	 groups.	 The	 initial	 discovery	 stage	 will	
typically	 utilise	 a	 relatively	 small	 number	 of	 samples	 and	may	 identify	 thousands	 of	 potential	
markers.	 At	 each	 step	 of	 the	 process,	 the	 biomarker	 specificity	 and	 sensitivity	 is	 validated.	












such	 as	 proteins,	 hormones	 and	 metabolites	 are	 also	 detectable.	 Urine	 is	 an	 advantageous	
biofluid	for	study	as	it	 is	readily	and	abundantly	available,	and	can	be	obtained	non-invasively.	
Furthermore,	as	it	has	been	filtered	by	the	glomerulus,	it	has	relatively	low	complexity.	Disease	





the	presence	of	extracellular	vesicles	 (EVs)	 that	are	 found	 in	urine.	These	are	vesicles	 ranging	
from	5-1000	nm	in	diameter	and	categorised	into	subtypes	depending	on	their	size;	exosomes	
(50-100	nm),	microvesicles	(up	to	1000	nm)	and	apoptotic	bodies.	EVs	are	used	to	traffic	secreted	
proteins,	 lipids,	 and	 RNA	 between	 cells,	 and	 thus	 provide	 a	 valuable	 insight	 into	 intercellular	
communication	 (Raposo	 and	 Stoorvogel	 2013).	 Furthermore,	 cells	 can	 release	 EVs	 under	
pathological	 conditions,	 hence	 soluble	 luminal	 proteins	 may	 provide	 additional	 insight	 into	
disease.	A	multistep	fractionation	study	culminating	 in	mass	spectrometry	uncovered	that	 the	
urine	proteome	consists	of	at	least	2362	proteins	(Kentsis	et	al.	2009).	In	a	separate	investigation,	





pressure	 and	 act	 as	 a	 transport	 system	 for	 blood	 cells	 and	 soluble	 macromolecules.	 Plasma	
contains	proteins	secreted	by	tissues,	typically	of	sizes	less	than	45kDa,	as	larger	molecules	are	







that	 proteins	 can	 be	 secreted	 into	 the	 blood	 by	 diseased	 cells	 (Parker	 and	 Borchers	 2014).	
Clinically,	it	is	suitable	since	it	can	be	obtained	through	routine	procedure.	However,	proteomic	
analysis	of	plasma	is	a	formidable	challenge	due	to	the	vast	range	of	protein	concentrations;	the	




equates	 to	 approximately	 55%	of	 plasma	mass	 (Anderson	 and	Anderson	2002).	 Furthermore,	
proteomic	analysis	indicates	that	the	remaining	proportion	of	plasma	may	represent	up	to	3400	
plasma	proteins	(Gold	et	al.	2010).	Analysis	of	a	highly	complex	sample	complicates	the	sample	
preparation,	 where	 long	 depletion	 and	 fractionation	 methods	 are	 required	 for	 sensitive	 and	









For	 mass	 spectrometry	 experiments	 within	 this	 chapter,	 ultra-performance	 liquid	
chromatography	 (UPLC)	 coupled	 to	 a	 quadrupole	 time	 of	 flight	 (Q-ToF)	 mass	 spectrometer	
(Waters	Corporation)	was	utilised	for	an	untargeted,	label-free	strategy.	Quadrupole	and	ToF	are	
both	types	of	mass	analysers,	which	are	coupled	together	to	allow	generation	of	MS/MS	spectra	
by	 tandem	 mass	 spectrometry	 (MS/MS).	 This	 enhances	 resolution	 for	 accurate	 peptide	
identification.	As	mass	spectrometry	separates	analytes	by	mass	and	charge,	samples	are	ionised	








mass	 spectrometer,	 where	 it	 undergoes	 ionisation	 and	 desolvation	 by	 ESI	 or	 MALDI.	 Once	
charged	through	the	loss	of	one	or	more	electron,	the	analyte	enters	the	vacuum	system	of	the	
first	(quadrupole)	mass	analyser,	where	the	sample	is	separated	by	molecular	weight	and	charge.	












instrument	and	 is	 ionised	by	ESI	or	MALDI.	Peptide	 ions	are	separated	by	mass	and	charge	through	the	







cell	 for	 fragmentation	 (Glish	 and	Vachet	 2003).	 As	 only	 peptides	 that	 are	 fragmented	 can	 be	
reliably	 identified,	 this	 leads	 to	 a	misrepresentation	 of	 the	 exact	 peptide	 composition	 of	 the	




















the	 human	 proteome	 database.	 The	 quality	 of	 fragmentation	 is	 reflected	 by	 a	 peptide	
identification	 score.	 Peptides	with	 high	 fragmentation	 efficiency,	 and	 thus	 a	 clear	 amino	 acid	








The	 accurate	 quantification	 of	 proteins	 identified	 in	 a	 sample	 is	 crucial	 for	 statistical	 analysis	


















A	 sophisticated	 approach	 for	 peptide	 quantitation	 is	 employed	 by	 Progenesis	 QIP,	 called	 ion	
abundance	quantification.	This	technique	averages	and	normalises	unique	peptide	ion	peaks	and	
calculates	 the	abundance	 from	 the	volume	of	each	peak.	The	 first	 step	 requires	alignment	of	
spectra	 to	 remove	 variability	 of	 retention	 time	 acquired	 for	 the	 same	 ion	over	 different	 runs	
(figure	 4.4).	 Consequently,	 high	 reproducibility	 of	 the	 instrument	 is	 essential	 for	 accurate	
quantification.	 The	 abundances	 are	 calculated	 from	 these	 aligned	 runs,	 only	 for	 ions	 that	 are	
unique	and	shared	between	runs.	Therefore,	if	the	ion	is	only	found	once,	it	cannot	be	quantified.	






































spectrometry	 to	 reduce	 the	 sample	 complexity.	 As	 utilised	 in	 this	 project,	 ultra-performance	





















component	 space	 to	 observe	 the	 distribution	 of	 data	 points	 (figure	 4.5).	 As	 the	QC	 runs	 are	
technical	 replicates,	 these	 should	 cluster	 on	 the	 principle	 component	 analysis	 (PCA)	 plot.	
Furthermore,	as	a	pool	of	all	samples,	the	QC	cluster	should	lie	in	the	centre	of	the	plot,	with	all	














proteomic	 study,	 large-scale	multiplexing	 of	 assays	 is	 required.	 However,	 ELISAs	 have	 limited	
multiplexing	 ability	 due	 to	 inherent	 cross-reactivity	 of	 antibodies.	 The	 answer	 was	 found	 in	
oligonucleotide	comprised	three-dimensional	molecules,	first	described	over	20	years	ago,	called	




Aptamers	 are	 derived	 through	 an	 in	 vitro	 process	 called	 systemic	 evolution	 of	 ligands	 by	







aptamers	 (referred	to	as	SOMAmers),	which	have	a	greater	affinity	 for	 the	target	 than	typical	
aptamers	 (Lollo	 et	 al.	 2014).	 Specificity	 to	 the	 target	 can	be	 altered	 through	modifications	of	
deoxyuridine	bases,	 controlled	by	additions	of	benzyl,	napthyl,	 tryptophan	or	 isobutyl	groups,	





An	advantage	of	 SOMAscan	 is	 that	 it	 utilises	 robust	nucleic	 acid	hybridisation	properties,	 and	
employs	the	same	chemistry	as	a	microarray	(Gold	et	al.	2010).	The	oligonucleotide	SOMAmer	is	
able	 to	 distinctly	 fold	 into	 a	 unique	 structure,	 which	 specifically	 binds	 to	 the	 target	 protein.	









SOMAscan	 is	 limited	 only	 by	 its	 optimisation	 and	 library	 of	 SOMAmer	 probes.	 At	 the	 time	 of	
writing,	the	SOMAscan	was	optimised	for	detection	of	plasma	proteins,	but	the	scope	is	vast	for	
optimisation	of	SOMAmers	distinct	to	many	different	tissue-specific	proteins	(Gold	et	al.	2010).	
The	 SOMAmers	 are	 not	 designed	 to	 discriminate	 between	 posttranslational	 modifications	
(PTMs).	PTMs	could	either	block	the	epitope	or	induce	a	conformational	change	in	the	protein,	
which	would	compromise	SOMAmer	binding	and	prevent	protein	detection	(Hathout	et	al.	2015).	












aid	 administration	 of	 treatment.	 Currently,	 there	 are	 no	 specific	 molecular	 biomarkers	 to	
measure	disease	progression	or	detect	secondary	features	of	BBS.	The	current	biomarker	used	in	
clinic	is	CRP,	a	generic	indictor	of	inflammation.	The	aim	of	this	chapter	was	to	profile	plasma	and	








BBS	 patients	 are	 phenotypically	 heterogeneous,	 of	 which	 the	 patients	 in	 this	 cohort	 are	 no	
exception.	For	statistical	comparison,	ideally	the	biological	groups	need	to	be	as	homogeneous	
as	 possible.	 There	 are	 two	 phenotypes	 that	 are	most	 prevalent	 in	 this	 study’s	 cohort:	 retinal	
dystrophy	(affecting	15/15	patients)	and	obesity	(affecting	13/15	patients).	In	addition	to	obesity,	
some	 patients	 exhibited	 secondary	 features,	 such	 as	 type	 II	 diabetes	 in	 patient	 BBS002	 and	
hypercholesterolemia	in	BBS006,	as	well	as	factors	associated	with	CVD,	including	hypertension	





Additionally,	 the	 aim	 was	 to	 evaluate	 different	 proteomic	 techniques	 for	 use	 within	 future	




proteins	 were	 quantified	 from	 each	 technique,	 respectively.	 Statistical	 analysis	 identified	
differentially	expressed	proteins	between	patient	and	control	groups,	where	PEDF,	ORM1,	leptin	



















Progenesis	 QIP	 software	 version	 2	 (Nonlinear	 Dynamics,	Waters	 Corporation)	 was	 utilised	 to	
analyse	the	HPLC-MS/MS	experiment	featuring	25	samples.	These	samples	consisted	of	15	BBS	
patients,	6	controls	and	4	quality	control	(QC)	technical	replicates.	The	QC	sample	was	comprised	
of	 a	 pool	 of	 all	 samples	 and	was	 used	 to	 determine	 if	 instrument	 sensitivity	was	maintained	
throughout	the	course	of	the	run.	The	first	stage	of	the	analysis	pipeline	required	alignment	of	















































BBS001	 0.25	 2.8	 9.0	
BBS002	 0.26	 3.0	 8.5	
BBS003	 0.22	 2.1	 11.9	
BBS004	 0.18	 1.3	 19.2	
BBS005	 0.14	 0.6	 41.9	
BBS006	 0.28	 3.3	 7.5	
BBS007	 0.27	 3.1	 8.0	
BBS008	 0.23	 2.3	 10.8	
BBS009	 0.22	 2.1	 11.6	
BBS010	 0.18	 1.4	 18.0	
BBS011	 0.24	 2.6	 9.6	
BBS012	 0.21	 1.9	 13.0	
BBS013	 0.14	 0.5	 48.8	
BBS014	 0.15	 0.7	 35.2	
BBS015	 0.17	 1.2	 21.6	
CTRL019	 0.18	 1.5	 17.1	
CTRL021	 0.19	 1.5	 16.1	
CTRL023	 0.20	 1.9	 13.3	
CTRL024	 0.17	 1.2	 20.3	
CTRL025	 0.17	 1.3	 19.8	
CTRL026	 0.24	 2.5	 10.0	






were	 identified	 across	 all	 samples.	 Peptides	were	 refined	 further	 by	 removing	 corresponding	






















Progenesis	 QIP	 software	 provided	 quality	 control	 metrics	 to	 monitor	 the	 presence	 of	
experimental	 anomalies.	 The	 graphs	 shown	 in	 figure	 4.7	were	 generated	 from	each	 sample’s	
MS/MS	spectra	and	 illustrate	 that	 individually	 there	was	a	 large	 range	 in	peptide	and	protein	
abundances	over	the	experiment.	Samples	BBS004,	BBS005,	BBS008,	BBS015	and	CTRL026	had	a	
consistently	low	count	for	all	metrics.	This	is	indicative	of	poor	identification	data	from	the	MS/MS	









analysis,	 inclusive	 of	 quantifiable	 proteins	 without	 duplications.	 A)	 Box	 plots	 for	 aggregated	 data	 sets	
(excluding	QCs),	displaying	the	spread	of	peptide	ions,	peptide	identifications	and	subsequent	quantifiable	
proteins.	B)	Number	of	proteins	identified	across	patient	and	control	samples	(patient	mean	=	204	(70,228);	





low	 counts	 have	 been	 labelled.	 F)	 Venn	 diagrams	 illustrating	 the	 number	 of	 overlapping	 protein	
identifications	between	each	biological	group	and	QCs	
	






count	 of	 proteins	 acquired	 through	 unique	 peptide	 identifications	 from	MS/MS	 spectra.	 This	
provides	a	visual	overview	of	which	biological	groups	 the	726	quantifiable	proteins	originated	






Proteins	 were	 quantified	 from	 the	 normalised	 MS1	 ion	 spectra	 using	 relative	 label-free	 ion	
abundance	 quantitation.	 The	 abundance	 of	 726	 proteins	was	 detected	 over	 5	magnitudes	 of	
concentration	(figure	4.8).	To	display	the	distribution	of	abundance,	the	mean	abundance	for	all	













































Score	 BBS	mean	 Control	mean	 FDR	 Log2FC	
ORM1	 Alpha-1	acid	
glycoprotein	1	























































































Score	 BBS	mean	 Control	mean	 Log2FC	 FDR	 Relationship	to	disease	





































(6.39,	7.88)	 2.24	 0.042	 	









(10.27,	11.52)	 1.83	 0.047	 Ciliary	dyskinesia	(OMIM:	244400)	









(10.00,	10.97)	 -1.72	 0.064	 Type	II	diabetes	(Soni	et	al.	2013)	




(13.47,	14.29)	 1.70	 0.064	 	




(8.77,	11.11	 2.72	 0.064	 	












































(11.64,	12.22)	 2.37	 0.064	 Type	II	diabetes	(Soggiu	et	al.,	2012)	













(6.93,	9.38)	 2.52	 0.068	 	
LYVE1	 Lymphatic	vessel	endothelial	
hyaluronic	acid	receptor	1	





































(11.78,	12.28)	 2.04	 0.078	 	
ARHGAP35	
Rho	GTPase-activating	




(10.30,	10.77)	 1.71	 0.078	 	
AADACL2	
Arylacetamide	deacetylase-




(7.43,	9.80)	 2.66	 0.080	 	
























(8.86,	9.13)	 1.52	 0.085	 	




(10.96,	11.70)	 1.41	 0.085	 	









(8.68,	9.39)	 1.10	 0.087	 	
HINT3	 Histidine	triad	nucleotide-
binding	protein	3	





















(6.10,	8.42)	 1.65	 0.097	 	




























proteins	 with	 FDR<0.05	 included	 alpha-1	 acid	 glycoprotein	 1,	 alpha-1	 acid	 glycoprotein	 2,	
carbonic	anhydrase	1,	armadillo	repeat	protein,	titin,	dynein	intermediate	chain	1,	and	PHD	finger	







(PEDF,	 alpha-1-acid	 glycoprotein	1	 and	 carbonic	 anhydrase	1).	 In	 addition,	mutations	 in	PHF6	







Subsequently,	 the	 difference	 in	 protein	 expression	 was	 observed	 at	 an	 individual	 level.	 The	
log2(RQ)	 was	 established	 for	 each	 individual	 for	 all	 proteins	 with	 FDR<0.01.	 The	 heatmap.2	
package	 from	 gplots	 was	 used	 to	 generate	 a	 heatmap	 in	 R,	 with	 hierarchical	 clustering	 to	
determine	 related	 groups	 of	 proteins	 or	 biological	 groups	 (figure	 4.11)	 (Warnes	 et	 al.	 2005).	






Figure	 4.11	 –	 Heatmap	 of	 DE	 proteins	 with	 FDR<0.1,	 generated	 by	 heatmap.2	 in	 R	 from	 scaled	 and	
normalised	log2(relative	quantitation)	data,	where	blue	is	low	expression	and	red	is	high	expression.	Data	
is	organised	by	hierarchical	clustering,	where	the	top	bar	highlights	patients	(light	blue),	controls	(purple),	



















proteins	 were	 entered	 into	 PANTHER	 database	 for	 statistical	 overrepresentation	 testing	 and	
searched	 against	 Reactome	 pathway,	 cell	 component,	 and	 biological	 process	 GO	 terms.	 58	







and	 secretory	 granule.	 There	 were	 also	 terms	 related	 to	 immunological	 processes,	 including	


































Anderson	 and	 Anderson	 2002).	 These	 proteins	 can	 be	 removed	 through	 enrichment	 of	 low	
abundance	 proteins,	 technology	 demonstrated	 by	 ProteoMiner	 (Bio-Rad	 Laboratories),	 or	




Preliminary	 investigations	 were	 undertaken	 for	 method	 development	 purposes.	 In	 the	 first	
instance,	plasma	samples	obtained	from	2	individuals	were	enriched,	fractionated	by	SDS-PAGE	
and	analysed	by	UPLC-MS/MS.	Samples	were	quantified	by	BCA	assay,	where	the	standard	curve	

















BBS010	 0.80	 6.8	 405.7	 7.4	
BBS011	 0.82	 7.0	 418.7	 7.2	
Proteominer	FT	 0.43	 3.1	 187.1	 16.0	
Proteominer	wash	1	 0.36	 2.3	 139.8	 21.5	
Proteominer	wash	2	 0.42	 3.0	 177.5	 16.9	
	





loaded	onto	 chromatographic	 beads	 containing	 a	 library	 of	 highly	 diverse	hexapeptides.	 Each	
hexapeptide	uniquely	bound	to	a	different	protein.	Highly	abundant	proteins	oversaturated	their	




highly	 abundant	 proteins	 were	 successfully	 washed	 through	 the	 column,	 and	 resulted	 in	 a	
comprehensible	sample	for	further	analysis.	As	an	example,	albumin	(molecular	weight	66.5kDa)	
saturated	the	gel	in	the	first	flow-through,	but	dramatically	reduced	throughout	the	subsequent	











































Normalisation	 occurred	 both	 within	 fractions	 and	 between	 fractions	 to	 reduce	 variability	
































































chain	 76	 69	 660.326	 137.19	 152.43	 144.81	
FGA	 Fibrinogen	alpha	chain	 170	 168	 1124.698	 135.29	 150.48	 142.89	
FGB	 Fibrinogen	beta	chain	 107	 87	 959.443	 93.54	 106.46	 100.00	
ALB	 Serum	albumin	 104	 82	 702.502	 112.60	 34.29	 73.45	
APOA1	 Apolipoprotein	A	1	 61	 58	 624.243	 68.95	 76.75	 72.85	
VTN	 Vitronectin	 47	 43	 331.224	 67.04	 78.24	 72.64	
IGHM	 Ig	mu	chain	C	region	 60	 21	 399.970	 59.12	 54.87	 56.99	
F2	 Prothrombin	 52	 50	 484.531	 44.82	 54.73	 49.78	
TESK2	
Dual	specificity	testis-
specific	protein	kinase	2	 1	 1	 12.034	 31.99	 39.92	 35.96	














































































groups	 (supplemental	data,	 table	S.25,	 table	S.27).	100	proteins	were	 found	to	be	statistically	

















































































































(9.05,	10.26)	 -1.603	 0.0058	 0.482	
S100A9	 Protein	S100-A9	 12.85	(12.51,	13.19)	
11.78	















































(9.44,	11.24)	 -0.920	 0.0093	 0.503	
CRP	 C-reactive	protein	 15.29	(14.86,	15.72)	
14.01	




































The	 protein	 identifications	 for	 untargeted	 mass	 spectrometry	 and	 targeted	 SOMAscan	 were	
compared	to	determine	whether	these	techniques	were	able	to	recognise	the	same	proteins.	Out	
of	1243	SOMAscan	findings	and	222	proteins	identified	by	mass	spectrometry,	34	proteins	were	
shared	 (figure	4.19;	 appendix,	 table	A.5).	 This	demonstrates	 that	 these	different	 technologies	
may	 be	 suited	 to	 detect	 different	 types	 of	
proteins	 and	 suggests	 that	 they	 may	 be	 most	
effectively	used	in	combination	with	one	another.	
	
Figure	 4.19	 –	 The	 number	 of	 total	 protein	
identifications	from	plasma	for	SOMAscan,	untargeted	
























































































layer	 in	 the	 retina.	 RPE	 functions	 to	 support	 and	 maintain	 photoreceptor	 and	 neural	 retina	
function	(German	et	al.	2008).	PEDF	was	shown	to	be	secreted	from	RPE	cells,	where	it	exhibited	
neurotrophic	activity	to	promote	photoreceptor	and	retinal	neuronal	cell	survival	 (Steele	et	al.	
1993;	 Cayouette	 et	 al.	 1999).	 Furthermore,	 Cayouette	 and	 colleagues	 (1999)	 prolonged	 the	
survival	 of	 photoreceptors	 in	 a	mouse	model	 of	 retinal	 degeneration	 (rd)	 through	 intraocular	
injection	of	PEDF.	It	has	not	yet	been	established	whether	RPE	cells	increase	expression	of	PEDF	
in	response	to	photoreceptor	degeneration	in	models	of	retinal	dystrophy.	However,	it	is	worth	












to	 normal	 controls.	 CVD	 is	 a	 secondary	 phenotype	 of	 BBS,	 linked	 to	 the	 syndrome’s	 obesity	
phenotype.	 Indeed,	 patients	 in	 this	 cohort	 exhibit	 risk	 factors	 or	 features	 of	 CVD,	 such	 as	
hypertension	 (BBS002,	 BBS003,	 BBS005),	 aortic	 valve	 complications	 (BBS013),	 and	 angina	
pectoris	 (BBS005).	 In	 a	 gene	 expression	 experiment,	 upregulation	 of	ORM1	 was	 recorded	 in	
circulating	blood	of	metabolic	syndrome	patients,	but	not	in	patients	with	coronary	artery	disease	




cardiovascular	 abnormalities.	 ORM2	 was	 shown	 to	 be	 significantly	 elevated	 in	 plasma	 from	







After	 investigation	 of	 the	 significant	 proteins	 at	 an	 FDR<0.05,	 the	 confidence	 interval	 was	









CI=	 12.76,	 13.67;	 control	 mean	 log2RQ=	 14.36,	 95%	 CI=	 14.02,	 14.69;	 log2(FC)	 =	 -0.95;	
FDR=0.097)	(Soni	et	al.	2013;	Soggiu	et	al.	2012;	Ruotolo	et	al.	1991).	Although	these	proteins	
may	have	a	genuine	specificity	to	BBS-related	metabolic	syndrome,	 it	 is	 important	to	consider	
that	 they	 may	 be	 an	 artefact	 of	 disease	 associated	 inflammation.	 To	 test	 this,	 further	
experimentation	will	be	required	with	larger	BBS	and	control	groups.	To	evaluate	whether	these	
differentially	 expressed	 proteins	 are	 specific	 to	 BBS,	 a	 control	 group	 composed	 of	metabolic	
syndrome	patients	could	be	used.	A	greater	improvement	would	be	to	compare	the	proteomes	






of	 proteins	 associated	 with	 extracellular	 vesicles	 and	 exosomes	 GO	 terms	 (p<0.0001).	













weight	 cut-off.	 This	 removed	 low	molecular	weight	molecules	 such	 as	metabolites,	 salts,	 and	
detergents,	however	the	resulting	mixture	would	have	retained	 its	complexity	of	proteins.	For	
future	investigations,	the	complexity	of	the	sample	could	be	reduced	by	sequencing	exclusively	
exosomes.	This	may	provide	a	greater	 insight	 into	disease-specific	 intracellular	 interactions,	as	









proteins	 such	 as	 albumin	 and	 fibrinogen	 (Anderson	 and	 Anderson	 2002),	 plasma	 samples	
required	a	greater	number	of	processing	steps	compared	to	urine	analysis.	First,	low	abundance	
proteins	were	enriched	by	use	of	the	ProteoMiner	column,	followed	by	the	separation	of	proteins	







(gamma,	 alpha,	 and	 beta	 chains)	 and	 serum	 albumin	 (table	 4.5).	 The	 ProteoMiner	 column	 is	
composed	 of	 a	 dynamic	 library	 of	 hexapeptides	 that	 should	 have	 affinity	 for	 all	 proteins	 in	 a	




resulting	 in	 a	 less	 complex	 protein	 sample	 for	 mass	 spectrometry	 (Millioni	 et	 al.	 2011).	 The	
greatest	issue	with	this	technique	is	that	it	relies	on	the	specificity	of	the	column,	where	some	
non-specific	 proteins	may	be	washed	 through.	Moreover,	 this	method	 coincidently	 alters	 the	










capability,	 so	 has	 reduced	 sensitivity.	 This	 difference	 in	 performance	 has	 been	 shown	 to	
dramatically	decrease	 the	number	of	protein	 identifications	by	up	 to	half	 (Tonge	et	al.	2011).	
Fractionation	 is	 able	 to	 enhance	 the	 identification	 potential	 to	 the	 same	 level	 as	 an	
unfractionated	 run	 on	 a	 UPLC-MS/MS	 system	 (Plumb	 et	 al.	 2006).	 In	 this	 study,	 protein	was	
separated	offline	by	SDS-PAGE	into	8	distinct	fractions.	The	benefit	of	SDS-PAGE	is	that	proteins	
can	be	visualised	on	the	gel	so	approximately	comparable	amounts	of	protein	can	be	separated	
in	each	 fraction.	This	 can	also	be	valuable	as	a	quality	 control	 step	 to	 identify	degradation	or	







(Anderson	 and	 Anderson	 2002).	 Proteins	 may	 have	 been	 lost	 through	 sample	 preparation,	











6	 control	 plasma	 samples.	 However,	 due	 to	 the	 limitations	 of	 this	 experiment,	 such	 as	 long	






the	 1310	 probes	 available,	 1243	 targets	 were	 measured	 over	 12	 relative	 fluorescent	 units.	









finding	 supports	 studies	where	obese	BBS	patients	were	 shown	 to	have	 leptin	 resistance	and	
elevated	circulatory	leptin	(Feuillan	et	al.	2011).	Leptin	is	a	hormone	secreted	by	adipocytes	in	
response	to	energy	intake	and	acts	to	regulate	energy	homeostasis	through	activation	of	leptin	
receptors	 on	 hypothalamic	 neurons	 (Rosenbaum	 and	 Leibel	 2014).	 Secreted	 leptin	 levels	
correlate	with	adiposity	(Han	and	Lean	2016),	thus	elevated	leptin	is	not	specific	to	BBS	patients.	
However,	in	a	study	conducted	by	Seo	et	al.	(2009),	obese	control	mice	could	be	rescued	by	leptin	












Despite	being	used	as	a	biomarker	 in	clinic,	 this	protein	was	narrowly	within	 the	 top	25	most	




















blood.	As	a	 targeted	panel,	 this	 technique	 is	 limited	by	 the	number	and	affinity	of	 the	SOMA	







SOMAscan	 is	 highly	 sensitive	 and	 only	 requires	 a	 small	 sample	 volume	 (65µl).	 This	 makes	 it	
beneficial	for	clinical	analysis,	especially	for	patients	where	only	small	volumes	of	blood	can	be	
acquired	 (e.g.	 infants).	 Protease	 inhibitors	 are	 added	 upon	 sample	 collection,	 which	 acts	 to	
protect	 samples	 against	 degradation	 during	 transport	 from	 the	 clinic	 and	 sample	 storage.	 By	










may	 not	 be	 able	 to	 provide	 a	 complete	 proteomic	 solution.	 To	 investigate	 this,	 protein	
identifications	for	targeted	and	untargeted	plasma	proteomics	were	compared.	Only	34	proteins	
were	seen	in	both	SOMAscan	and	mass	spectrometry	experiments	(figure	4.19).	This	highlights	
how	 different	 technologies	may	 be	more	 suited	 for	 detection	 of	 certain	 proteins,	 and	 that	 a	




















In	 terms	of	morbidity	and	mortality	 in	BBS,	 renal	dysfunction	and	 secondary	 complications	of	
obesity	are	the	most	common	contributing	factors	(Guo	and	Rahmouni	2011;	Forsythe	and	Beales	
2013).	Therefore,	a	biomarker	for	both	of	these	phenotypes	would	aid	patient	management	and	




















be	 implemented	 again,	 samples	 should	 be	 assayed	 by	 mass	 spectrometry	 in	 replicate	 after	















into	 this	 complex	 organelle	 and	 the	 pathology	 of	 ciliopathies	 (Davis	 and	 Katsanis	 2012).	 The	















transition	 between	 cell	 cycling	 and	 cilia	 assembly	 must	 be	 tightly	 regulated.	 Cilia	 are	 not	 a	
necessity	for	the	cell	cycle	to	occur,	as	there	are	cell	types	that	do	not	ciliate,	yet	still	proliferate,	
such	as	lymphocytes	(Plotnikova	et	al.	2009).	Studies	in	Drosophila	melanogaster	and	mammalian	











subsequent	 cytokinesis.	 Depletion	 of	 either	 protein	 results	 in	 polyploidy,	 but	 also	 induces	
premature	 ciliogenesis	 in	 proliferating	 cells,	 demonstrating	 that	 CCP110-CEP97	 acts	 as	 an	




initiating	 ciliogenesis	 (Tsang	 and	 Dynlacht	 2013).	 Ciliogenesis	 is	 also	 controlled	 through	
manipulation	 of	 microtubule	 dynamics.	 PLK1	 and	 NEK2	 induce	 cilia	 disassembly	 through	
phosphorylation	of	kinesins,	KIF2A	and	KIF24,	respectively	(Miyamoto	et	al.	2015;	S.	Kim	et	al.	
2015).	 Activation	 of	 these	 kinesins	 stimulates	 microtubule	 depolymerisation	 and	 induces	
deacetylation	of	tubulin.	NEK2	and	KIF24	also	act	to	prevent	reassembly	of	the	cilium	as	the	cell	
progresses	 into	 late	G1/S	 phase	 (Kobayashi	 et	 al.	 2011;	 Izawa	 et	 al.	 2015).	 Furthermore,	 key	
signalling	pathways,	such	as	sonic	hedgehog	(SHH)	pathway,	can	promote	cell	cycle	progression	





roles	 in	cell	 cycle	 regulation.	For	example,	 IFT88	 localised	 to	 the	centrosome	during	cell	 cycle	
where	it	was	shown	to	regulate	G1/S	transition	in	non-ciliated	cells.	Furthermore,	overexpression	






















The	 cytoskeleton	 refers	 to	 three	 structural	 protein	 filaments;	 microtubules,	 intermediate	
filaments,	and	actin.	 In	addition	to	microtubule	dynamics,	the	actin	cytoskeleton	is	thought	to	
regulate	cilia	formation	(Malicki	and	Johnson	2017).	The	evidence	arises	from	research	showing	
that	 ablation	 of	 ciliary	 proteins	 increased	 actin	 stress	 fibre	 formation,	 shortened	 cilia,	 and	
reduced	cell	motility	(Hernandez-Hernandez	et	al.	2013).	Furthermore,	a	web	of	actin	filaments	
has	been	demonstrated	to	act	as	a	docking	site	for	the	basal	body	at	the	apical	surface	of	mouse	
primary	culture	epithelial	 cells	 (Pan	et	al.	2007).	This	 interaction	was	dependent	on	 the	 small	
GTPase	RHOA,	which	regulates	actin	dynamics	and	formation	of	focal	adhesions	between	cells.	
BBS	proteins	were	shown	to	control	RHOA	activity,	as	ablation	of	Bbs4	and	Bbs6	in	mouse	renal	


















Figure	 5.1	 –	 Schematic	 representation	 of	 the	 centrosome’s	 dual	 function	 linking	 the	 cell	 cycle	 with	
ciliogenesis.	During	early	G1	of	the	cell	cycle,	the	centrosome	translocates	to	the	apical	membrane	where	
the	mother	centriole	nucleates	to	form	the	basal	body	of	the	primary	cilium.	Cilia	reach	their	full	length	
and	are	most	abundant	 in	G0	when	cells	are	 in	a	quiescent	state.	Upon	re-entry	 into	the	cell	cycle,	the	
cilium	disassembles	 prior	 to	 S	 phase	 entry.	 As	DNA	 replicates	 in	 S,	 the	 centrioles	 duplicate,	where	 the	
daughter	centriole	from	the	previous	cycle	matures	to	become	the	mother	centriole	for	the	next	cycle.	











responsible	 for	 degradation	 of	 ~80-90%	 of	 a	 cell’s	 proteins	 (Lilienbaum	 2013).	 In	 addition	 to	
degradation	 of	 surplus	 or	 defective	 proteins,	 the	 proteasome	 also	 acts	 as	 a	 modulator	 for	
signalling	pathways,	such	as	HH	and	Wnt	signalling.	The	proteasome	is	responsible	for	proteolytic	
cleavage	of	Gli2/3	from	an	active	to	a	repressor	form	(Wang	et	al.	2007),	in	addition	to	switching	
Wnt	 signalling	 to	b-catenin	 independent	 pathways	 by	 degradation	 of	b-catenin	 (Aberle	 et	 al.	
1997).	Proteins	are	marked	for	degradation	through	addition	of	ubiquitin	molecules	by	a	three-
step	 cascade,	 requiring	 respective	 activity	 of	 E1	 ubiquitin-activating	 enzymes,	 E2	 ubiquitin-
conjugating	enzymes,	and	E3	ubiquitin	ligases	(Lilienbaum	2013).	
	
















involved	 in	 ciliary	 function	 and	 maintenance	 are	 highly	 dynamic,	 requiring	 continuous	



















samples	 are	distinctly	 labelled	and	pooled	prior	 to	processing.	 Furthermore,	 isotopic	 labelling	
offers	 a	 robust	 quantification	 method	 (Wang	 et	 al.	 2012).	 The	 accuracy	 of	 label-free	 mass	
spectrometry	relies	on	chromatographic	reproducibility,	and	the	sensitivity	of	the	instrument,	to	
measure	the	same	ion	precisely	across	different	samples.	In	contrast,	pooling	of	labelled	samples	


























by	 serum	 fed	 or	 serum	 starved	 experiments	 for	 fractionation	 and	 mass	 spectrometry.	 Peptides	 were	
identified	and	quantified	from	MS/MS	spectra.	The	peptide	fragmentation	ions,	represented	by	the	black	
peaks,	 were	 used	 for	 peptide	 identification.	 iTRAQ	 tags	 produced	 a	 fragment	 ion,	 represented	 by	 the	
coloured	peaks,	with	a	specific	m/z.	Peptides	from	a	single	sample	were	quantifiable	by	the	intensity	of	the	








of	 21	 serum	 starved	 fibroblast	 samples	 (15	 patients,	 6	 controls)	 and	 the	 other	 for	 21	 fed	
fibroblasts	samples.	The	8th	sample	on	each	iTRAQ	run	consisted	of	a	total	pool	of	all	samples,	
named	 a	 bridge	 sample.	 During	 analysis,	 this	 sample	 was	 used	 to	 normalise	 across	 the	 two	







is	 generally	 unknown.	 Investigation	 of	 the	 crystal	 structure	 of	 the	 BBS1:ARL6GTP	 interaction	
demonstrated	 that	 p.M390R	 reduces	 the	BBS1’s	 affinity	 for	ARL6,	which	 is	 required	 for	 BBS1	
recruitment	 to	 the	 basal	 body	 (Mourão	 et	 al.	 2014).	 However,	 outside	 of	 the	 BBSome,	 the	
function	of	BBS1	remains	elusive.	Various	ciliopathy	proteins,	including	those	that	function	within	








(serum	starved	with	0.5%	FBS	 for	48	hours).	 The	purpose	of	 this	was	 to	 identify	differentially	
expressed	 genes	 and	 proteins	 that	 would	 be	 up	 or	 downregulated	 as	 a	 consequence	 of	
ciliogenesis.	 These	could	also	be	compared	between	disease	and	control	groups.	The	analysis	
strategy	 was	 divided	 into	 three	 sections,	 which	 aimed	 to	 identify	 differentially	 expressed	
candidates,	 significantly	 enriched	 gene	 sets,	 and	 differentially	 regulated	 pathways,	 both	 for	
transcriptomic	 and	 proteomic	 datasets	 (figure	 5.4).	 Further	 to	 this,	 different	 datasets	 were	
integrated	 to	 find	pathways	 that	were	 interconnected	between	 transcriptomic	and	proteomic	
datasets,	thereby	enhancing	the	power	of	the	analysis.	These	aims	were	implemented	through	
use	 of	 various	 computational	 databases	 and	 analytical	 tools.	 Of	 note,	 unpublished	




between	 fibroblast	 cultures	 obtained	 from	 controls	 and	 patients	 carrying	 the	BBS1	 p.M390R	
variant.	
	
























experimental	design.	Ciliogenesis	 studies	were	carried	out	using	5	primary	 fibroblast	 cultures,	










staining	 of	 acetylated	 tubulin.	 There	 was	 an	 increase	 in	 ciliated	 cells	 after	 48	 hours	 serum	


























TapeStation.	 An	 RNA	 integrity	 number	 (RIN)	 was	 provided	 by	 the	 TapeStation	 output	 as	 a	
numerical	 assessment	 of	 the	 quality	 of	 RNA.	A	 score	 of	 10	 indicates	 intact	 RNA	whereas	 1	 is	
completely	 degraded;	 a	 recommended	 threshold	 for	 good	 quality	 is	 a	 RIN	 score	 above	 8.	 All	
samples	that	were	sequenced	had	an	RIN	of	8	or	above.	The	results	featuring	RNA	extracted	from	






Patient	ID	 Condition	 Concentration	(ng/µl)	 Yield	(µg)	 RIN	 28S/18S	
BBS001	 Starved	(treated)	 36.8	 1.104	 9.4	 3.2	
BBS002	 Starved	(treated)	 66	 1.98	 9.8	 2.2	
BBS003	 Starved	(treated)	 53.1	 1.593	 10	 2.4	
BBS004	 Starved	(treated)	 57.4	 1.722	 8.9	 2.8	
BBS005	 Starved	(treated)	 45.6	 1.368	 9.5	 3.1	
BBS006	 Starved	(treated)	 64.4	 1.932	 9.9	 2.5	
BBS007	 Starved	(treated)	 98.6	 2.958	 9.9	 3.4	
BBS008	 Starved	(treated)	 63	 1.89	 10	 3	
BBS009	 Starved	(treated)	 66.1	 1.983	 10	 3.1	
BBS010	 Starved	(treated)	 83.3	 2.499	 10	 3.1	
BBS011	 Starved	(treated)	 31.4	 0.942	 9.4	 2.4	
BBS012	 Starved	(treated)	 123.0	 3.69	 9.9	 2.6	
BBS013	 Starved	(treated)	 46.8	 1.404	 9.3	 2.8	
BBS014	 Starved	(treated)	 49.6	 1.488	 8.9	 3.3	
BBS015	 Starved	(treated)	 88.0	 2.64	 10	 2.6	
CTRL019	 Starved	(treated)	 75.5	 2.265	 9.8	 3.1	
CTRL020	 Starved	(treated)	 98.6	 2.958	 9.8	 3.3	
CTRL031	 Starved	(treated)	 50.2	 1.506	 8.9	 3.1	
CTRL032	 Starved	(treated)	 306	 9.18	 10	 3.2	
CTRL033	 Starved	(treated)	 19.4	 0.582	 9.4	 2	
CTRL030	 Starved	(treated)	 138	 4.14	 10	 2.8	
BBS001	 Fed	(untreated)	 79.8	 2.394	 10	 2.8	
BBS002	 Fed	(untreated)	 60.2	 1.806	 10	 2.7	
BBS003	 Fed	(untreated)	 55.2	 1.656	 9.4	 3.8	
BBS004	 Fed	(untreated)	 74.4	 2.232	 9.4	 2.7	
BBS005	 Fed	(untreated)	 89.2	 2.676	 10	 2.9	
BBS006	 Fed	(untreated)	 19.94	 0.5982	 9.4	 3.3	
BBS007	 Fed	(untreated)	 47.6	 1.428	 9	 3.7	
BBS008	 Fed	(untreated)	 114	 3.42	 10	 3	
BBS009	 Fed	(untreated)	 21.2	 0.636	 9.5	 2.7	
BBS010	 Fed	(untreated)	 20.8	 0.624	 8.6	 2.1	
BBS011	 Fed	(untreated)	 153.0	 4.59	 10	 3.1	
BBS012	 Fed	(untreated)	 181.0	 5.43	 10	 3.1	
BBS013	 Fed	(untreated)	 135.0	 4.05	 10	 3	
BBS014	 Fed	(untreated)	 95.6	 2.868	 10	 3.6	
BBS015	 Fed	(untreated)	 354.0	 10.62	 8.3	 2.2	
CTRL019	 Fed	(untreated)	 116	 3.48	 9.9	 3.3	
CTRL020	 Fed	(untreated)	 218	 6.54	 10	 3	
CTRL031	 Fed	(untreated)	 68.4	 2.052	 8	 3.1	
CTRL032	 Fed	(untreated)	 127	 3.81	 9.9	 3.9	
CTRL033	 Fed	(untreated)	 267	 1.716	 9.4	 3.1	







RNA	quality	was	 additionally	 assessed	by	 the	 ribosomal	 28S/18S	 ratio.	 This	was	 calculated	by	
electrophoretic	 separation	 of	 the	 RNA	 within	 the	 TapeStation	 chip	 and	 comparison	 of	 the	














































BBS001	 Starved	(treated)	 1.49	 447.82	 Pool	1	 Run	1	
BBS002	 Starved	(treated)	 1.48	 443.45	 Pool	1	 Run	1	
BBS003	 Starved	(treated)	 1.74	 520.55	 Pool	1	 Run	1	
BBS004	 Starved	(treated)	 1.87	 559.82	 Pool	2	 Run	1	
BBS005	 Starved	(treated)	 1.52	 456.73	 Pool	2	 Run	1	
BBS006	 Starved	(treated)	 2.29	 686.00	 Pool	2	 Run	1	
BBS007	 Starved	(treated)	 2.08	 624.00	 Pool	3	 Run	1	
BBS008	 Starved	(treated)	 1.44	 430.55	 Pool	3	 Run	1	
BBS009	 Starved	(treated)	 1.54	 463.27	 Pool	3	 Run	1	
BBS010	 Starved	(treated)	 1.09	 326.18	 Pool	4	 Run	1	
BBS011	 Starved	(treated)	 1.39	 416.00	 Pool	4	 Run	1	
BBS012	 Starved	(treated)	 1.68	 502.55	 Pool	4	 Run	1	
BBS013	 Starved	(treated)	 2.46	 736.73	 Pool	5	 Run	1	
BBS014	 Starved	(treated)	 1.68	 502.55	 Pool	5	 Run	1	
BBS015	 Starved	(treated)	 1.42	 426.55	 Pool	5	 Run	1	
CTRL019	 Starved	(treated)	 1.50	 450.91	 Pool	6	 Run	1	
CTRL020	 Starved	(treated)	 1.34	 402.00	 Pool	6	 Run	1	
CTRL030	 Starved	(treated)	 1.18	 355.27	 Pool	6	 Run	1	
CTRL031	 Starved	(treated)	 1.20	 361.09	 Pool	7	 Run	1	
CTRL032	 Starved	(treated)	 1.47	 440.36	 Pool	7	 Run	1	
CTRL033	 Starved	(treated)	 1.33	 400.36	 Pool	7	 Run	1	
BBS001	 Fed	(untreated)	 1.34	 401.64	 Pool	1	 Run	2	
BBS002	 Fed	(untreated)	 1.26	 376.55	 Pool	1	 Run	2	
BBS003	 Fed	(untreated)	 1.24	 370.55	 Pool	1	 Run	2	


























BBS005	 Fed	(untreated)	 1.58	 474.36	 Pool	2	 Run	2	
BBS006	 Fed	(untreated)	 1.53	 459.09	 Pool	2	 Run	2	
BBS007	 Fed	(untreated)	 1.44	 430.55	 Pool	3	 Run	2	
BBS008	 Fed	(untreated)	 1.46	 438.55	 Pool	3	 Run	2	
BBS009	 Fed	(untreated)	 1.63	 488.00	 Pool	3	 Run	2	
BBS010	 Fed	(untreated)	 1.53	 458.73	 Pool	4	 Run	2	
BBS011	 Fed	(untreated)	 1.52	 457.09	 Pool	4	 Run	2	
BBS012	 Fed	(untreated)	 1.54	 461.82	 Pool	4	 Run	2	
BBS013	 Fed	(untreated)	 1.58	 472.55	 Pool	5	 Run	2	
BBS014	 Fed	(untreated)	 1.47	 440.36	 Pool	5	 Run	2	
BBS015	 Fed	(untreated)	 1.60	 480.18	 Pool	5	 Run	2	
CTRL019	 Fed	(untreated)	 1.60	 478.55	 Pool	6	 Run	2	
CTRL020	 Fed	(untreated)	 1.25	 374.18	 Pool	6	 Run	2	
CTRL030	 Fed	(untreated)	 1.70	 508.91	 Pool	6	 Run	2	
CTRL031	 Fed	(untreated)	 1.57	 471.82	 Pool	7	 Run	2	
CTRL032	 Fed	(untreated)	 1.22	 365.45	 Pool	7	 Run	2	
CTRL033	 Fed	(untreated)	 1.02	 365.45	 Pool	7	 Run	2	



























log2	 of	 fold	 change	 (FC).	 Transcripts	 were	 defined	 as	 differentially	 expressed	 with	 FDR	 <0.05.	 A-B)	









Control	starved	vs	fed	 1003	 14,169	 1164	 16,336	 2167	
BBS	starved	vs	fed	 1852	 10,368	 4116	 16,336	 5968	
Fed	BBS	vs	control	 690	 15,522	 124	 16,336	 817	
Starved	BBS	vs	control	 9	 16,307	 20	 16,336	 29	










data	 into	biologically	meaningful	 processes	 (Khatri	 et	 al.	 2012).	Gene	 set	 enrichment	 analysis	
(GSEA)	with	Hallmark	gene	sets	was	used	to	probe	the	data.	The	advantage	of	this	technique	is	
two-fold.	Firstly,	the	Hallmark	gene	sets	encompass	a	broad	range	of	biological,	non-overlapping	
processes,	 allowing	 a	 refined	 and	 concise	 analysis.	 Secondly,	 the	 input	 for	GSEA	 is	 the	 entire	
transcriptome	dataset,	which	is	not	restricted	by	a	p-value	threshold.	Therefore,	it	can	reliably	be	







showing	 significantly	 positively	 or	 negatively	 enriched	 gene	 sets	 (figure	 5.9).	 Although	 the	
Hallmark	gene	sets	were	derived	to	allow	a	broad	overview	of	general	pathways,	there	were	a	
handful	of	significantly	enriched	gene	sets	that	were	relevant	to	primary	cilia	or	BBS	pathology.	
Two	gene	 sets	were	 found	 to	be	negatively	enriched	 in	 starved	BBS	vs	 control,	namely	notch	
signalling	and	cholesterol	homeostasis	(normalised	enrichment	score	(NES)=-1.336,	FDR=0.1415;	
NES=-1.928,	FDR=0.0006,	respectively).	Notch	signalling	 is	a	pathway,	 that	 like	hedgehog	(HH)	
and	Wnt	signalling,	is	thought	to	be	partly	orchestrated	by	the	primary	cilium	(Ezratty	et	al.	2011;	
Leitch	 et	 al.	 2014).	 The	 cholesterol	 homeostasis	 gene	 set	 may	 be	 worth	 investigation	 as	
hypercholesterolemia	is	commonly	present	in	BBS	patients	(Forsythe	et	al.	2015).	An	additional	
finding	related	to	obesity	in	BBS	was	a	positive	enrichment	of	the	adipogenesis	gene	set	in	the	





















79	 genes	 contributed	 to	 the	 leading	 edge	of	 the	 adipogenesis	 gene	 set	 in	 fed	BBS	 vs	 control	
experiment	(figure	5.11A).	Of	interest,	the	gene	with	the	greatest	fold	change	was	LEP	(log2(FC)=	
2.38),	which	 encodes	 the	 satiety	 hormone	 known	 to	 be	 elevated	 in	 BBS,	 leptin.	 Other	 genes	
upregulated	 in	 the	 leading	 edge	 include	 those	 required	 for	 adipocyte	 differentiation,	 CD36,	
PPARG,	SLC27A1,	and	MTCH2,	and	fatty	acid	biosynthesis,	SLC25A1,	ECH1,	ACAA2,	ACADS,	and	






in	 lipid	 metabolism	 (figure	 5.11B).	 This	 may	 suggest	 a	 mechanism	 for	 high	 adiposity	 in	 BBS	
patients,	where	there	is	an	imbalance	between	adipose	tissue	biogenesis	and	lipid	metabolism.	
Finally,	there	were	8	genes	associated	with	a	negative	enrichment	of	Notch	signalling,	including	








starved	vs	 fed	experiments.	 It	was	hypothesised	 that	any	 similarities	would	be	 in	 response	 to	
starvation	and	cell	cycle	arrest,	and	any	differences	uncovered	may	be	due	to	the	BBS1	defect	in	
the	patient	cells.	There	were	two	differentially	enriched	pathways;	myogenesis	(BBS	starved	vs	
fed:	 NES	 =	 -1.360,	 FDR	 =	 0.0519;	 control	 starved	 vs	 fed:	 NES	 =	 1.341,	 FDR	 =	 0.0731),	 and	
inflammatory	response	(BBS	starved	vs	fed:	NES	=	-1.412,	FDR	=	0.0456;	control	starved	vs	fed:	
NES	 =	 1.385,	 FDR	 =	 0.0555),	which	were	 both	 negatively	 enriched	 in	 BBS	 starved	 vs	 fed	 and	
positively	 enriched	 in	 control	 starved	 vs	 fed	 (figure	5.9).	 A	 link	between	myogenesis	 and	BBS	
pathobiology	 has	 not	 yet	 been	 reported,	 so	 this	 may	 require	 further	 experimentation	 to	
determine	 the	 significance	 of	 this	 finding.	 Components	 of	 the	 acute	 phase	 inflammatory	
response,	such	as	C-reactive	protein,	are	raised	in	BBS	patients	as	a	consequence	of	secondary	


























BBS	 vs	 controls.	 However,	 there	 were	 only	 29	 DE	 transcripts	 for	 this	 comparison,	 making	 it	
challenging	 to	 draw	 any	 inferences	 from	 such	 a	 small	 statistically	 significant	 set	 of	 genes.	
Therefore,	a	different	method	for	analysis	was	adopted,	where	BBS	starved	vs	fed	and	control	
starved	vs	fed	experiments	were	directly	compared	with	one	another.	For	this	investigation,	the	
PANTHER	 statistical	 enrichment	 test	 was	 implemented	 with	 gene	 sets	 from	 the	 Reactome	
pathways	database.	Compared	to	the	Hallmark	gene	sets,	the	Reactome	database	features	a	vast	
range	of	biological	processes,	which	may	increase	biological	understanding	to	complement	GSEA.	
PANTHER	 statistical	 enrichment	 test	 was	 completed	 with	 all	 protein-coding	 genes,	 where	
log2(FC)	 for	 each	 protein	 was	 inputted	 as	 enrichment	 criteria.	 Pathways	 were	 considered	
statistically	enriched	after	Bonferroni	correction	with	adjusted	p<0.05	(figure	5.13).	
	
The	 resulting	 pathways	 were	 compared	 for	 BBS	 starved	 vs	 fed	 and	 control	 starved	 vs	 fed	
experiments,	selecting	pathways	that	were	unique	or	shared	for	the	comparisons.	As	expected	in	
response	to	cell	cycle	arrest	by	starvation,	negative	enrichment	of	cell	cycle	and	mitotic	pathways	
were	 identified,	 including	 “mitotic	 anaphase”,	 “mitotic	 prometaphase”,	 “cyclin	 E	 association	
events	during	G1/S	 transition”,	 “APC:Cdc20	mediated	degradation	of	 cell	 cycle	proteins”,	 and	
“cell	cycle”.	This	negative	enrichment	of	cell	cycle	components	was	concordant	with	GSEA.	There	
was	also	evidence	of	 reduced	cytoskeletal	 remodelling	 in	 response	 to	 starvation,	 indicated	by	














starved	 vs	 fed,	 highlighting	 the	 overlapping	 nature	 of	 the	 Reactome	 gene	 sets.	 For	 example,	











The	 assembly	 of	 the	 primary	 cilium	 is	 a	well-orchestrated	 pathway	 that	 requires	 a	 functional	
switch	from	centrosome	genes	required	for	mitosis	to	basal	body	and	IFT	associated	genes	(Izawa	
et	 al.	 2015).	 In	 order	 to	 investigate	 whether	 differential	 regulation	 occurred	 within	 an	
interconnected	 biological	 network,	 protein-protein	 interactions	 were	 mapped	 within	 STRING	
(figure	5.14).	In	total,	there	were	186	genes	associated	with	the	term	“assembly	of	the	primary	






















There	 were	 a	 larger	 number	 of	 DE	 genes	 for	 cilia	 assembly	 within	 the	 BBS	 starved	 vs	 fed	
comparison	compared	to	the	control	group.	It	is	possible	that	this	is	a	result	of	having	a	larger	
group	of	BBS	patients	than	controls,	creating	a	statistical	artefact.	Therefore,	making	inferences	







and	CEP152),	mitotic	 spindle	 formation	 (CKAP5,	HAUS3,	HAUS6,	 and	HAUS8),	 or	 are	 negative	
regulators	 of	 ciliogenesis	 (CEP97	 and	 KIF24)	 (Spektor	 et	 al.	 2007;	 Kobayashi	 et	 al.	 2011).	
Moreover,	 HAUS3,	 HAUS6,	 and	 HAUS8	 form	 part	 of	 a	 hetero-octamer	 complex	 named	
Homologous	 to	 Augmin	 subunits	 (HAUS),	 and	 are	 required	 for	 mitotic	 spindle	 assembly	 and	
maintenance	of	centrosome	integrity	 (Lawo	et	al.	2009).	Therefore,	 it	would	be	expected	that	
expression	 of	 these	 genes	 would	 downregulate	 in	 response	 to	 cell	 cycle	 arrest.	 Further	
investigation	 of	 expression	 data	 for	 these	 genes	 demonstrated	 that	 read	 counts	 were	 not	
significantly	different	between	starved	BBS	and	starved	control	fibroblasts,	but	4	out	of	the	10	
genes	 were	 significantly	 different	 between	 fed	 BBS	 and	 fed	 control	 (figure	 5.15;	 table	 5.4).	
Furthermore,	expression	was	significantly	higher	in	fed	control	compared	to	starved	control	for	
all	 genes,	whereas	 this	was	not	 the	 case	 for	BBS	 comparisons.	 Expression	of	HAUS3	 (BBS	 fed	
mean=	3.87,	95%	CI=	3.65,	4.26;	control	fed	mean=	4.67,	95%	CI=	4.29,	5.06;	FDR=	0.0157),	CEP41	




































































































































The	 spectra	 obtained	 from	 iTRAQ	mass	 spectrometry	 runs	 for	 serum	 fed	 and	 serum	 starved	
samples	 were	 analysed	 for	 identifications	 separately,	 and	 implemented	 by	 the	 BGI.	 Peptide	


















Statistical	 analysis	with	 T-test	 and	multiple	 correction	 for	 FDR	was	 applied	 to	 comparisons	 of	
protein	 ratios	 between	 biological	 groups	 (supplemental	 data,	 tables	 S.30-S.33).	 The	 same	
analytical	design	that	compared	treatment	and	disease	data	in	RNA-seq	experiments	were	also	
utilised	here.	Proteins	were	considered	differentially	expressed	with	an	FDR	less	than	0.05	(figure	





proteins,	where	 1267	 and	 961	were	 down	 and	 upregulated,	 respectively.	 Comparison	 of	 BBS	
starved	vs	 fed	 identified	773	downregulated	and	1313	upregulated	proteins,	whereas	 control	


























starved	vs	fed	 211	 3805	 373	 52	 96	 4389	 584	
BBS	starved	
vs	fed	
773	 2303	 1313	 118	 349	 4389	 2086	
Fed	BBS	vs	
control	
1267	 3211	 961	 62	 23	 5439	 2228	
Starved	BBS	
vs	control	









gene	 sets	 that	 were	 enriched	 at	 the	 protein	 level.	 26	 Hallmark	 gene	 sets	 were	 returned	 as	
significantly	enriched	in	at	least	one	comparison	with	FDR<0.25	(figure	5.17,	supplemental	data,	










Of	 interest	 to	 cilia	 function,	 the	 mTOR	 signalling	 pathway	 was	 established	 as	 significantly	
enriched.	This	pathway	functions	to	regulate	cellular	growth	in	response	to	cellular	energy	levels.	
Dysregulation	of	the	mTOR	pathway	has	been	shown	to	reduce	ciliary	length,	and	is	implicated	in	


















control.	 As	 it	 was	 not	 possible	 to	 investigate	 this	 comparison	 in	 detail	 through	 analysis	 of	
transcripts,	the	opportunity	was	taken	for	the	iTRAQ	dataset.	To	investigate	Reactome	pathways	
that	were	significantly	enriched,	all	proteins	identified	from	starved	BBS	vs	control	were	entered	




17	 pathways	 were	 found	 to	 be	 significantly	 positively	 enriched	 and	 a	 single	 pathway	 was	
significantly	negatively	enriched.	From	this	analysis,	there	were	5	pathways	that	were	recognised	
as	 biologically	 interesting	 due	 to	 association	with	 ciliary	maintenance,	 signalling,	 or	 function.	
These	were	“assembly	of	the	primary	cilium”,	“hedgehog	‘off’	state”,	“RHO	GTPase	effectors”,	




pathways.	 It	 was	 also	 investigated	 whether	 these	 pathways	 may	 be	 implicated	 with	 BBS1	
function,	 thereby	 forming	 a	 link	 between	 protein	 dysfunction	 caused	 by	 the	 BBS1	 p.M390R	















proteins	 found	 in	 “centrosome	maturation”,	many	overlapped	with	 “assembly	 of	 the	primary	




effectors”	 and	 “cytoskeletal	 regulation	 by	 RHO	 GTPases”,	 which	 had	 73	 and	 28	 DE	 proteins,	
respectively.	Finally,	“hedgehog	‘off’	state”	was	associated	with	40	DE	genes.	27	of	these	were	











Next,	 the	 protein	 network	map	was	 used	 to	model	 the	 putative	 involvement	 of	 BBS1,	where	
mutation	of	p.M390R	may	have	led	to	the	upregulation	of	these	5	pathways	in	starved	cultures.	
BBS1	is	incorporated	into	the	network	through	interactions	with	RAB3IP,	also	known	as	RABIN8,	





cilium	 for	 HH	 signalling,	 an	 interaction	 also	 involving	 LZTFL1	 (Seo	 et	 al.	 2011),	 which	 was	
upregulated	in	starved	BBS	fibroblasts	compared	to	starved	controls.	SMO	is	also	predicted	to	
interact	 with	 the	 cAMP-dependent	 protein	 kinase,	 PRKACB,	 which	 in	 turn	 networks	 with	
members	of	the	“RHO	GTPase	effectors”	and	“cytoskeletal	regulation	by	RHO	GTPase”	pathways.	
Furthermore,	BBS1	 is	 linked	to	components	of	“assembly	of	primary	cilium”	and	“centrosome	
maturation”	 through	 RAB3IP.	 Although	 RAB3IP	 was	 not	 identified	 by	 the	 iTRAQ	 proteomics	
experiment,	it	can	provide	an	insight	into	how	the	presence	of	the	BBS1	p.M390R	variant	impacts	
these	pathways.	The	interaction	with	BBS1	and	RAB3IP	is	required	for	transport	of	cargo	to	the	










However,	 due	 to	 sample	 heterogeneity	 and	 often	 low	 correlation	 between	 different	 types	 of	
technology,	this	is	not	a	trivial	task	(Gomez-Cabrero	et	al.	2014).	This	challenge	is	exacerbated	
when	attempting	to	integrate	data	at	the	individual	gene/protein	level,	as	there	are	far	too	many	







Figure	 5.20	 (on	 previous	 page)	 –	 Protein-protein	 interaction	 network	 featuring	 DE	 proteins	 from	 5	
pathways	significantly	positively	enriched	by	PANTHER	statistical	enrichment	test.	DE	proteins	from	the	5	
different	pathways	are	coloured	differently,	where	proteins	may	be	coloured	multiple	colours	if	involved	





The	 analysis	 completed	 with	 RNA-seq	 and	 iTRAQ	 proteomics	 data	 by	 GSEA	 and	 PANTHER	




that	were	present	 in	BBS	starved	vs	 fed	but	not	control	 starved	vs	 fed.	These	pathways	were	
highlighted	for	dysregulation,	where	it	was	not	important	whether	pathways	were	consistently	
positively	 or	 negatively	 enriched,	 or	 contained	 the	 exact	 same	 genes,	 across	 different	 omic	
technologies.	Interestingly,	epithelial	mesenchymal	transition	was	identified	for	both	starved	BBS	





























KRAS	signalling	(up)	 Negative	 Negative	 GSEA	
Epithelial	mesenchymal	transition	 Positive	 Negative	 GSEA	
Fed	BBS	vs	
control	
MYC	targets,	1	 Negative	 Negative	 GSEA	
E2F	targets	 Negative	 Negative	 GSEA	
IL2	STAT5	signalling	 Positive	 Positive	 GSEA	
Adipogenesis	 Positive	 Positive	 GSEA	
Oxidative	phosphorylation	 Positive	 Positive	 GSEA	
Hypoxia	 Positive	 Negative	 GSEA	





G2/M	Transition	 Negative	 Positive	 PANTHER	
Hedgehog	‘off’	state	 Negative	 Positive	 PANTHER	







Respiratory	electron	transport	 Negative	 Positive	 PANTHER	
rRNA	processing	in	the	nucleus	and	cytosol	 Negative	 Positive	 PANTHER	




The	 protein-protein	 interaction	map	 output	 from	 STRING	was	 highly	 complex,	with	 few	well-
structured	 complexes	 or	 networks.	 Therefore,	 interacting	 genes	 from	 the	 respective	
transcriptome	and	proteome	datasets	were	highlighted	and	reanalysed	to	find	more	manageable	
clusters	of	protein-protein	interactions.	This	grouped	the	nodes	into	5	complexes	depending	on	
their	 molecular	 function.	 The	 first	 identified	 network	 within	 the	 transcriptome	 dataset	 was	
adipocyte	 differentiation,	 which	 featured	 genes	 that	 are	 regulators	 of	 adipogenesis,	 such	 as	
PPARG,	 CD36,	 LEP,	 and	 SLC27A1.	 Another	 complex	 from	 the	 RNA-seq	 analysis	 was	 glucose	
metabolism,	 featuring	components	of	 the	pentose	phosphate	pathway,	TALDO1	 and	TKT,	 and	
glycolysis,	such	as	PFKL,	PFKFB3,	and	PGM1.	Within	the	proteomic	set	there	were	rich	interactions	
involving	 mitochondrial	 components,	 including	 those	 involved	 in	 the	 respiratory	 chain	 (also	
known	as	oxidative	phosphorylation),	UQCR10,	UQCRQ,	NDUF	subunits,	ATP1B3,	COX6A1,	and	
ATP5O.	Nodes	were	also	found	for	both	transcriptomic	and	proteomic	datasets	to	be	involved	in	



















This	 investigation	 aimed	 to	 identify	 dysregulation	 of	 cellular	 pathways	 in	 BBS	 fibroblasts	
compared	to	controls	to	elucidate	the	pathobiology	of	BBS1	p.M390R.	BBS	and	control	fibroblasts	
were	 probed	 at	 both	 mRNA	 transcriptomic	 and	 proteomic	 levels,	 unveiling	 over	 15,000	
differentially	expressed	 transcripts	and	proteins	combined,	and	over	100	statistically	enriched	
gene	 sets	 and	 pathways.	 Furthermore,	 integration	 of	 omic	 technologies	 at	 the	 pathway	 level	
refined	 and	 enhanced	 reliability	 of	 findings,	 identifying	 17	 pathways	 across	 the	 different	
experimental	 comparisons	 that	 were	 found	 in	 both	 transcript	 and	 protein	 datasets.	 The	
experimental	design	presented	a	novel	approach	for	analysis	of	cellular	components	that	were	
differentially	regulated	in	conditions	to	promote	cell	cycle	progression	or	to	promote	ciliogenesis.	
These	 were	 then	 compared	 between	 disease	 and	 control	 groups.	 The	 consequence	 was	
identification	 of	 processes	 associated	 with	 obesity,	 upregulation	 of	 signalling	 pathways,	 and	






concise,	 yet	 relatively	 general,	 Hallmark	 gene	 sets.	 The	 analysis	 identified	 the	 gene	 set	
adipogenesis,	as	statistically	positively	enriched	for	the	fed	BBS	vs	control	comparison.	This	was	
a	 highly	 interesting	 and	 relevant	 finding,	 as	 obesity	 is	 a	 cardinal	 feature	 of	 BBS.	 Increased	
confidence	of	this	result	was	achieved	through	positive	enrichment	of	both	transcriptomic	and	























LEP	 (Tontonoz	et	 al.	 1994;	Qiao	et	 al.	 2008;	Challa	 et	 al.	 2015).	 To	determine	how	 these	 key	
adipogenic	genes	 interacted	with	the	rest	of	 the	enriched	adipogenesis	gene	set,	gene	names	
from	the	GSEA	leading	edge	from	RNA-seq	and	proteomics	data	were	incorporated	into	a	protein-
protein	 interaction	map	 (figure	5.21).	This	 revealed	a	 complex	network,	 that	when	simplified,	
identified	 components	 of	 glucose	metabolism,	mitochondrial	 respiratory	 chain,	 and	 fatty	 acid	
metabolism,	 in	 addition	 to	 adipocyte	 differentiation.	Many	 components	 of	 the	 network	were	
involved	in	mitochondrial	biogenesis	and	function.	This	included	a	number	of	proteins	involved	
in	 the	 mitochondrial	 respiratory	 chain,	 such	 as	 subunits	 of	 complex	 I	 (NDUFB7,	 NDUFA5,	
NDUFAB1,	and	NDUFS3),	complex	III	(UQCR10	and	UQCRQ),	complex	IV	ATP	synthase	(ATP5O),	
and	cytochrome	c	oxidase	(COX6A1).	Mitochondria	have	an	important	role	in	the	regulation	of	
adipocyte	 differentiation,	 as	 during	 adipogenesis,	 increased	 oxygen	 consumption	 and	
mitochondrial	 biogenesis	 has	 been	 observed	 (Lu	 et	 al.	 2010;	 Shi	 et	 al.	 2008).	 Concurrently,	
inhibition	 of	 mitochondrial	 function	 results	 in	 diminished	 ability	 to	 store	 triglycerides	 and	
prevented	 differentiation	 of	 MSCs	 into	 adipocytes	 (Zhang	 et	 al.	 2013).	 The	 upregulation	 of	









the	 mitochondrial	 generation	 of	 acetyl-CoA	 from	 triglycerides	 for	 energy	 production,	 and	 is	
particularly	high	in	brown	adipose	tissue	for	thermogenesis	(Festuccia	et	al.	2011).	A	significant	
increase	in	brown,	as	well	as	white	adipose	tissue	was	demonstrated	in	the	Bbs1	M390R	knock-
in	mouse	 (Davis	 et	 al.	 2007).	 Overall,	 there	 were	many	 genes	 within	 the	 positively	 enriched	
adipogenesis	gene	set	related	to	mitochondrial	function.	As	fatty	acid	metabolism	and	multiple	





that	 morphologically,	 fibroblasts	 can	 be	 difficult	 to	 distinguish	 from	 preadipocytes	 (Ali	 et	 al.	
2013).	 Furthermore,	 dermal	 fibroblasts	 can	 be	 reprogrammed	 into	 adipocytes,	 either	 by	
overexpression	of	PPARG	(Tontonoz	et	al.	1994)	or	by	exogenous	adipogenic	induction	through	
cell	culture	(Marion	et	al.	2009).	With	this	knowledge	and	upregulation	of	proadipogenic	factors	
within	 this	 study,	 it	 is	 tempting	 to	 speculate	 that	 serum	 fed	 BBS	 fibroblasts	 exhibit	 a	 gene	
expression	signature	similar	to	differentiating	adipocytes.	Specific	markers	of	adipocytes,	such	as	
FABP4,	PEPCK,	CEBPA,	GLUT4,	and	LPL	(Moseti	et	al.	2016),	weren’t	detected	in	transcriptomic	
and	proteomic	data	 (supplemental	data,	 table	S.5,	 table	S.32),	and	 fibroblast	markers	 such	as	
fibroblast	specific	protein	1	(FSP1,	encoded	by	S100A4)	and	collagen	genes	(Strutz	et	al.	1995)	








predisposition	 to	 adipogenesis.	 Firstly,	 validation	 of	 markers,	 such	 as	 PPARG	 and	 LEP,	 in	
fibroblasts	 would	 be	 essential	 in	 a	 larger	 cohort	 to	 determine	 whether	 there	 is	 a	 significant	
increase	 in	 gene	 expression	 compared	 to	 controls.	 Secondly,	 it	 would	 be	 an	 interesting	
experiment	to	induce	differentiation	of	BBS	fibroblasts	into	adipocytes	and	serially	follow	gene	



















2011).	 GSEA	 revealed	many	 parallels	 between	 BBS	 starved	 vs	 fed	 and	 control	 starved	 vs	 fed	
cultures,	 demonstrating	 cellular	 similarities	 in	 regulation	 as	 a	 response	 to	 starvation.	 These	
included	 a	 highly	 significant	 negative	 enrichment	 of	 processes	 associated	with	 the	 cell	 cycle,	
including	mitotic	 spindle,	G2M	checkpoint,	 and	E2F	 targets,	 and	downregulation	of	other	 key	
pathways,	such	as	HH,	mTORC1,	hypoxia,	and	unfolded	protein	response.	Two	differences	were	
identified	 between	 BBS	 and	 control	 for	 starved	 vs	 fed	 comparisons,	 namely	myogenesis	 and	
inflammatory	response,	which	were	both	negatively	enriched	in	BBS	and	positively	enriched	in	
control	 experiments.	 Further	 elucidation	 is	 required	 to	 determine	 the	 significance	 of	 these	





analysis	was	 applied,	 PANTHER	enrichment	 test	 using	 the	Reactome	pathways	 database.	 This	
identified	that	“ciliary	part”	was	upregulated	in	BBS	starved	vs	fed,	but	“assembly	of	the	primary	
cilium”	was	downregulated	 in	 control	 starved	 vs	 fed.	As	 serum	 starvation	 intended	 to	 induce	
ciliary	 assembly,	 it	 was	 unexpected	 that	 this	 pathway	 was	 downregulated	 in	 controls,	 and	















statistical	 bias	 created	 by	 analysing	 a	 larger	 patient	 than	 control	 group.	 This	 was	 a	 known	
limitation	of	the	study	design,	and	was	not	possible	to	overcome	due	to	limited	access	to	control	
material	at	the	time	of	conducting	experiments.	However,	one	may	be	able	to	infer	differences	if	
seen	 in	 the	 control	 group	 and	 not	 patients.	 10	 genes	 that	 interacted	 within	 the	 complex	 of	
transition	zone/centrosome	were	downregulated	in	control	and	not	in	the	BBS	experiment.	These	




and	centrosome	 integrity.	HAUS3,	HAUS6,	and	HAUS8	 form	a	complex	 responsible	 for	mitotic	
spindle	generation	and	cytokinesis	(Uehara	et	al.	2009;	Lawo	et	al.	2009).	The	complex	localises	
to	 interphase	centrosomes	and	 regulates	 the	 formation	of	mitotic	 spindles.	Deletion	of	HAUS	
subunits	 was	 shown	 to	 result	 in	 delayed	 attachment	 of	 microtubules	 to	 kinetochores	 and	
diminished	 centrosome	 integrity	 (Lawo	 et	 al.	 2009;	 Uehara	 et	 al.	 2009).	 CKAP5	 also	 plays	 an	






molecular	 scaffold	 to	orchestrate	 the	 interaction	between	PLK4	and	CENPJ	 (Cizmecioglu	et	al.	
2010),	both	of	which	are	also	 involved	 in	centrosome	duplication	and	were	downregulated	 in	











which	 prevents	 premature	 ciliogenesis	 (Spektor	 et	 al.	 2007).	 KIF24	mediates	 this	 process	 by	
ensuring	destabilisation	of	microtubules	at	 the	mother	centriole,	 to	prevent	nucleation	of	 the	
basal	 body	 (Kobayashi	 et	 al.	 2011).	 Furthermore,	 upon	 re-entry	 into	 the	 cell	 cycle,	 KIF24	 is	
upregulated	to	stimulate	depolymerisation	of	microtubules	at	the	basal	body,	a	process	driven	
by	 the	kinase,	NEK2	 (S.	Kim	et	al.	2015).	Thus,	cilia	assembly	 is	 induced	by	 inactivation	of	 the	
CCP110-CEP97	complex	and	KIF24,	via	phosphorylation	by	kinases,	such	as	TTBK2	(Čajánek	and	
Nigg	2014).	Downregulation	of	CEP97	and	KIF24	is	therefore	a	logical	finding	for	cells	stimulated	
for	 ciliogenesis	 by	 serum	 starvation.	 Interestingly,	 CCP110	 is	 significantly	 upregulated	 in	 BBS	
starved	vs	fed.	The	fact	that	CCP110,	CEP97,	and	KIF24	expression	is	reduced	or	opposite	to	what	























PANTHER	 enrichment	 testing	 was	 used	 to	 simplify	 the	 data	 and	 categorise	 DE	 proteins	 into	
biological	 groups.	Out	of	18	pathways	 from	 the	Reactome	database	 shown	 to	be	 significantly	
enriched,	5	were	recognised	as	being	involved	in	the	regulation	or	maintenance	of	the	primary	
cilium,	namely	“assembly	of	the	primary	cilium”,	“hedgehog	‘off’	state”,	“RHO	GTPase	effectors”,	
“centrosome	 maturation”,	 and	 “cytoskeletal	 regulation	 by	 RHO	 GTPases”.	 The	 DE	 proteins	
enriched	 for	 these	 pathways	 were	 predicted	 by	 pathway	 topology	 mapping	 to	 be	 highly	
interconnected.	It	was	then	considered	how	BBS1	and	its	interacting	partners	were	incorporated	
into	the	network,	with	the	postulation	that	the	BBS1	p.M390R	variant	was	driving	the	pathways	










with	 unusual	 presentation	 featuring	 situs	 inversus	 and	 insertional	 polydactyly,	 in	 addition	 to	
visual,	renal,	endocrine,	and	cognitive	phenotypes	(Marion,	Stutzmann,	et	al.	2012).	These	BBS-
like	 features	were	 shown	 to	be	 caused	by	defective	 regulation	of	 SMO,	as	 loss	of	 function	of	
LZTFL1	resulted	in	increased	SMO,	PTCH1,	and	GLI2	expression	(Marion,	Stutzmann,	et	al.	2012).	
Within	the	present	study,	SMO	was	classified	to	function	within	the	“HH	‘off’	state”,	due	to	the	




2010).	 To	determine	whether	 “HH	 ‘off’	 state”	 is	 a	 true	 finding,	 it	 is	 crucial	 to	understand	 the	
localisation	of	proteins,	such	as	SMO	and	the	proteasome;	information	that	mass	spectrometry	
cannot	provide.	Localisation	of	some	proteins	determines	their	function.	For	example,	if	SMO	has	
accumulated	 in	 the	 cytoplasm	 of	 the	 cell,	 then	 this	 induces	 processing	 of	 repressor	 GLIs.	
However,	 SMO	 localises	 to	 the	 ciliary	membrane	upon	binding	of	HH	 ligand	 to	PTCH1,	which	
activates	GLIs	and	triggers	downstream	HH	pathways	(Rohatgi	et	al.	2007;	Goetz	and	Anderson	







BBS1	was	also	 interconnected	 to	 the	network	via	direct	 interaction	with	RABIN8	 (encoded	by	
RAB3IP),	which	 is	 a	guanine	nucleotide	exchange	 factor	 (GEF)	 required	 for	activation	of	RAB8	
(Hattula	 et	 al.	 2002).	 The	 interaction	 of	 the	 BBSome,	 RABIN8,	 and	 RAB8	 is	 crucial	 for	 the	
mediation	of	vesicle	docking	and	fusion	to	the	ciliary	membrane	(Nachury	et	al.	2007;	Jin	et	al.	




for	cilia	assembly,	knockdown	of	BBS1	 resulted	 in	 reduction	of	cilia	on	RPE	cells	 (Loktev	et	al.	
2008;	Jin	et	al.	2010).	This	evidence	suggests	that	the	interaction	between	RABIN8	and	BBS1,	but	
not	other	components	of	the	BBSome,	is	necessary	for	cilia	assembly	(Nachury	et	al.	2007;	Jin	et	
al.	 2010).	 Within	 the	 network,	 the	 connection	 with	 RABIN8	 links	 BBS1	 to	 components	 of	
“centrosome	maturation”	and	“assembly	of	the	primary	cilium”,	such	as	CEP290,	OFD1,	EXOCs,	
























main	 finding	 is	 that	 BBS1	 interacts	 indirectly	 with	 members	 of	 5	 pathways	 related	 to	 ciliary	
function,	that	were	statistically	positively	enriched	 in	starved	BBS	vs	control	experiments.	This	
occurs	 through	 direct	 interaction	 with	 SMO	 or	 RABIN8.	 As	 a	 result,	 a	 new	 hypothesis	 was	
developed	stating	that	the	observed	upregulation	of	the	components	in	the	presented	pathways	
are	due	to	reduced	function	of	BBS1,	caused	by	harbouring	the	variant	p.M390R.	This	may	be	




this	 hypothesis,	 as	 a	 greater	 number	 of	 upregulated	 transcripts	 for	 “assembly	 of	 the	 primary	






Statistical	 enrichment	 tools,	 such	 as	 GSEA	 and	 PANTHER	 used	within	 this	 chapter,	 addressed	
limitations	of	other	pathway	analyses,	such	as	overrepresentation	testing,	by	not	restricting	the	
data	by	p-value	thresholds	(Khatri	et	al.	2012).	 In	the	enrichment	tests,	genes	are	not	treated	
equally	but	 ranked	by	 a	metric,	 such	as	 log2(FC)	used	 in	 this	 study.	Although	a	more	 reliable	
analysis	than	overrepresentation	testing,	there	are	limitations.	It	is	commonly	understood	that	a	
gene	or	a	complex	of	genes	can	function	in	multiple	different	pathways;	however,	enrichment	
testing	 considers	 each	 pathway	 independently.	 For	 example,	 the	 proteasome	 is	 a	 negative	
regulator	 of	 multiple	 cellular	 processes,	 including	 Wnt	 signalling,	 HH	 signalling,	 cell	 cycle,	
apoptosis,	and	cancer	associated	pathways	(Adams	2003;	Malicki	and	Johnson	2017).	Therefore,	








Gene	 enrichment	 analysis	 is	 well	 complemented	 by	 pathway	 topology	 mapping,	 as	 it	
demonstrates	 how	 pathways	 are	 interconnected	 and	 cross-talking.	 As	 demonstrated	 in	 this	
thesis,	 it	 also	 allows	 identification	 of	 complexes	 that	 are	 up	 or	 downregulated,	 or	 that	 are	
contributing	the	most	to	significant	enrichment.	The	utility	of	topological	analysis	relies	on	well	
characterised	pathways,	where	 some	 interactions	will	 be	more	 comprehensively	 studied	 than	
others.	For	example,	within	the	STRING	database,	interactions	involved	in	cilium	assembly	were	
extensively	 documented	 by	 experimental	 data	 or	 in	 curated	 databases.	 On	 the	 other	 hand,	








Data	 used	 to	 create	 gene	 sets	 and	 pathways	 are	 typically	 generated	 from	 gene	 expression	
experiments	implemented	by	different	labs	under	different	conditions,	often	with	different	cell	
types	(Khatri	et	al.	2012).	Although	most	databases	have	been	manually	curated	to	ensure	gene	























genes.	 One	 reason	 for	 fewer	 significant	 differences	 between	 biological	 groups	 is	 likely	 to	 be	





In	 total,	14,573	protein-coding	 transcripts	and	6,683	proteins	were	detected	 from	fibroblasts,	
generating	a	46%	rate	of	protein	detection	 for	expressed	genes.	This	 is	a	high	detection	 rate,	
which	can	be	attributed	to	the	reduced	sample	complexity	achieved	by	separating	samples	into	
20	 peptide	 fractions	 each.	 On	 the	 other	 hand,	 many	 BBS	 proteins,	 including	 BBS1	 and	 its	
interactors,	were	not	detected	by	iTRAQ	proteomics.	This	may	be	due	to	the	low	expression	levels	
of	these	genes	in	fibroblasts	(for	example,	RAB3IP	mean	log2CPM=	1.77;	BBS1	mean	log2CPM=	




was	not	 realistic	 to	obtain	 for	 this	project,	due	 to	 the	expense	of	 fractionation	and	extensive	
instrument	running	time	required	for	the	number	of	samples	used.	Furthermore,	sample	pooling	


























key	modulators	of	ciliogenesis,	 including	 those	 involved	 in	cilium	assembly,	actin	cytoskeleton	
remodelling,	and	HH	signalling.	 I	have	hypothesised	that	this	upregulation	may	be	an	effect	of	
reduced	affinity	of	BBS1	with	 its	 interactors,	such	as	SMO	or	RABIN8,	caused	by	the	p.M390R	
variant.	 Firstly,	 this	 finding	 would	 need	 to	 be	 validated	 in	 a	 larger	 sample	 size	 to	 determine	
whether	 this	 collective	upregulation	 is	 reproducible.	Next,	 it	would	be	 interesting	 to	establish	

















































(figure	6.1).	The	surface	ectoderm	 invaginates	and	separates	 to	 form	the	 lens,	 leaving	behind	
what	then	becomes	the	cornea	and	the	epithelial	layers	at	the	front	of	the	eye.	Simultaneously,	
the	 neural	 ectoderm	 forms	 from	 the	 optic	 vesicle,	 an	 outgrowth	 of	 the	 neural	 tube,	 which	
invaginates	 to	 form	 the	 optic	 cups,	 comprised	 of	 the	 neural	 retina	 (NR),	 retinal	 pigmented	
epithelial	 (RPE)	 cells,	 and	 other	 epithelial	 layers	 continuous	 with	 the	 retina.	 The	 periocular	
mesenchyme	 is	 a	 population	 of	 neural	 crest	 cells	 that	 differentiate	 into	 cells	 responsible	 for	













retina	 (figure	 6.2).	 In	 vivo,	 this	 phenomenon	 is	 orchestrated	 by	 the	 surface	 ectoderm,	which	
secretes	 fibroblast	 growth	 factors,	 FGF1	 and	 FGF2	 (Horsford	 et	 al.	 2005).	 The	 RPE	 has	 a	
fundamental	role	in	maintaining	and	supporting	the	cells	within	the	retina	(Marmorstein	et	al.	











the	 sensory	 photoreceptors	 reside;	 the	 inner	 nuclear	 layer,	 represented	 by	 the	 processor	
interneurons	 called	horizontal,	bipolar,	 and	amacrine	cells;	 and	 the	 retinal	 ganglion	cell	 layer,	









than	 its	 cone	 counterpart	 (Luo	 et	 al.	 2008)),	 which	 is	 detected	 by	 the	 only	 visual	 pigment	
expressed	 in	 these	 cells,	 called	 rhodopsin.	 Conversely,	 cone	 photoreceptors	 are	 receptive	 to	
conditions	of	bright	light,	in	addition	to	providing	visual	acuity	and	colour	perception.	Cones	are	
accountable	for	trichromatic	vision,	as	each	cone	cell	expresses	one	of	three	visual	pigments;	S-









transcription	 factor	 NRL.	 By	 Fwk	 11-12,	 markers	 indicative	 of	 functionality	 appear,	 such	 as	
recoverin	(encoded	by	RCVRN),	CRX,	and	 IRBP.	 It	 is	not	until	Fwk	15	that	proteins	essential	for	
photosensitivity,	 including	 rhodopsin,	 emerge	 (Hendrickson	 et	 al.	 2008).	 Conversely,	 cone	
photoreceptors	start	to	materialise	at	fwk	8,	with	S-opsin	expressing	from	fwk	11,	which	is	earlier	









disorders	 in	 humans	 with	 over	 250	 genes	 identified,	 with	 a	 prevalence	 of	 around	 1	 in	 3000	
(Hartong	 et	 al.	 2006;	Wright	 et	 al.	 2010).	 The	 largest	 category	 of	 gene	mutations	 that	 cause	
photoreceptor	degeneration	are	involved	in	ciliary	trafficking,	accounting	for	20%	of	these	250	










rich	 inner	 segment	 and	 the	 photosensitive	 outer	 segment.	 The	 outer	 segment	 is	 a	 dynamic	













The	presence	of	 the	cilium	 in	 the	photoreceptor	means	 that	 the	outer	 segment	behaves	as	a	







that	 run	 perpendicular	 to	 the	 axoneme	 (Wolfrum	 and	 Schmitt	 2000;	 Smith	 et	 al.	 2013).	 The	
connecting	 cilium	 is	 also	 required	 for	 cell	 maintenance,	 as	 well	 as	 retrograde	 transport	 of	
intraflagellar	transport	(IFT)	machinery	(Krock	et	al.	2009).	Although	very	similar	in	structure	to	
the	standard	primary	cilium,	the	connecting	cilium	is	essentially	the	structural	equivalent	to	the	
transition	 zone	 of	 primary	 cilia	 on	 other	 cell	 types	 (Mykytyn	 et	 al.	 2004;	 Pazour	 et	 al.	 2002).	
Through	 this	organelle,	 the	 turnover	of	proteins	must	be	efficient	and	well	organised	as	each	
minute	 an	 estimated	 2000	 opsin	molecules	 are	 transported	 to	 the	 outer	 segment	 through	 a	




Evaluation	of	 ciliopathy	 in	 vivo	models	 can	provide	an	 insight	 into	 the	pathobiology	of	 retinal	
degeneration	when	IFT	 is	disrupted.	Aberrant	anterograde	IFT	 in	mice,	 induced	through	knock	
out	of	Kif3a,	led	to	complete	mislocalisation	and	accumulation	of	key	phototransduction	proteins	
in	the	inner	segment,	ultimately	resulting	in	progressive	photoreceptor	death	(Marszalek	et	al.	
2000).	 Many	 groups	 have	 recapitulated	 this	 study	 with	 disruption	 of	 other	 principle	 IFT	
components,	such	as	IFT88	(Pazour	et	al.	2002),	IFT122	(Boubakri	et	al.	2016;	Keady	et	al.	2011;	
Ross	et	al.	2005;	Kulaga	et	al.	2004),	and	IFT20	(Keady	et	al.	2011).	Although	this	shows	a	clear	
link	 with	 IFT	 function,	 the	 BBS	mouse	model	 shows	 that	 regulation	 of	 vesicle	 trafficking	 and	
entry/exit	to	IFT	has	an	impact	on	photoreceptor	structure	and	degeneration.	For	example,	the	
Bbs6-/-	mouse	shows	a	progressive	loss	of	photoreceptors	where	onset	starts	at	3	weeks	of	age	
and	 continues	 until	 total	 loss	 of	 the	 outer	 segment	 by	 26	 weeks	 of	 age	 (Ross	 et	 al.	 2005).	
Additionally,	 transmission	 electron	 microscopy	 (TEM)	 shows	 structural	 disorganisation	 and	
fragmentation	of	outer	segments	at	13	weeks	of	age	(Ross	et	al.	2005).	This	pattern	is	mimicked	
in	the	Bbs1-/-,	Bbs2-/-,	Bbs4-/-,	and	Bbs1M390R/M390R	knock-in	mice	(Nishimura	et	al.	2004;	Mykytyn	et	














BBSome	 interactor	 Rab8	 docks	 and	 fuses	 with	 rhodopsin-bearing	 vesicles,	 thus	 providing	 a	
functional	 link	between	rhodopsin	and	the	BBSome	(Moritz	et	al.	2001).	Furthermore,	a	study	
featuring	a	BBS4-/-	mouse	found	that	even	as	early	as	2	weeks	of	age	mislocalised	opsin	proteins	
were	 seen	 and,	 to	 a	 lesser	 extent,	 some	 apoptotic	 nuclei	 (Abd-El-Barr	 et	 al.	 2007).	 They	
hypothesised	 that	 since	 the	 quantity	 of	 mislocalised	 proteins	 was	 greater	 than	 the	 latter,	
apoptosis	must	 succeed	 this	 aberrant	 localisation,	 and	 thus	 photoreceptor	 death	 occurs	 as	 a	
consequence	of	defectively	trafficked	proteins.		
	
Datta	 et	 al.	 (2015)	 have	 suggested	 that	 the	 cause	 of	 photoreceptor	 death	 is	 not	 due	 to	
mislocalisation	of	phototransduction	proteins,	but	of	aberrant	protein	localisation	to	the	outer	
segment	 (Datta	 et	 al.	 2015).	 In	 contrast	 to	 other	 studies,	 they	 found	 that	 rhodopsin	 did	 not	






of	 the	 photoreceptors,	 and	 the	 BBSome	 functions	 to	 prevent	 entry	 of	 non-outer	 segment	
proteins	to	the	outer	segment	(Datta	et	al.	2015).	
	
Although	 a	 great	 deal	 of	 focus	 has	 been	 dedicated	 to	 researching	 the	 role	 of	 anterograde	
transport	in	photoreceptor	degeneration,	the	process	of	retrograde	transport	has	received	less	
interest.	 It	 is	generally	accepted	that,	due	to	the	 large	turnover	of	the	photoreceptor	through	
shedding	vesicles	at	its	distal	tip,	damaged	proteins	are	removed	and	do	not	need	shuttling	back	
to	 the	cell	body	 (Insinna	and	Besharse	2008).	Additionally,	 some	proteins,	 such	as	 transducin,	
require	 ultra-rapid	movement	 from	 the	 outer	 segment	 to	 the	 inner	 segment,	 and	 can	 do	 so	
passively,	 without	 the	 need	 for	 IFT	 (Sokolov	 et	 al.	 2002).	 Nevertheless,	 knock	 down	 of	 the	






not	 for	 phototransduction	 proteins.	 However,	 the	 build-up	 of	 IFT	 proteins	 alone	 could	 be	
responsible	for	cell	stress	and	ultimately	apoptosis.		
	
One	 aspect	 that	 is	 particularly	 reproducible	 in	 ciliopathy	 retinopathy	 models	 is	 the	 highly	




in	 the	 inner	 segment,	 Mockel	 et	 al.	 shows	 that	 the	 unfolded	 protein	 response	 (UPR)	 is	
upregulated	in	Bbs12	depleted	retina	(Mockel	et	al.	2012).	This	is	a	mechanism	that	is	initiated	
due	to	stress	on	the	endoplasmic	reticulum	caused	by	protein	misfolding,	and	aims	to	restore	
homeostasis	 to	 the	 cell.	 If	 cellular	 balance	 is	 not	 reinstated,	 apoptosis	 is	 activated.	 Indeed,	
inhibition	of	certain	players	in	the	UPR,	such	as	a	caspase12	inhibitor	(INH)	or	BiP	agonist	valproic	















As	previously	described,	 the	development	of	 the	mammalian	eye	 is	a	complex	process,	which	
requires	 the	 coordination	 of	 multiple	 events	 to	 occur	 at	 precise	 time	 points.	 The	 idea	 of	
generating	 an	 eye	 in	 vitro	 therefore,	 may	 seem	 far-fetched	 and	 futuristic.	 In	 recent	 years	































exhibited	 a	 response	 to	 the	 light	 stimulus.	 What	 is	 surprising	 about	 this	 particular	
accomplishment	 is	 that	 unlike	 other	 labs,	 this	 protocol	 did	 not	 add	 exogeneous	 agonists	 or	
antagonists	 to	 their	 culturing	 system.	 The	 phenomenon	 of	 retinal	 cup	 formation	 occurred	












There	 are	 clear	 advantages	 to	 using	 a	model	 developed	 from	patient-derived	 iPSCs.	 For	 one,	
retinal	 tissue	 from	 BBS	 patients	 is	 inaccessible,	 unless	 obtained	 post-mortem,	 and	 thus	 the	
patient’s	degenerative	progression	cannot	be	investigated	in	vivo.	Therefore,	iPSC	derived	optic	
cups	can	be	used	to	interrogate	the	pathobiology	of	rod-cone	dystrophy,	specifically	investigating	
whether	 there	 is	an	underlying	developmental	defect	or	a	 light	stimulus	 is	 required	 to	 induce	




















developed.	 To	 determine	 whether	 differentiation	 followed	 the	 same	 course	 as	 in	 vivo	
development,	key	gene	markers	were	assayed	 for	expression	at	8	 time	points	 throughout	the	






iPSCs	 derived	 from	 patient	 BBS001	 differentiated	 well	 into	 mature	 optic	 cups.	 Immuno-
histochemical	 staining	 exhibited	 a	 well	 organised	 structure	 of	 retinal	 cells,	 expression	 of	












iPSC	 lines	 were	 reprogrammed	 from	 patient	 fibroblasts	 by	 the	 HipSci	 laboratories	 at	 the	
Wellcome	Trust	Sanger	Institute.	Following	the	popularisation	of	stem	cell	culturing,	there	have	
been	 a	myriad	of	 culturing	 systems	 released	 for	 research	use,	 such	 as	 different	matrices	 and	
media.	The	lines	obtained	from	HipSci	were	feeder-free	and	utilised	the	E8	media	with	vitronectin	
matrices.	This	culturing	system	was	adopted	and	maintained	throughout	iPSC	culturing.	The	key	
















the	 presence	 of	 the	 reference	 genotype	 in	 control	 lines,	 CTRL037	 and	 CTRL038.	 Similarly,	
sequencing	affirmed	the	mutation	in	all	three	BBS	patient	lines,	derived	from	patients	BBS008,	









		 iPSC	line	ID	 Donor	age	 Donor	sex	 Genotype	allele	1	 Genotype	allele	2	
Patient	 BBS001	 30-34	 Female	 BBS1	p.M390R	 BBS1	p.M390R	
Patient	 BBS007	 40-44	 Male	 BBS1	p.M390R	 BBS1	p.M390R	
Patient	 BBS008	 35-39	 Male	 BBS1	p.M390R	 BBS1	p.M390R	
Control	 CTRL037	 65-69	 Male	 Reference	 Reference	



















was	 therefore	 imperative	 that	 a	 reliable	 housekeeping	 gene	 was	 established	 that	 remained	
consistently	 expressed	 over	 the	 differentiation	 time	 frame.	 In	 order	 to	 determine	 a	 suitable	
housekeeping	gene,	cDNA	was	obtained	from	mRNA	extracted	from	the	patient	BBS001	line	at	
day	0,	6,	16,	37,	60,	98,	and	124	after	 initial	differentiation.	Six	commonly	used	housekeeping	

































differentiations	 followed	 the	 correct	 gene	 expression	 patterns	 and	morphology	 at	 a	 suitable	
frequency	 so	 that	 samples	 could	 be	 taken	 for	 analysis	 throughout.	 One	 particular	 line,	 from	
patient	 BBS001,	 differentiated	 accordingly,	 mimicking	 gene	 expression	 of	 both	 in	 vivo	
development	and	other	published	protocols	(Meyer	et	al.	2009;	Zhong	et	al.	2014;	Parfitt	et	al.	


































media	 (NIM),	 which	 contained	 N2	 supplementation.	 This	 media	 was	 designed	 to	 encourage	































(RDM)	 containing	 B27	 supplementation.	 B27	 has	 been	 shown	 to	 promote	 neural	 progenitor	
differentiation	 and	 facilitate	 development	 of	 phototransduction	 machinery	 (Mellough	 et	 al.	
2012).	 Switching	 to	 RDM	 encouraged	 differentiation	 towards	 a	 retinal	 progenitor	 fate	 and	
initiated	expression	of	markers	that	distinguish	the	optic	vesicle.		
	



































Concordantly,	 it	 was	 important	 to	 assess	 the	 presence	 of	 these	 two	 genes	 during	 the	
development	 of	 the	 neural	 retina.	 RT-PCR	 analysis	 showed	 VSX2	 and	MITF	 expression	 was	






















et	 al.	 2014).	 The	 putative	 expression	 and	 localisation	 of	 photoreceptor	 precursor	 cells	 was	
investigated	 through	 analysis	 of	 two	 photoreceptor	 specific	 genes,	CRX	 and	RCVRN.	CRX	 is	 a	
transcription	 factor	 specific	 to	 rod	 and	 cone	 photoreceptor	 precursors	 and	 is	 key	 for	 the	
prospective	expression	of	phototransduction	proteins.	Failure	to	express	CRX	in	mice	in	vivo	leads	
to	lack	of	outer	segments	and	subsequent	photoreceptor	degeneration	(Furukawa	et	al.	1999;	
Swaroop	 et	 al.	 2010).	RCVRN	 encodes	 a	 phototransduction	 protein,	 Recoverin,	 that	 precedes	
expression	of	opsins	 in	development	of	the	fetal	retina	(Hendrickson	et	al.	2008).	This	pattern	




































Within	 patient	 BBS001,	 immunohistochemistry	 specific	 for	 recoverin	 at	 day	 98	 mimicked	
expression	 seen	 for	 Parfitt	 et	 al.	 Furthermore,	 CRX	 was	 also	 expressed	 in	 cells	 expressing	
recoverin,	demonstrating	that	the	majority	of	CRX-	and	RCVRN-positive	cells	were	concentrated	
in	the	outer	nuclear	layer	(Figure	6.12	C-D).	By	day	198,	limited	expression	of	phototransduction	
proteins,	 rhodopsin	 and	 cone	 arrestin	 was	 detected	 (figure	 6.12	 E-F).	 In	 comparison	 to	 the	













































from	 CTRL037	 and	 BBS008	 that	 differentiated	 with	 the	 most	 successful	 morphology	 and	
investigated	further	by	qPCR.	Since	BBS001	followed	the	correct	morphology	and	temporal	gene	








CI=	 2.70,	 3.25;	 CTRL037	 vs	 BBS008	 p=	 0.0129).	 In	 CTRL037,	 NANOG	 expression	 decreased	 as	
expected	 over	 the	 first	 16	 days,	 however,	 it	 remained	 significantly	 higher	 than	 BBS001	 and	
BBS008	over	this	period	(day	16:	CTRL037	∆CT	mean=	4.21,	95%	CI=	3.87,	4.57;	BBS001	∆CT	mean=	
6.75,	95%	CI=	6.28,	7.24;	CTRL037	vs	BBS001	p=	0.0011;	BBS008	∆CT	mean=	5.41,	95%	CI=	5.22,	








development	 of	 the	 retina.	 Expression	 for	 BBS008	 (green)	 and	 CTRL037	 (purple)	 were	 normalised	 to	
BBS001	 (red),	 allowing	 comparison	 across	 the	 differentiation	 process.	 All	 experiments	 were	 primarily	




from	day	0	 to	day	6	 (RX:	RFC=	137.6;	PAX6:	RFC=	166.96)	 (figure	6.13	B-C),	but	decreased	as	
differentiation	 continued	 through	 to	 day	 37,	 effecting	RX	 in	 particular	 (RX:	 RFC=	 34.1;	PAX6:	
RFC=393.10).	 Though	 there	 was	 reduced	 expression	 of	 RX	 and	 PAX6	 compared	 to	 BBS001,	




6.13D),	 VSX2	 (figure	 6.13E),	 CRX	 (figure	 6.13F),	 and	 RCVRN	 (figure	 6.13G).	 Within	 CTRL037	




mean=	10.03,	95%	CI=	9.08,	 10.98;	BBS001	∆CT	mean=	1.99,	 95%	CI=	0.75,	 3.22;	BBS008	∆CT	
mean=	 4.85,	 95%	 CI=	 3.30,	 6.41)	 (figure	 6.13	 B-C).	 These	 results	 would	 fit	 with	 personal	
observations	that	the	least	successful	line	for	differentiation	was	CTRL037,	which	concordantly	








The	 viable	 CTRL037	 and	 BBS008	 differentiations	were	 kept	 in	 culture	 until	 day	 147	 and	 160,	
respectively.	The	optic	cups	with	a	morphology	featuring	defined	NR	and	RPE	were	retained	for	
immunohistochemical	staining.	Both	CTRL037	and	BBS008	expressed	CRX	and	RCVRN	at	day	98	
and	day	 147,	 respectively	 (figure	 6.13	 F-G).	Overall,	 CTRL037	optic	 cups	 had	 a	 less	 organised	
structure	(figure	6.14	D-G)	and	showed	little	lamination	compared	with	BBS001.	Although	CRX	
and	RCVRN	were	detected	in	the	apical	layer	of	the	cup,	expression	was	sparse	and	disjointed	in	
places	 (Figure	 6.14	D-F).	 Conversely,	 BBS008	 showed	 a	well-ordered	outer	 nuclear	 layer	with	
consistent	CRX	and	RCVRN	expression	throughout	the	optic	cup	(Figure	6.14	A-B).	In	the	outer	























These	 experiments	 were	 conducted	 in	 BBS001	 derived	 optic	 cups	 collected	 at	 day	 198	 of	
differentiation.	
	
















































































Furthermore,	 in	 late	 stage	 differentiations	 spanning	 day	 147	 to	 day	 198,	 mature	







Moreover,	 the	neural	 retina	was	able	 to	 form	without	 the	presence	of	 the	surface	ectoderm,	
which	is	known	to	have	a	crucial	role	in	retinal	specification.	Zhong	et	al.	(2014)	hypothesise	that	













outer	segments	of	photoreceptors	 in	vivo	at	 fetal	week	18	 (Hendrickson	et	al.	2008).	 In	some	
cases,	disordered	tubulovesicular	structures	were	distinguishable	in	the	nascent	outer	segment.	







mutually	 beneficial	 to	 the	 other.	 The	 RPE	 is	 known	 to	 be	 essential	 for	 the	 development	 and	
maintenance	 of	 photoreceptors,	 but	 its	 direct	 role	 in	 maturation	 of	 the	 NR	 is	 not	 entirely	








However,	 it	 is	 known	 that	 during	 development	 in	 vivo,	 photoreceptors	 extend	 and	 elongate	
towards	 the	RPE	 (German	et	 al.	 2008).	 As	 a	 result,	 it	 is	 likely	 that	 outer	 segment	maturation	
cannot	occur	without	support	and	direct	contact	with	RPE	cells.	With	regards	to	functionality,	
efficient	 phototransduction	 and	maintenance	 of	 the	 visual	 cycle	 cannot	 occur	 without	 direct	
contact	between	photoreceptors	and	RPE.	Therefore,	adjustments	should	be	made	to	current	














Although	 it	 is	 generally	 thought	 that	BBS	patients	are	born	with	normal	 vision,	 it	 is	not	100%	












some	 IFT	 particles	 at	 the	 distal	 tips	 of	 the	 connecting	 cilia.	 These	 results	 indicate	 that	 active	
ciliogenesis	 was	 able	 to	 occur,	 which	 suggests	 that	 during	 development	 the	 BBSome	 allows	
normal	entry	into	the	connecting	cilium.	
	
Despite	 the	underlying	BBS1	mutation	 seen	 in	 this	 patient,	 the	differentiation	procedure	was	
consistent	with	in	vivo	development,	and	BBS	and	IFT	proteins	localised	correctly.	Therefore,	from	
the	experiments	conducted	in	this	study,	there	were	no	recognisable	BBS-specific	abnormalities	
discovered	 in	 these	developing	photoreceptors.	 This	observation	 is	 supported	by	 a	 functional	
study	by	Mockel	et	al.	(2012),	where	apoptosis	of	Bbs12-/-	photoreceptors	occurred	only	once	the	
outer	segments	had	differentiated	and	matured.	Accordingly,	I	would	surmise	that	in	general	BBS	





that	 visual	 degeneration	 is	 triggered	 by	 a	 light	 stimulus.	 In	 support	 of	 this,	 the	 BBSome	 has	
demonstrated	 some	 light	 sensitivity.	 BBS5	 has	 been	 shown	 to	 undergo	 phosphorylation	 in	
response	to	light	to	facilitate	arrestin	transport	(Smith	et	al.	2013)	and	BBS4	is	required	for	light-
dependent	 protein	 transport	 to	 the	 outer	 segment	 (Abd-El-Barr	 et	 al.	 2007).	 Encompassing	
evidence	 from	 my	 own	 and	 published	 studies,	 I	 present	 a	 model	 as	 the	 foundation	 of	
photoreceptor	degeneration	in	BBS	patients:	The	transportation	of	phototransduction	proteins	









Barr	 et	 al.	 2007;	Mockel	 et	 al.	 2012).	 This	 accumulation	 leads	 to	 stress	 on	 the	 endoplasmic	
reticulum	and	triggers	the	unfolded	protein	response	pathway	and	imminent	apoptosis	(Mockel	
et	al.	2012).	In	order	to	investigate	this	hypothesis	further,	I	would	need	to	conduct	light	response	





success	 rate	 was	 low	 and	 two	 lines	 failed	 to	 express	 key	 retinal	 genes	 entirely.	 Due	 to	 the	
irregularities	 between	 cultures	 being	 so	 great,	 comparison	 between	 lines	 for	 functional	





























day	 20	 in	 the	 control	 line	 CTRL038	 (supplemental	 data,	 movie	 S.1).	 The	 presence	 of	 this	





identical	 to	 ESCs,	 multiple	 reports	 have	 identified	 that	 iPSCs	 possess	 an	 epigenetic	 memory	
retained	from	their	host	cell	(Lister	et	al.	2011;	Kim	et	al.	2010;	Polo	et	al.	2010;	Hu	et	al.	2010).	
This	epigenetic	memory	can	be	transmitted	at	a	high	frequency	through	differentiation	and	affect	















and	 showed	 that	 the	 greatest	 variation	 factor	 in	 reprogrammed	 iPSCs	 was	 in	 fact	 genetic	
background	 from	 the	 donor	 (Kilpinen	 et	 al.	 2017).	 These	 differences	 were	 shown	 to	 affect	
pluripotency,	 cell	 morphology	 and	 importantly,	 differentiation	 capacity.	 Concordantly,	 in	 my	
experiments,	 large	 differences	 were	 noticeable	 in	 differentiation	 capacity	 between	 lines,	
irrespective	of	whether	they	were	BBS	patient-derived	or	from	healthy	control	 individuals.	For	







fibroblasts.	 The	 skin	 is	 typically	 prone	 to	 ultraviolet	 radiation	 exposure,	 which	 causes	 a	 high	
frequency	of	point	mutations	that	would	otherwise	be	absent	 in	germ	cells.	The	selection	and	
accumulation	 of	 somatic	 mutations	 occurs	 through	 reprogramming	 and	 passaging	 selection	
during	fibroblast	and	iPSC	culture	(Gore	et	al.	2011).	This	also	poses	problems	downstream	for	
therapeutic	uses	of	 iPSCs	and	introduces	the	need	for	high-throughput	functional	genomics	to	
identify	 detrimental	 or	 carcinogenic	 mutations	 before	 clinical	 use.	 The	 HipSci	 project	 have	
addressed	this	issue	by	implementation	of	genotyping	arrays	on	both	somatic	cells	and	iPSCs	prior	














ingredients,	 typically	obtained	 from	animal	 sera,	 such	as	albumin	and	Matrigel	 (Ludwig	and	A	
Thomson	2007).	As	a	result,	variability	across	cultures	grown	with	mTESR	can	be	substantial.	On	
the	 other	 hand,	 E8	 is	 nonxenogeneic	 and	 contains	 8	 essential	 ingredients	 that	 ensure	
pluripotency	and	cell	health,	whilst	controlling	for	variability.	Despite	the	benefits	of	iPSC	culture	
using	E8,	 there	have	 yet	 to	be	any	published	 reports	 that	have	used	E8	maintained	 iPSCs	 for	
differentiation.	Similarly,	no	studies	are	available	demonstrating	that	iPSCs	grown	on	vitronectin	
can	differentiate	successfully	to	a	neuroepithelial	lineage.	In	all	cases	in	the	literature,	a	Matrigel	
substrate	 is	 utilised	 for	 differentiation	 into	 neurospheres.	Matrigel’s	 efficiency	 is	 owing	 to	 its	






















3	 and	 4	 of	 differentiation	 (Reichman	 et	 al.	 2014).	 Additionally,	 introduction	 of	 FGF2	may	 be	






be	 to	 switch	 a	 6-well	 culture	 plate	with	 a	 96-well	 U-bottomed	 plate.	 This	 would	 allow	more	
precision	 and	 control	 over	 the	 development	 of	 each	 individual	 optic	 cup.	 Additionally,	 this	
technique	would	reduce	some	of	the	variability	caused	by	EB	agglomeration.	On	the	other	hand,	














there	 is	 much	 to	 accomplish	 before	 utilisation	 as	 a	 disease	 model.	 The	 greatest	 barrier	 to	











restraints,	 it	 was	 not	 possible	 to	 test	 BBS	 optic	 cups	 for	 functionality.	 For	 future	 work,	
demonstration	 of	 a	 light	 response	 may	 provide	 answers	 to	 the	 role	 of	 the	 BBSome	 in	
photoreceptors.	If	functionality	were	observed,	the	utility	of	the	optic	cups	could	be	invaluable	
to	 test	 therapeutics	 in	 a	patient	 specific	model.	 For	 example,	 gene	 therapy	models	 are	being	
developed	to	rescue	eyesight	in	BBS1M390R/M390R	knock-in	mice.	This	involves	injecting	a	functional	
gene	 copy	 packaged	 in	 Adeno-Associated	 Virus	 (AAV)	 vectors	 into	 the	 retina.	 Before	 use	 in	
patients,	 this	 therapy	would	 need	 to	 be	 optimised	 and	 validated	 in	 a	 patient-specific	model.	
Furthermore,	this	model	could	be	used	for	a	drug	screen	to	decelerate	the	loss	of	photoreceptors.	





2013;	Homma	et	al.	 2013;	 Lamba	et	al.	 2010;	Tucker	et	 al.	 2011).	 iPSCs	derived	 from	patient	












































































supported	 a	 previous	 study,	 which	 determined	 a	 similar	 finding	 with	 31	 ciliopathy	 patients	
(Shaheen	et	al.	2016).	Further	investigation	of	patients	with	BBS1	p.M390R	uncovered	that	they	
























completed	 to	 determine	 the	 reliability	 of	 these	 findings	 in	 a	 larger	 BBS	 cohort.	 Biomarker	
discovery	 hierarchy	 described	 by	 Rifai	 et	 al.	 (2006)	 indicates	 that	 verification	 should	 be	








Fibroblasts	 from	patients	 and	 controls	were	 investigated	under	 serum	 fed	and	 serum	starved	
conditions,	to	compare	differences	in	cell	cycling	and	ciliated	cells	(described	in	chapter	5).	To	
our	knowledge,	the	resulting	3-way	comparison	strategy	was	the	first	example	of	an	investigation	





Pathway	 analysis	 of	 RNA-seq	 genes	 uncovered	 discordant	 expression	 of	 centrosomal	 genes	
between	BBS	and	control	cells.	It	was	revealed	that	genes	involved	in	mitotic	spindle	nucleation,	
such	 as	 HAUS3	 and	 CEP152,	 were	 significantly	 downregulated	 in	 serum	 fed	 BBS	 cultures	
compared	to	controls.	This	may	suggest	a	disruption	of	mitotic	spindle	organization	or	cytokinesis	













into	 obesity	manifested	 by	 BBS	 patients.	 Although,	 individually	 genes	were	 rarely	 statistically	
significant,	GSEA	determined	that	the	collective	trend	was	significant.	Evaluation	of	the	individual	
genes	 and	 pathway	 topology	mapping	 identified	 that	 components	 predominantly	 involved	 in	
mitochondrial	 function	 were	 upregulated,	 which	 may	 suggest	 that	 the	 enrichment	 for	
adipogenesis	 was	 driven	 by	 unbalanced	 mitochondrial	 activity	 in	 BBS	 fed	 cells	 compared	 to	




Within	 this	 thesis,	 RNA-seq	 was	 analysed	 by	 looking	 at	 changes	 in	 gene	 expression	 and	
dysregulation	of	pathways	between	biological	groups.	However,	integration	of	RNA-seq	data	with	
genetic	variation	information	can	be	used	to	aid	analysis	of	the	genome.	For	example,	differences	
in	 gene	 expression	may	 be	 linked	 to	 regulatory	 variants,	 such	 as	 eQTLs,	 which	 influence	 the	
expression	level	of	genes	(Morley	et	al.	2004).	Although,	large	sample	sizes	are	required	for	eQTL	
association	 studies,	 this	project	 identified	 some	 interesting	 variants	 for	 further	 study,	 such	as	
RPGRIP1L,	which	was	 flagged	 in	 both	 the	 genetic	modifier	 and	 RNA-seq	 studies	 (discussed	 in	
chapter	 3	 and	 5,	 respectively).	 There	 were	 2	 qualifying	 variants	 in	 RPGRIP1L	 from	 the	 4-tier	










Within	 this	 thesis,	 it	was	demonstrated	 for	 the	 first	 time	 that	 iPSCs	derived	 from	BBS	patient	

















not	 tissue	 types	 that	 are	 known	 to	 exhibit	 BBS-specific	 phenotypes.	 Disease	 relevant	 tissues	
obtained	from	patients	may	be	a	more	valuable	source	of	biological	information,	such	as	renal	
progenitors	to	study	polycystic	kidney	disease,	hypothalamic	neurons	for	investigation	of	satiety	
response,	 or	 retina	 to	 model	 rod-cone	 dystrophy.	 These	 tissues	 are	 difficult	 to	 obtain	 from	
patients	for	research	purposes,	which	is	why	iPSCs	are	a	highly	valuable	resource.	A	future	project	
would	be	to	 implement	models,	such	as	BBS	patient-derived	optic	cups,	 in	a	multi-omic	study	
with	 the	 framework	 developed	 in	 this	 thesis.	 This	 would	 provide	 valuable	 insight	 into	 the	



























(described	 in	chapter	5).	 It	 is	possible	 that	 the	study	of	a	 loss	of	 function	mutation	may	have	
exhibited	a	greater	difference.	
	
As	 well	 as	 advancing	 our	 understanding	 of	 BBS1	 p.M390R	 pathobiology,	 this	 study	 has	
demonstrated	proof	of	 principle,	 and	ensured	optimisation	of	methodology	 and	expertise	 for	
future	experiments.	Increased	sample	size	has	already	been	discussed	as	a	limitation	throughout	






mutation	 found	 in	 BBS	 (Forsythe	 and	 Beales	 2013),	 present	 in	 ~145	 registered	 patients	 at	
Professor	 Beale’s	 clinics	 (Prof	 P.	 Beales,	 personal	 communication).	 It	 would	 be	 interesting	 to	
determine	whether	the	findings	of	this	study	were	specific	to	BBS1	p.M390R,	or	a	general	finding	
to	 BBS	 by	 comparison	 between	 these	 two	 genotypes.	 As	 a	 loss	 of	 function	 variant,	 I	 would	










AHI1	 BBS9	 EVC2	 NEK1	 SPATA7	 USH1C	
ARL13B	 BBIP1	 GLIS2	 NEK8	 TCTN1	 USH1G	
ARL6	 C2orf71	 GPR98	 NPHP1	 TCTN2	 USH2A	
ATXN10	 C8orf37	 HYLS1	 NPHP3	 TMEM138	 VHL	
B9D1	 CC2D2A	 IFT43	 NPHP4	 TMEM216	 WDPCP	
B9D2	 CCDC28B	 IFT80	 OFD1	 TMEM231	 WDR19	
BBS1	 CDH23	 IFT172	 PCDH15	 TMEM237	 WDR35	
BBS10	 CEP164	 INVS	 PKD2	 TMEM67	 XPNPEP3	
BBS12	 CEP290	 IQCB1	 PKHD1	 TOPORS	 ZNF423	
BBS2	 CEP41	 KIF7	 RPGR	 TRIM32	 		
BBS4	 DFNB31	 LCA5	 RPGRIP1	 TTC21B	 		
BBS5	 DYNC2H1	 MKKS	 RPGRIP1L	 TTC8	 		
BBS7	 EVC	 MKS1	 SDCCAG8	 TULP1	 		
Table	A.1	–	Genes	known	to	cause	nonmotile	ciliopathies,	referred	to	as	the	ciliopathy	panel.	
	
ADCY3	 CEP97	 HSPB11	 NEK4	 RPGR	 TRAPPC9	
AHI1	 CLDN2	 HTR6	 NEK8	 RPGRIP1	 TRIM32	
ALMS1	 CLUAP1	 HTT	 NGFR	 RPGRIP1L	 TRIP11	
ARF4	 CP110	 HYLS1	 NME5	 RTTN	 TTC12	
ARL13B	 CRB3	 IFT122	 NME7	 SASS6	 TTC21B	
ARL3	 CROCC	 IFT140	 NOTO	 SCLT1	 TTC26	
ARL6	 CTNNB1	 IFT172	 NPHP1	 SDCCAG8	 TTC30A	
ASAP1	 DCDC2	 IFT20	 NPHP3	 SEPT2	 TTC30B	
ATXN10	 DCDC2	 IFT27	 NPHP4	 SEPT7	 TTC8	
AZI1	 DFNB31	 IFT43	 OCRL	 SHH	 TTK	
B9D1	 DPYSL2	 IFT46	 ODF2	 SLC47A2	 TTLL3	
B9D2	 DRD1	 IFT52	 OFD1	 SMO	 TTLL6	
BBS1	 DRD2	 IFT57	 PARD3	 SNAP25	 TTLL9	
BBS10	 DRD5	 IFT74	 PARD6A	 SNX10	 TUBA1A	
BBS12	 DVL1	 IFT80	 PCDH15	 SPATA7	 TUBA1C	
BBS2	 DYNC2H1	 IFT81	 PCM1	 SPEF2	 TUBA4A	
BBS4	 DYNLT1	 IFT88	 PDE6D	 SSNA1	 TUBB2A	
BBS5	 DYX1C1	 INPP5E	 PDZD7	 SSTR3	 TUBB2B	
BBS7	 EVC	 INVS	 PHF17	 STIL	 TUBB3	
BBS9	 EVC2	 IQCB1	 PIBF1	 STK38L	 TUBE1	
BBIP1	 EXOC4	 KIF17	 PKD1	 STOML3	 TUBGCP2	
C21orf2	 EXOC5	 KIF19	 PKD1L1	 STX3	 TUBGCP3	
C2CD3	 EXOC6	 KIF24	 PKD2	 SUFU	 TUBGCP4	




C8orf37	 FAM161A	 KIF3A	 PLK1	 TBC1D30	 TUBGCP6	
CBY1	 FBF1	 KIF3B	 POC1A	 TBC1D7	 TULP1	
CC2D2A	 FLNA	 KIF3C	 PTCH1	 TCTN1	 TULP3	
CCDC28B	 FOPNL	 KIF7	 PTPDC1	 TCTN2	 USH1C	
CCDC37	 FOXJ1	 LCA5	 RAB11A	 TCTN3	 USH1G	
CCDC41	 FUZ	 LZTFL1	 RAB11FIP3	 TMEM138	 USH2A	
CDH23	 GLI1	 MAK	 RAB17	 TMEM216	 VHL	
CENPJ	 GLI2	 MAL	 RAB23	 TMEM231	 WDPCP	
CEP104	 GLI3	 MAPRE1	 RAB3IP	 TMEM237	 WDR19	
CEP135	 GLIS2	 MCHR1	 RAB8A	 TMEM67	 WDR35	
CEP164	 GPR161	 MDM1	 RABL5	 TNPO1	 WDR60	
CEP250	 GPR98	 MKKS	 RFX3	 TOPORS	 XPNPEP3	
CEP290	 GSK3B	 MKS1	 RILPL1	 TPPP2	 ZNF423	
CEP41	 HAP1	 MLF1	 RILPL2	 TRAF3IP1	 		
CEP72	 HNF1B	 NEK1	 RP1	 TRAPPC10	 		
CEP89	 HSPA8	 NEK2	 RP2	 TRAPPC3	 		
Table	A.2	–	Nonmotile	cilia	genes	from	the	SYSCILIA	gold	standard	version	1	gene	panel.	
	
PLEKHG5	 FGD4	 PIKFYVE	 IKBKAP	 DNMT1	 CARS	
KIF1B	 HSPB8	 SOD1	 SETX	 DYNC1H1	 NARS	
MFN2	 TDP1	 SOX10	 GJB1	 INF2	 IARS	
YARS	 SLC12A6	 RAB7A	 PRPS1	 TFG	 VARS	
NGF	 LITAF	 CCT5	 MED25	 HARS	 SARS	
LMNA	 KARS	 SH3TC2	 PMP22	 KIF1A	 EPRS	
NTRK1	 GAN	 FIG4	 TRPV4	 FAM134B	 SPTLC3	
MPZ	 SEPT9	 GARS	 AARS	 HK1	 GNB4	
EGR2	 CTDP1	 HSPB1	 LRSAM1	 RARS	 PDK3	
SBF2	 DNM2	 ARHGEF10	 MARS	 TARS	 		
BSCL2	 PRX	 GDAP1	 SPTLC2	 FARSA	 		
IGHMBP2	 DCTN1	 NDRG1	 ATP7A	 FARSB	 		







BBS001	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS002	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS003	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS004	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS005	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS006	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	




BBS008	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS009	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS010	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS011	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS012	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS013	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS014	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
BBS015	 Patient	genome	 WGS	batch	2	 Bardet-Biedl	Syndrome	
SRS002	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS003	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS005	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS006	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS008	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS009	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS011	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS012	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS014	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS015	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS017	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS018	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS020	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS021	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS023	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS024	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS026	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS027	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS029	 Control	genome	 WGS	batch	3	 Clinically	healthy	
SRS030	 Control	genome	 WGS	batch	3	 Clinically	healthy	
IBD001	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD002	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD003	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD006	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD007	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD010	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD011	 Control	genome	 WGS	batch	1	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD012	 Control	genome	 WGS	batch	3	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD016	 Control	genome	 WGS	batch	3	 Very	Early	Onset	Inflammatory	Bowel	Disease	
IBD018	 Control	genome	 WGS	batch	3	 Very	Early	Onset	Inflammatory	Bowel	Disease	
UCLG_502	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_518	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_520	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	




UCLG_508	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_511	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_512	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_513	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_514	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_519	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_521	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_522	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_524	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_525	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_506	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
UCLG_507	 Patient	exome	 WES	batch	3	 Bardet-Biedl	Syndrome	
PE_1	 Control	exome	 WES	batch	1	 Cleft	lip	and	palate	
PE_2	 Control	exome	 WES	batch	1	 Cleft	lip	and	palate	
PE_3	 Control	exome	 WES	batch	1	 Cleft	lip	and	palate	
PE_27	 Control	exome	 WES	batch	4	 Severe	Combined	Immunodeficiency	
PE_7	 Control	exome	 WES	batch	4	 Spina	Bifida	Occulta	
PE_8	 Control	exome	 WES	batch	4	 Spina	Bifida	Occulta	
PE_5	 Control	exome	 WES	batch	4	 Spina	Bifida	Occulta	
PE_4	 Control	exome	 WES	batch	4	 Spina	Bifida	Occulta	
PE_10	 Control	exome	 WES	batch	4	 Spina	Bifida	Occulta	
PE_11	 Control	exome	 WES	batch	4	 Spina	Bifida	Occulta	
PE_51	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_55	 Control	exome	 WES	batch	5	 Severe	Combined	Immunodeficiency	
PE_43	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_45	 Control	exome	 WES	batch	5	 Multiple	Congenital	Anomalies	
PE_40	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_42	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_36	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_38	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_37	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_37	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_49	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_53	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_52	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	
PE_54	 Control	exome	 WES	batch	5	 Congenital	Melanocytic	Naevus	










FGG	 VTN	 IGHG1	 PROS1	 C3	 TF	
FGA	 F2	 C1S	 IGHG2	 FN1	 C1QA	
FGB	 CLU	 APOE	 CFH	 SERPINA1	 HBA1	
ALB	 PON1	 ITIH4	 IGHA1	 HBB	 PLG	
APOA1	 C4B	 C1QC	 C1QB	 SERPINC1	 C1R	
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